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Abstract 
This thesis explores the value of including protective factors in the 
violence risk assessment and risk management processes of forensic 
mental health services.  More specifically it investigates whether 
assessment of protective factors improves predictive accuracy of violence 
risk assessment tools, and discusses the implications for clinical practice.  
The impact on patient motivation to change is also considered.  A critique 
is presented of the Historical Clinical Risk-20 Version 3 (HCR-20V3; 
Douglas, Hart, Webster, & Belfrage, 2013), one of the most popular and 
widely used violence risk assessment tools.  Despite its popularity and 
good measurable properties, the HCR-20V3 does not include an 
assessment of protective factors.  A systematic review examined 
research investigating the predictive accuracy of the three violence risk 
assessment tools recommended for use in forensic mental health services 
in the National Health Service: HCR-20V3, the Structured Assessment of 
Protective Factors (SAPROF; de Vogel, de Ruiter, Bourman, & de Vries 
Robbé, 2012), and the Short Term Assessment of Risk and Treatability 
(START; Webster, Martin, Brink, Nicolls, & Desmarais, 2004).  The 
SAPROF had superior predictive accuracy of absence of violence 
compared to the other measures; however, limited reliability and validity 
evidence was found for its use in English forensic inpatient settings.  An 
empirical research project conducted a prospective validation study of the 
SAPROF, also reporting on the reliability and validity of the measure 
across a number of domains, and in relation to the HCR-20V3 and START.  
The SAPROF demonstrated better absence of violence risk predictive 
abilities than the HCR-20V3 and the START (presence of violence risk); 
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combined use of the SAPROF and HCR-20V3 significantly increased 
predictive accuracy of presence of violence risk.  Finally, a single case 
study explores the impact of collaborative risk assessment and 
management training on a patient’s motivation to engage in treatment 
and interventions to manage risk.  Collaborative risk assessment had a 
positive impact on motivation; however it was not reliably or clinically 
significant.  This thesis provides positive research evidence for the 
inclusion of protective factors in the violence risk assessment and 
management process. 
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1.1. Introduction 
Violence risk assessment and risk management is a core 
component of forensic mental healthcare (Rogers, 2000).  To provide 
effective care clinicians need to be aware of the individual’s overall 
needs, and the level of risk they may pose towards others or to 
themselves (Department of Health; DoH 2007a).  Clinicians have a duty 
of care to reduce and manage any risks to assist in improving an 
individual’s quality of life and recovery (DoH, 2007a).  When violence risk 
is involved there is an additional duty of care towards other patients, 
professionals, and society as a whole (DoH, 2007a).  There is no widely 
accepted definition of violence.  For the purpose of this thesis the 
following definition, taken from the Historical Clinical Risk-20 Version 3 
(HCR-20V3), was applied:  ‘…actual, attempted, or threatened infliction 
of bodily harm of another person’ (Douglas, Hart, Webster, & Belfrage, 
2013, p. 2).  This includes both physical and serious psychological harm, 
and is consistent with the World Health Organisation’s definition of 
interpersonal violence (Krug, Dahlberg, Mercy, Zwi, & Lozano, 2002).  
Acts of collective violence committed during war, terrorism, or gang 
conflict are excluded.   
Decisions made about how to manage potential for violence should 
be based on ‘knowledge of the research evidence, knowledge of the 
individual patient and their social context, knowledge of the patient’s own 
experience, and clinical judgement’ (p. 7, DoH, 2007a).  This thesis aims 
to examine the research evidence for the inclusion of protective factors in 
the violence risk assessment and management process. 
 
16 
 
 
1.2. What is violence risk assessment and risk management? 
Effective treatment of offenders, including those with mental 
illness, is directed by the principles of risk, need, and responsivity (RNR 
model; Andrews, Bonta, & Hoge, 1990).  The principles allow 
interventions to be tailored to the patient’s individual risks, needs, and 
personal circumstances or conditions to most effectively reduce and 
manage risk (Andrews & Bonta, 2006).   
The ‘risk principle’ states that treatment should reflect the level of 
risk posed by the individual (Andrews & Bonta, 2006).  As such, high risk 
individuals should receive the most intense treatment, and lower risk 
individuals should be offered less intense treatment.  Risk can be defined 
as the likelihood, imminence, and severity of the occurrence of a negative 
event (DoH, 2007a).  The level of risk is usually determined by the 
completion of a risk assessment.  This identifies static (unchangeable) 
and dynamic (changeable) personal characteristics or circumstances 
which may lead to the negative event occurring (Kraemer, Kazdin, 
Offord, Kessler, Jenson, & Kupfer, 1997).  The definition of risk 
assessment adopted by Whittington and Logan (2011, p. 295) was 
applied for this thesis: ‘The process of gathering information via personal 
interviews, psychological/medical testing, review of case records, and 
contact with collateral informants, for use in making decisions pertaining 
to an individual’s risk and its most appropriate, effective, and 
proportionate prevention or minimization’.   
There are three main approaches to risk assessment: unstructured 
clinical judgement, actuarial, and structured professional (or clinical) 
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judgement (SPJ).  The unstructured clinical judgement approach relies on 
human decision making, and there are no guidelines regarding what 
information the clinician should include or discount (Dolan & Doyle, 
2002).  Decisions are based on the facts available, the clinician’s 
knowledge of the individual, and their intuition and instincts.  This 
information is combined with what the clinician feels is relevant to predict 
future violence (Mossman, 2004).  Some argue this approach is 
subjective, and it has been demonstrated to have low inter-rater 
reliability (Hart, 1998). 
In contrast, the actuarial method discounts clinical judgement 
(Hart, 1998), and instead decisions are made based on statistical 
methods, and empirically based risk factors related to violent behaviour 
(Doyle & Dolan, 2002).  This methodology increases reliability and 
objectivity (Heilbrun, Yasuhara, & Shar, 2010).  However, Mossman 
(2004) argues actuarial methods are flawed because they rely on static 
risk factors, and do not account for dynamic factors which could be 
related to treatment and supervision, resulting in over-prediction of 
future violence.   
The majority of violence risk assessment tools follow the SPJ 
approach (Douglas et al., 2013), and the DoH (2007a) recommend 
utilising a tool which follows this method.  The SPJ method is a shared 
approach using clinical judgement and actuarial methods, combining the 
strengths of each (Dolan & Doyle, 2002).  A final clinical judgement 
regarding the level of risk for future violence is made following 
consideration of a standardised, empirically-derived checklist of static and 
dynamic risk factors, clinical experience and knowledge of the patient, 
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and the patient’s own view of their experience (de Vries Robbe, de Vogel, 
& Stam, 2012).  This enables a risk formulation to be developed, where 
the clinician outlines what may trigger or heighten the risk, and what can 
be done to manage the risk.   
According to a recent international survey (Singh, Fazel, 
Gueorguieva, & Buchanan, 2014) the most commonly used SPJ violence 
risk assessment tools are the Historical Clinical Risk-20 (HCR-20V2; 
Webster, Douglas, Eaves, & Hart, 1997, and HCR-20V3; Douglas et al., 
2013), the Sexual Violence Risk-20 (SVR-20; Boer, Hart, Kropp, and 
Webster, 1997), the Spousal Assault Risk Assessment Guide (SARA; 
Kropp, Hart, Webster, and Eaves, 1999), and the Structured Assessment 
of Violence Risk in Youth (SAVRY; Borum, Bartel, and Forth, 2006). 
Risk management aims to prevent and reduce the likelihood of the 
negative event occurring, or at least minimise the level of potential harm 
(Andrews & Bonta, 2006).  This operates by working with the individual 
to suggest specific treatment targets, developing flexible strategies to 
manage risk factors (DoH, 2007a).  The ‘need principle’ states the most 
effective interventions and management plans are those which focus on 
the dynamic risk factors (Andrews & Bonta, 2006).  Dynamic risk factors 
are features of the individual’s environment and social situation, for 
example psychological vulnerabilities, substance use, and attitudes which 
increase their likelihood of risk.  Effective targeting of dynamic risk 
factors during treatment and risk management can result in a change in 
the level of risk, and reduce the likelihood of reoffending (Andrews & 
Bonta, 2006).     
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The ‘responsivity principle’ states treatment and interventions 
should be delivered in a way which is consistent with the individual’s 
strengths, for example their learning style, abilities, and personal 
circumstances (Andrews & Bonta, 2006).  It has been suggested 
treatment aimed at reducing risk of violence should focus on both 
reducing and managing risk factors, and building and maintaining 
protective factors (de Ruiter & Nicholls, 2011).  Rapp and Goscha (2006) 
report risk management is most effective when strengths and protective 
factors are recognised, and incorporated in management plans.  This 
approach has gained further vigour due to the introduction of positive 
intervention strategies such as the Good Lives Model (GLM; Ward & 
Stewart, 2003).  The GLM assumes that all individuals want to achieve a 
good life, and will do so by means which are most likely to help attain the 
positive outcome.  The approach promotes the use of pro-social methods 
of attaining these positive outcomes rather than previously used anti-
social methods. 
 
1.3. The emergence of protective factors 
The idea that risk factors need to be managed in order to reduce 
the likelihood of violence has been a longstanding principle (for example, 
Lombroso, 1887).  More recently it has been proposed protective factors 
should also be considered (de Vries Robbé, 2014).  De Ruiter and Nicholls 
(2011) state treatment to reduce violent reoffending should not only 
focus on reducing risk factors, but also on increasing and maintaining 
protective factors.  The personal resilience of individuals can be increased 
by developing personal strengths, and risk management strategies can 
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be enhanced by placing more emphasis on external and situational 
protective factors (de Vries Robbé, de Vogel, Koster, & Bogaerts, 2015).   
As yet there is no consensus as to how to define a protective 
factor, or how they work to reduce risk.  Rutter (1985) suggests that 
protective factors are variables within comparable groups of high risk 
individuals, some with positive behavioural outcomes and others with 
negative behavioural outcomes, which differ.  Others, for example 
Stattin, Romelsjo, & Stenbacka (1997), propose factors should only be 
considered protective if they reduce the problem behaviour when the risk 
is high, but have no influence when the risk is low.  Jessor, Turbin, Costa, 
Dong, Zhang, and Wang (2003) have suggested protective factors may 
result in a low probability of violence in general (direct positive effect), 
and a low probability of violence despite the presence of high risk 
(mediating effect on the relationship between risk factors and violence).  
It is also suggeted protective factors can help individuals to endure 
difficult circumstances without becoming violent (increase resilience), and 
help those who have previously engaged in violent behaviour to desist 
(de Vries Robbé, 2014).  For the purpose of the thesis the definition of 
protective factors as described by de Vogel, de Ruiter, Bouman, and de 
Vries Robbé (2012) was adopted: ‘any characteristic of a person, his or 
her environment or situation which reduces the risk of future violent 
behaviour’ (p. 23).  This is because this is the definition used in the 
Structured Assessment of Protective Factors for violence risk (SAPROF; 
de Vogel et al., 2012) manual. 
Research in mental health has identified a wide range of protective 
factors at the individual, family, and community levels which prevent 
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unfavourable outcomes from occurring (de Vries Robbé, 2014).  
According to Lösel (2001) protective factors in children and adolescents 
can include biological features, temperament characteristics, cognitive 
competencies, childrearing and attachment, school achievement and 
bonding, peer groups and social networks, self-related and social 
cognitions, and neighbourhood and community factors.  A review into the 
development of youth violence found protective effects of various factors 
at the individual, family, school, peer, and neighbourhood levels (Lösel & 
Farrington, 2012).  However, there has been limited focus on protective 
factors in violent adults, and what promotes desistance from their further 
violent offending (for example, Ullrich & Coid, 2011).   
 
1.4. Protective factors in violence risk assessment 
The best evaluations of violence risk can only explain a moderate 
amount of variance (Lösel, 2001).   Violence risk assessment tools 
traditionally focus on the assessment of risk factors, but as Rogers 
(2000) observes, ‘risk only evaluations are inherently inaccurate’ (p. 
589).  He argues that without taking into account protective factors, 
individuals can be classed at a higher risk of violent behaviour, resulting 
in longer admissions, and increased financial costs (Rogers, 2000).  Risk 
assessments often assist in the allocation of resources, and if protective 
factors are discounted an unnecessary emphasis may be placed on 
forensic patients, at the expense of care and treatment for non-forensic 
patients (Sullivan, Wells, Mortgenstern, & Leake, 1995).  Miller (2006) 
also states that a focus on risk factors can result in longer detention of 
forensic patients due to its influence on the attitudes of professionals 
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working with them, heightening the perception that individuals are more 
likely to reoffend or are more dangerous than they actually are.   
Assessment of protective factors in addition to risk factors in the 
risk assessment process is fairly new (de Vries Robbe et al., 2012).  To 
date there are few violence risk assessment tools which incorporate the 
assessment of protective factors.  These include the Structured 
Assessment of Violence Risk in Youth (SAVRY; Borum et al., 2006), and 
the Short Term Assessment of Risk and Treatability (START; Webster, 
Martin, Brink, Nicolls, & Desmarais, 2004).  The HCR-20 is the one of the 
best validated, and most widely used violence risk assessment tools 
(Singh et al., 2014), but it does not include an assessment of protective 
factors.  Clinicians using the HCR-20 are guided to make a final 
judgement of violence risk taking into account the presence and 
relevance of well-defined risk factors, and although the strengths of an 
individual would naturally be incorporated, it is based purely on the their 
clinical judgement (de Vries Robbé, 2014).  In 2007 the SAPROF (de 
Vogel, de Ruiter, Bourman, & de Vries Robbé, 2012) was developed 
specifically as an assessment of protective factors, to be used alongside  
a risk factor focused SPJ violence risk assessment tool such as the HCR-
20.  The SAPROF aims to balance the risk assessment process by offering 
structure to clinical judgement, and an empirical foundation in terms of 
protective factors in the violence risk assessment and management 
process (de Vries Robbé, 2014). 
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1.5. The present thesis 
This thesis aims to explore the research evidence for the inclusion 
of protective factors in the violence risk assessment and management 
process in forensic mental health services, in the National Health Service 
(NHS).  More specifically it investigates whether inclusion of protective 
factors improves the predictive accuracy of violence risk assessment, and 
discusses the implications for clinical practice.  The impact on patient 
motivation to change is also considered. 
 Chapter two provides an overview and critique of the HCR-20 
version 3 (HCR-20V3; Douglas et al., 2013), exploring its measurable 
properties, considering its clinical and research applications, whilst also 
taking into account its use in forensic inpatient mental health settings.  
Chapter three systematically reviews the research literature on the 
predictive accuracy of the violence risk assessment tools recommended 
for use in forensic mental health services in the NHS; the HCR-20, 
SAPROF, and START (service specification no. C03/S/a; NHS 
Commissioning Board, 2013).   The HCR-20 follows the traditional route 
of assessing the presence and relevance of risk factors, the SAPROF 
assesses the presence of protective factors, and the START evaluates the 
presence of strengths and vulnerabilities.  The START is considered a 
short-term risk assessment (up to three months; Webster et al., 2004), 
whereas the HCR-20 and SAPROF are used as long-term risk 
assessments (between six and 12 months; Douglas et al., 2013, and de 
Vogel et al., 2012).  
Chapter four is a research study exploring the implementation of 
the SAPROF in a forensic inpatient setting, to allow for a greater 
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understanding of its effectiveness in the risk assessment and 
management process.  The validity and reliability of the SAPROF as an 
assessment tool is investigated, and compared to the HCR-20 and START 
across a number of domains, to evaluate whether the assessment of 
protective factors improves predictive accuracy of violence risk 
assessment. 
Chapter five presents a case study which explores the impact of 
psycho-education on a patient’s motivation to engage in treatment, and 
interventions to manage risk.  The main objective was to establish 
whether risk assessment tools which follow a strength-based approach 
and focus on protective factors, have a positive impact on motivation to 
change when used in the collaborative risk assessment and risk 
management process.   
Finally, chapter six concludes the thesis by presenting a discussion 
on the findings in relation to the specific aims of the thesis: 1) to critically 
evaluate the most widely used violence risk assessment tool, the recently 
updated HCR-20V3; 2) to explore the predictive accuracy of the HCR-20, 
SAPROF, and START in terms of absence and presence of violence; 3) to 
investigate the reliability and validity of the SAPROF when implemented 
in a NHS forensic inpatient mental health service; 4) to evaluate the 
impact of protective factors in assessment of violence risk on a patient’s 
motivation to change.  The clinical implications of the findings and 
recommendations for future research are also discussed. 
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Chapter Two 
 
 
 
A Critique of the Historical Clinical Risk - 20 Version 3 Risk 
Assessment Instrument 
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2.1.  Introduction 
Assessing and managing the risk of violence in offenders with 
mental illness is essential for those working in forensic mental health 
services (Wilson, Desmarais, Nicholls, & Brink, 2010).  Such assessment 
protects the public (and the individual) from harm, but also allows for 
resources such as supervision and treatment to be allocated 
appropriately, and for individuals to be managed in the least restrictive 
environment (Yates, Prescott, & Ward, 2010).  A number of tools have 
been developed to assist the risk assessment and risk management 
process. In secure adult mental health services NHS England 
recommends the use of the Historical Clinical Risk - 20 (HCR-20; 
Webster, Douglas, Eaves, & Hart, 1997, and Douglas, Hart, Webster, & 
Belfrage, 2013; NHS Commissioning Board, 2013).  
The HCR-20 is a comprehensive guide for the structured 
assessment of violence risk.  Its properties have been investigated for 
research purposes.  The HCR-20’s intention is to establish the presence 
and relevance of risk factors, enabling the development of appropriate 
risk management strategies (Douglas, Shaffer, Blanchard, Guy, Reeves, 
& Weir, 2014).  The aim of this critique is to provide an overview of the 
HCR-20 version 3 (HCR-20V3; Douglas et al., 2013), exploring its 
properties, and its clinical and research applications, whilst also taking 
into account its use in forensic mental health settings. 
 
2.2. Overview of the HCR-20V3 
2.2.1. Background 
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Clinicians working within forensic settings are often under pressure 
from the expectations of the general public and their professional role to 
predict and manage risk of future violence (Whittington et al., 2013).  
They are also required to consider the best interests of the individual 
being assessed, and develop positive risk management strategies for the 
institutions and services they oblige (Whittington et al., 2013).  In 
forensic mental health services this means integrating the risk of 
reoffending with appropriate interventions to manage and reduce risk, 
otherwise known as ‘risk-needs assessment’ (Andrews, Bonta, & Hoge, 
1990).   
There is no ‘gold standard’ when it comes to choosing the correct 
risk assessment (NICE Guidelines, 2005).  The Department of Health 
recommends the best practice of utilising a tool which follows the 
structured clinical (or professional) judgement approach (SPJ; 
Department of Health, 2007a).   The SPJ model combines the strengths 
of actuarial methods with clinical judgement (Dolan & Doyle, 2002).  SPJ 
involves making a judgement about risk based on an assessment of 
clearly defined static (historical) and dynamic (changeable) factors 
derived from research, clinical experience and knowledge of the service 
user, and the service users own view of their experience (Department of 
Health, 2007a).  A recent international survey (Singh, Fazel, 
Gueorguieva, & Buchanan, 2014) found the HCR-20 (Webster et al., 
1997, and Douglas et al., 2013) was one of the most commonly used SPJ 
tools. 
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2.2.2. The instrument 
The HCR-20 was first pubished in 1995 (Webster, Eaves, Douglas, 
& Wintrup, 1995) but was updated in 1997 (version 2 or HCR-20V2; 
Webster et al., 1997).  The instrument was constructed following careful 
consideration of the empirical literature concerning factors that relate to 
violence (Douglas et al., 2014).  More recently, on the basis of extensive 
clinical beta testing and empirical evaluation, the HCR-20 has been 
further updated (version 3, or HCR-20V3; Douglas et al., 2013).   
The HCR-20V3 is a comprehensive set of professional guidelines 
for the assessment and management of violence risk, the latter defined 
as ‘…actual, attempted, or threatened infliction of bodily harm of another 
person’ (Douglas et al., 2013, p. 2).  The HCR-20V3 assists professionals 
to estimate a person’s likelihood of future violence, and determine the 
most appropriate treatment and management strategies.  Its most 
common applications are within correctional, forensic, and general or civil 
psychiatric settings, whether in the institution or in the community, and it 
is applicable for adults aged 18 and above who may pose a risk for future 
violence (Douglas et al., 2013).  The HCR-20V3 is not intended to act as 
a stand-alone assessment, and it is recommended additional measures 
should be employed to investigate any unique patterns of violence 
(Douglas et al., 2013).  The authors recommend the HCR-20V3 should be 
repeated (between 6 and 12 monthly) to take into account changes in 
circumstance which are inevitable with the nature of risk (Douglas et al., 
2013). To administer the HCR-20V3 the professional should be trained in 
conducting individual assessments, be familiar with the study of violence, 
and they should have experience of using SPJ tools.   
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The HCR-20V3 is not an actuarial tool.  The guidance regarding 
score interpretation are not based on algorithms or cut-off scores 
(Douglas et al., 2014), and the authors state the HCR-20V3 is not 
intended to give professionals a definitive prediction of violence (Douglas 
et al., 2013).  The outcome of the assessment is an estimate of the 
likelihood of future violence, and the test authors recommended this 
should be presented in terms of low, moderate, or high probability of 
violence (Douglas et al., 2013).  In addition, the levels of probability 
should be considered in terms of imminence, time frames (short and 
long-term), and in relation to relevant individualised factors.  These 
considerations can help in developing a risk management plan which 
reports the type and degree of risk presented by the person, and 
identifies interventions which may reduce the likelihood of that individual 
exhibiting violence in the future (Douglas et al., 2013).   
The HCR-20V3 allows for evaluation of the presence (and 
relevance) of 20 key violence risk factors in an individual.  These are 
organized into three areas: historical and clinical factors, and risk 
management.  The complete list is shown in table 2.1.  The presence of 
factors is coded using a three level response format: (Y) the factor is 
definitely or conclusively present; (P) the factor is possibly or partially 
present, or the risk factor is present, but the information is weak, 
contradictory, or inconclusive; and (N) the factor is absent, or the 
professional perceives no evidence the factor is present (Douglas et al., 
2013).    To rate historical factors, the professional must conduct an 
exhaustive review of background documents and ideally interview 
individuals who know the person being assessed.  The rating of the 
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clinical factors and risk management aspects requires a clinical interview 
with the person being assessed.  However, systematic review of the 
literature found only 16% of research studies included assessments with 
multiple information sources (see chapter three).  In addition to 
determining the presence or absence of each risk factor, the professional 
should judge their relevance with respect to the development of future 
risk management strategies.  Relevance is also coded on a three level 
scale: (low) the factor is of low relevance to the individual’s risk for 
violence; (moderate) the factor is relevant to some degree; and (high) 
the factor is present, and its role in causing violence or impairing the 
effectiveness of risk management strategies is likely to be substantial 
(Douglas et al., 2013).  Finally, there is the option to rate a final risk 
judgement following completion of the assessment (low, medium, and 
high).  De Vries Robbé and de Vogel (2012) have suggested using a five-
point scale instead of a three-point scale for the final risk judgement as 
they have found it to have higher predictive abilities. 
 
Table 2.1 
 
Factors in the HCR-20V3 violence risk assessment scheme 
Historical factors 
Problems with… 
Clinical factors 
Problems with… 
Risk management 
factors 
Problems with… 
H1: Violence 
H2: Other anti-social 
behavior 
H3: Relationships 
H4: Employment 
H5: Substance use 
H6: Major mental 
disorder 
H7: Personality disorder 
H8: Traumatic 
experiences 
H9: Violent attitudes 
H10: Treatment or 
supervision response 
C1: Insight 
C2: Violent ideation or 
intent 
C3: Symptoms of major 
mental illness 
C4: Instability 
C5: Treatment or 
supervision response 
R1: Professional services 
and plans 
R2: Living situation 
R3: Personal support 
R4: Treatment or 
supervision response 
R5: Stress or coping 
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2.2.3. Manual 
 The HCR-20V3 manual contains the guidelines defining the 
evaluation and judged presence of the 20 key violence risk factors, and 
their relevance to the individual being assessed.  It defines each of the 
risk factors and describes key indicators to guide the professional to 
make the relevant ratings.  It contains information to help professionals 
construct meaningful formulations of violence risk, future risk scenarios, 
appropriate risk management plans, and informative communication of 
risk.  The manual also highlights how the tool was developed, and 
outlines research regarding its characteristics in terms of reliability and 
validity.   
Despite detailed descriptions of the risk factors and provision of 
key indicators, it can be argued that there is subjectivity in the scoring 
guidelines (Rufino, Boccaccini, & Guy, 2011).  This is important because 
subjectivity can result in reduced predictive validity (Rufino et al., 2011).  
An example of subjectivity may be the inclusion of non-violent behaviour 
in the assessment, such as expression of frustration, when this is not 
included in the definition of violence (Douglas et al., 2013).  In fact, the 
authors of the tool state that the ‘definition of violence…is both imperfect 
and impractical…’ (Douglas et al., 2013, p.3). 
 
2.2.4. Research 
 The development of the HCR-20V3 was guided by empirical 
literature relating to factors consistent with violence, and it integrates the 
experience of professionals within the field (Douglas et al., 2014).  Since 
its first publication in 1995, the HCR-20 has been established as one of 
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the best validated violence risk assessments through both prospective 
and retrospective research designs.  The literature on the HCR-20V3 will 
be discussed in this critique as an evaluation of its psychometric 
properties.   
 
2.3. Psychometric Properties of the HCR-20V3 
2.3.1. Reliability 
2.3.1.1. Internal reliability 
In terms of the HCR-20V3, internal reliability can be defined as the 
degree to which each risk factor determines future violence (i.e. 
consistency within the tool).  See table 2.3 for synthesis of research 
conducted to date.  The internal reliability of the HCR-20V2 has been well 
established.  For example, using Cronbach’s Alpha, Belfrage (1998) 
reported good internal consistency for the historical factors (.96), clinical 
factors (.89), risk factors (.85), and the HCR-20V2 as a whole (.95).  
However, there is limited research into the internal reliability of the HCR-
20V3.   
Bjørkly, Eidhammer, and Selmer (2014) compared the internal 
consistency of the HCR-20V3 with the HCR-20V2 using Interclass 
Correlations (ICC).  Classifications of ICC values were used as follows: 
ICC ≥ .75 = excellent, ICC between .60 and < .75 = good, and ICC 
between .40 and .60 = moderate (Fleiss, 1986).  Moderate to good 
estimates of internal consistency were found between ratings of the two 
assessments for the same individual, with ICC values of .85, .57, .81, 
and .84 for the historical factors, clinical factors, risk factors, and overall 
assessment respectively.  Due to their similarity it could be argued the 
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evidence of good internal reliability for version 2 could be applied to 
version 3.  However, although both versions reflect common underlying 
dimensions, there are differences, particularly within the clinical factors.  
A paired sample t-test also revealed significant differences between the 
historical and clinical factor ratings on version 2 and version 3 (Bjørkly et 
al., 2014).  It was hypothesised this may have been due to more 
accurate descriptions of item indicators in the HCR-20V3 (Bjørkly et al., 
2014), and ulitimately, the tools include different items and definitions.   
 
2.3.1.2. Inter-rater reliability.    
In terms of the HCR-20V3, good inter-rater reliability means two 
independent professionals would code the presence (and relevance) of 
each risk factor similarly, resulting in the same final risk judgement, in 
the same time period.  See table 2.3 for synthesis of research conducted 
to date.  This construct can be measured using a variety of statistical 
tests, including Pearson’s correlation and ICCs.  Classifications of ICC 
values were used as follows: ICC ≥ .75 = excellent, ICC between .60 and 
< .75 = good, and ICC between .40 and .60 = moderate (Fleiss, 1986). 
Current research suggests good levels of inter-rater reliability for 
the HCR-20V3.  Doyle, Power, Coid, Kallis, Ullrich, and Shaw (2014) 
investigated the inter-rater reliability of the HCR-20V3 in a sample of 
discharged patients (n = 387) from medium secure units in England and 
Wales.  A prospective cohort design was utilised with a 12 month follow 
up period.  ICC values were reported at the 6 and 12 month period 
respectively for the overall assessment (.73; .92), historical factors (.72; 
.91), clinical factors (.69; .90), and risk factors (.76; .93).  Despite the 
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low ICC for clinical factors at the 6 month period (.69) this remains a 
good level of inter-rater reliability, and all other results show good or 
excellent inter-rater reliability.   
Some sample sizes exploring the integrity of the HCR-20V3 have 
been small.  Douglas and Belfrage (2014) investigated a sample of 32 
forensic patients where three professionals jointly interviewed the 
patients and then independently completed the HCR-20V3.  Using ICCs, 
they likewise found excellent levels of inter-rater reliability for the overall 
assessment (.94), historical factors (.94), clinical factors (.86), and the 
final risk judgement (.81), and good levels for risk factors (.69).  In a 
small sample of 15 detainees in Texas, Smith, Kelley, Rulesh, Sorman, 
and Edens (2014) reported ICC values for the historical, clinical, and risk 
factors of .92, .67, .68 respectively, showing good to excellent levels of 
inter-rater reliability. 
 Kötter, von Franqué, Bolzmacher, Eucker, Holzinger, and Müller-
Isberner (2014) investigated the inter-rater reliability of a draft version of 
the HCR-20V3.  Five raters were asked to rate independently the 
presence and relevance of the HCR-20V3 factors in 30 case vignettes.  
Inter-rater reliability of the overall assessment was found to be excellent 
(ICC = .86).  However, when exploring the individual factors the ICCs 
ranged between .06 (H3: Relationships) and .99 (H5: Substance use and 
H6: Major mental disorder).  The mean ICC’s for the historical, clinical, 
and risk management factors were .65, .66, and .73 respectively.  The 
generalizability of the results to the clinical domain can be disputed, as 
the assessments were completed using case summary vignettes rather 
than formal assessments of real clients.  Strub and Douglas (2009) also 
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examined a draft version of the historical factors of the HCR-20V3, based 
on archival data from 80 psychiatric patients.  ICCs were completed for 
the total score of the historical factors using 12 pairs of ratings randomly 
chosen from the dataset.  Inter-rater reliability was found to be 
acceptable.  However, the assessment information was gathered purely 
from file review and the authors of the tool recommend conducting an 
interview as well, as the single source of information could have 
negatively affected the data obtained as it increases bias (DoH, 2007a). 
 De Vogel, van den Broek, and de Vries Robbé (2014) investigated 
a preliminary version of the HCR-20V3 using a retrospective file study, 
with a sample of 25 discharged patients.  Using ICCs, inter-rater 
reliability was found to be good for the overall assessment (.84) and the 
final risk judgement (.72).   
 The research described demonstrates the HCR-20V3 has good to 
excellent inter-rater reliability as classified by Fleiss (1986).  However, 
only one study had a large sample and another investigated a draft 
version of the tool. 
   
2.3.2. Validity 
2.3.2.1. Face validity    
Face validity refers to whether the HCR-20V3 appears (to those 
using it) to examine what it claims to predict (future violence).  All the 
risk factors included in the HCR-20V3 have a literature associating them 
with violence, and appear relevant to existing risk assessment and 
management literature which suggests face validity.  The inclusion of 
past, present, and future risk factors, and the addition of relevance 
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ratings further supports this.  However, some of the items may 
significantly overlap with one another (for example, H1 and H9), so 
cannot be seen as proven independent predictors.  Due to the absence of 
specific research investigating the face validity of the HCR-20V3 a 
conclusion can not be reached in this regard. 
 
2.3.2.2. Concurrent validity  
For the HCR-20V3 to satisfy the criteria for concurrent validity, it 
would need to correlate with other tools which propose to estimate risk of 
violence.  See table 2.3 for synthesis of research conducted to date.  
There is currently limited research using this strategy, but most studies 
compare the HCR-20V3 with the HCR-20V2 which has been shown to 
have good concurrent validity (Douglas et al., 2014).   
Strub, Douglas, and Nicholls (2014) compared the HCR-20V2 with 
the HCR-20V3 in a sample of 106 Canadian civil psychiatric and 
correctional offenders.  A correlation of .91 was reported, and 
correlations of .89, .76, and .81 were reported for the historical, clinical, 
and risk factors respectively.  Douglas and Belfrage (2014) have reported 
that six international studies found the HCR-20V3 has concurrent validity 
with the HCR-20V2, and Bjørkly et al. (2014) reported correlations 
between both versions for the historical factors (.85), clinical factors 
(.59), risk factors (.81), and the overall assessment (.84).   
Comparing the HCR-20V3 with the HCR-20V2 to evaluate 
concurrent validity is a flawed process.   They are similar measures and 
you would expect them to correlate.  It would be more beneficial to 
investigate comparisons between the HCR-20V3 and other violence risk 
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assessment tools.  Strub and Douglas (2009) compared a draft version 
the HCR-20V3 historical factors with the HCR-20V2 and the Violence Risk 
Appraisal Guide (VRAG; Quinsey, Harris, Rice, & Cormier, 2006).  The 
HCR-20V3 correlated significantly with the HCR-20V2 (r = .60, p < .01) 
and the VRAG (r = .60; p < .01), and it was concluded the HCR-20V3 
had concurrent validity.  However, only the historical factors were 
investigated and it is therefore unclear whether the clinical and risk 
factors, or indeed the overall assessment, correlate with the HCR-20V2 
and VRAG.   
In conclusion, there is currently a lack of research investigating the 
concurrent validity of the HCR-20V3.  Studies comparing the HCR-20V3 
to the HCR-20V2 are not sufficient as they are characteristically the same 
tool (Douglas et al., 2013); for true concurrent validity to be assumed 
the HCR-20V3 should be compared to other violence risk assessment 
tools.  The research conducted by Strub and Douglas (2009) is more 
beneficial in this regard as it compares the HCR-20V3 to the VRAG, 
however if only investigates a draft versions of the historical factors, not 
the completed version of the tool which differs. 
 
2.3.2.3. Predictive validity 
The predictive validity of the HCR-20V3 relates to its ability to 
predict future violence.  See table 2.3 for synthesis of research conducted 
to date.  The predictive accuracy of risk assessment tools is most 
commonly evaluated using Receiver Operating Characteristic (ROC) 
analysis (Mossman, 2013).  The ROC yields an Area Under the Curve 
(AUC) which represents the probability a randomly chosen actually 
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violent person will score greater than a randomly chosen nonviolent 
person (Swets, 1988).    Table 2.2 shows the classification of effect size 
(Rice and Harris, 2005) and compares AUC and Cohen’s d (1969).   
 
 
Table 2.2 
 
AUC and Cohen’s d effect size comparisons and classifications 
AUC Cohen’s d Classification 
0.556 0.200 Small 
0.639 0.500 Moderate 
0.714 0.800 Large 
 
 Initial research suggests the HCR-20V3 has good predictive 
validity.  In a sample of 387 patients discharged from medium secure 
hospitals in England and Wales, Doyle et al. (2014) investigated the 
predictive validity of the HCR-20V3 for violence, defined as sexual 
assault, assaultative acts or threats with a weapon, and all acts of 
battery, at 6 and 12 month follow up periods.  At the 6 and 12 month 
period (respectively) the AUC values were found to have a moderate to 
large effect for the  overall assessment (.73; .70), historical factors (.63; 
.63), clinical factors (.75; .71), and risk factors (.67; .63).  Correlations 
with the frequency of violence at 6 and 12 months (respectively) were 
also explored and found to be significant, but small effect size, for the 
overall assessment (r = .23; p < .001; r = .23; p < .001), historical 
factors (r = .14; p < .01; r = .14; p < .01), clinical factors (r = .22; p < 
.001; r = .24; p < .001), and risk factors (r = .18; p < .001; r = .19; p 
< .001).   
 Strub et al. (2014) investigated the HCR-20V3’s predictive validity 
in a sample of 106 civil psychiatric patients and offenders.  An average 
AUC value of .74 was reported, and an AUC value of .76 was reported for 
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the final risk judgement rating.  At the 6 - 8 month follow up period 16%, 
36%, and 67% of individuals rated low, moderate, and high risk 
respectively were violent, and at the 4-6 week follow up period 2%, 16%, 
and 44% of individuals rated low, moderate, and high risk respectively 
were violent.   
Some researchers have stated that because the primary aim of a 
risk assessment is to predict future violence, prospective study designs 
are more appropriate when investigating predictive validity (Caldwell, 
Bogat, & Davidson, 1988).  However, the usefulness of retrospective 
designs has also been recognised, and are commonly more tractable 
(Maden, 2001).  De Vogel et al. (2014) completed a retrospective file 
study, with a sample of 86 discharged patients.  Significant AUC values 
with violence were reported 1 year (.77), 2 years (.75), and 3 years (.67) 
following discharge.  AUC values were also reported for the final risk 
judgement rating for the same time periods (.72, .67, and .64 
respectively).  They also reported that the HCR-20V2 and HCR-20V3 
were comparable in their predictive validity.  Blanchard and Douglas 
(2011) also conducted a retrospective study with a sample of 27 civil 
psychiatric patients and 16 offenders, using a draft version of the HCR-
20V3.  The AUC was found to be larger for physical violence (.75) in 
comparison to any violence (.69).  The final risk judgement rating yielded 
the largest effect for both physical violence (.83) and any violence (.76).  
  In conclusion, the research to date demonstrates the HCR-20V3 is 
valid in terms of prediction, with moderate to large effects sizes.  
However, it should be noted that half the reported studies were 
conducted by the authors of the HCR-20V3 indicating publication.  
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Selection bias is also present with much of the research being conducted 
with mental health participants, neglecting prison samples. 
 
2.3.2.4. Content validity 
In terms of the HCR-20V3, content validity relates to whether the 
assessment considers all aspects of violence.  There is currently no 
available research which discusses the content validity of the HCR-20V3.  
However, the HCR-20V2 was found to be more strongly related to 
violence than other measures (Douglas & Belfrage, 2014) and the HCR-
20V3 was developed with the aim of retaining the core concepts of 
version 2.  It could therefore be assumed version 3 also retains content 
validity.  Nevertheless changes have been made; items have been 
reformed, relevance ratings and sub items have been included, and there 
is more emphasis on formulation and risk management.  The coding of 
H7 (personality disorder) no longer requires the completion of a 
Psychopathy Checklist (PCL-R; Hare, 2003) which was previously thought 
to be an important factor in the consideration of future violence risk 
(Guy, Douglas, & Hendry, 2010). 
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Table 2.3 
 
Data synthesis 
Reference Country Setting Sample size Inter-rater reliability (ICC) Concurrent validity (r) Predictive validity (AUC) 
Bjørkly et al. (2014) Norway Inpatient 20  With HCR-20V2: 
.85 historical factors 
.59 clinical factors 
.81 risk factors 
.84 total scores 
 
Blanchard & Douglas 
(2011) 
Canada Inpatients 
Offenders 
27 
16 
  Overall assessment: 
.75 physical violence 
.69 any violence 
 
Final risk judgement: 
.83 physical violence 
.76 any violence 
De Vogel et al. 
(2014) 
Netherlands Community 25 .84 overall assessment 
.72 final risk judgement 
  
   86   Overall assessment: 
.77 1 year 
.75 2 years 
.67 3 years 
 
Final risk judgement: 
.72 1 year 
.67 2 years 
.64 3 years 
Douglas & Belfrage 
(2014) 
Canada Inpatient 32 .94 overall assessment 
.94 historical factors 
.86 clinical factors 
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Reference Country Setting Sample size Inter-rater reliability (ICC) Concurrent validity (r) Predictive validity (AUC) 
.69 risk factors 
.81 final risk judgement 
Doyle et al. (2014) UK Community 387 6 months: 
.73 overall assessment 
.72 historical factors 
.69 clinical factors 
.76 risk factors 
 
12 months: 
.92 overall assessment 
.91 historical factors 
.90 clinical factors 
.93 risk factors 
 6 months: 
.73 overall assessment 
.63 historical factors 
.75 clinical factors 
.67 risk factors 
 
12 months: 
.70 overall assessment 
.63 historical factors 
.71 clinical factors 
.63 risk factors 
Kötter et al. (2014) Germany Inpatient 30 .86 overall assessment 
.65 historical factors 
.66 clinical factors 
.73 risk factors 
  
Smith et al. (2014) USA Prison 15 .92 historical factors 
.67 clinical factors 
.68 risk factors 
  
Strub & Douglas 
(2009) 
Canada Inpatient 80  .60 with HCR-20V2 
.60 with VRAG 
 
Strub et al. (2014) Canada Inpatient 
and prison 
106  With HCR-20V2:  
.91 overall assessment 
.89 historical factors 
.76 clinical factors 
.81 risk factors 
.74 overall assessment 
.76 final risk judgement 
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2.3.3. Appropriate norms 
 The HCR-20V3 is not an actuarial measure and as such appropriate 
norms are not suitable.  However, Webster et al. (1997) provided 
normative data for the prevalence of risk factors in a number of different 
samples (for example civil, forensic psychiatric patients, and correctional 
offenders) for the HCR-20V2.  Due to the revisions to the risk factors 
these would not be applicable to the HCR-20V3, and further research in 
this regard is required.  In addition, limitations were evident in the data 
for version 2, including no appropriate information regarding non-
criminals, and the questionable diversity of the standardised sample 
(primarily North American forensic populations).   
 
2.4. Clinical Utility 
The clinical utility of a tool refers to its effectiveness in clinical 
settings and how easy it is to apply (Smart, 2006).  Flaata and Marthe 
(2013) completed a case study, comparing the HCR-20V2 and the HCR-
20V3 assessments of a male maximum security patient.  Both were 
completed by two independent raters and hospital staff, and the outcome 
of the risk assessment, the management plan, and the clinical utility was 
discussed.  It was found that HCR-20V3 provided a better structure for 
the assessment process, and that the HCR-20V3 was more precise in 
regards to the risk management plan.  The HCR-20V3 was found to be 
more time consuming to complete than the HCR-20V2, but this was 
counterbalanced by the provision of a more comprehensive violence risk 
assessment.  A study exploring the implementation of the HCR-20V3 (de 
Vogel & de Vries Robbé, 2013), found on average it took an extra 27 
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minutes to code the HCR-20V3 than the HCR-20V2.  Participants reported 
there were factors on the HCR-20V3 which were easier to code, but that 
the unfamiliarity of the new factors made it harder.  Participant’s ratings 
of usefulness reported that sub items within the risk factors (89%), 
indicators to aid coding (78%), relevance ratings (75%), risk scenarios 
(74%), risk formulation (73%), and final risk judgement ratings (67%) 
were useful in the HCR-20V3.  In general the HCR-20V3, in comparison 
to the HCR-20V2, was more applicable, clear, structured, detailed, and 
more specific and dynamic. 
Wærp (2013) completed a case study with a female forensic 
psychiatric patient, focusing on changes in repeated assessments of the 
HCR-20V2 and HCR-20V3.  It was reported the sub-items of the HCR-
20V3 helped to structure judgement, the presence and relevance ratings 
improved the development of formulations, and the specification of time 
frame and priority of case ratings enhanced the structure of the risk 
management plan.  Bjørkly et al. (2014) investigated the clinical utility of 
the HCR-20V3 in comparison to the HCR-20V2 and found version 3 
enabled the development if a more systematic and detailed violence risk 
assessment.   
Therefore it can be concluded that the research to date shows the 
HCR-20V3 is beginning to prove its clinical utility.  However, there is a 
lack of research in this area (just three studies), and two of those were 
case studies which are difficult to generalise (Yin, 2003). 
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2.5. Limitations of the HCR-20V3 
In addition to the practical concerns outlined above, the HCR-20V3 
has a number of limitations.  There is an assumption of its worth on the 
evidence base of previous versions, and despite reassurances from the 
tool’s authors that this data should be applicable to the HCR-20V3, this 
view is yet to be supported by substantive research.  It should also be 
recognised that much of the current research has been conducted by one 
or more of the originating authors which may have resulted in bias. 
Of the research described in this critique, only two studies had 
sample sizes of over 100 (Doyle et al., 2014, and Strub et al., 2014), and 
the majority of studies were conducted outside the United Kingdom 
(Canada, Norway, Germany, Netherlands, and Sweden), making the 
results of the remaining studies hard to generalise to the United 
Kingdom.  It should also be noted that a number of the studies described 
in this critique were based on draft versions of the HCR-20V3, which 
differ from the published assessment.  Therefore the results may not be 
applicable to the final published HCR-20V3. 
As with much research investigating risk assessment, there is 
limited information about the use of the HCR-20V3 with women.  The 
manual suggests its use with female populations is possible; however 
there is currently no published research to support this.  The Female 
Additional Manual (FAM; de Vogel, de Vries Robbé, van Kalmthout, & 
Place, 2014) has been developed for use alongside the HCR-20V3, and it 
aims to provide more concrete guidelines for gender-sensitive risk 
assessment and management for women.  The HCR-20V3’s lack of 
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evidence base for use with women highlights the need for additional 
guidelines. 
The final limitation this critique focuses on is the HCR-20V3’s 
omission of assessed protective factors.  Protective factors are considered 
in the HCR-20V3 in so much as they contribute to the formulation and 
the risk management plan; however there is no guidance in terms of how 
to formally identify protective factors.  There is increasing evidence to 
suggest assessment of protective factors should be included when 
assessing the risk of future violent behaviour.  It is suggested a risk 
assessment is unbalanced if both risk factors and protective factors are 
not taken into account (Rogers, 2000).  Rogers (2000) states that 
focusing purely on risk factors can result in negative outcomes for 
forensic services, as individuals become classed as being at a higher risk 
of violent behaviour.  This can result in longer admissions, impacting 
negatively on resources (Miller 2006), and professionals viewing their 
clients as more dangerous than they actually are (Rogers, 2000).  
Ullrich and Coid (2009) observed that treatment to reduce violent 
reoffending should focus on reducing risk factors, and also increasing and 
maintaining protective factors.   Building on positive factors within 
treatment has always been integral to clinical practice, but the idea these 
factors can represent protection in regards to future violent behaviour is 
fairly new (de Vries Robbé, de Vogel, & Stam, 2012).  
Recently, the Structured Assessment of Protective Factors 
(SAPROF; De Vogel, de Ruiter, Bouman, & de Vries Robbé, 2009) has 
been developed for use in combination with a reliable and valid violence 
risk assesment tool,  such as the HCR-20, and it aims to balance the risk 
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assessment of future violent behaviour by assessing the presence or 
absence of protective factors.  The HCR-20V3’s neglect of protective 
factors highlights the need for such an assessment. 
 
2.6. Conclusion 
 Assessing and managing the risk of violence in offenders with 
mental illness is essential in forensic mental health services, and the use 
of the HCR-20 as an assessment tool has been recommended.  The aim of 
this critique was to provide an overview of the HCR-20V3, exploring its 
measurable properties, and clinical and research applications, whilst also 
taking into account its use in forensic mental health settings.  The HCR-
20 is considered the most researched and best empirically guided risk 
assessment of violence, and it has been widely adopted (Douglas et al., 
2014).  Version 3 of the instrument was introduced in 2013, and as such 
the evidence base for its reliability, validity, and clinical utility is still in its 
infancy.  However, if it maintains the core principles of the HCR-20V2, as 
stated by its authors, it is possible that it will prove itself a similarly 
reliable and valid assessment.  Despite its limitations the research to date 
is supportive of this, demonstrating high levels of internal and inter-rater 
reliability, and good levels of concurrent and predictive validity.  Its 
clinical utility has also been supported. 
 The research examining the HCR-20V3 has a number of 
limitations, including author bias, sample sizes, and neglect of validation 
with females.  It can also be argued that the omission of an assessment 
of protective factors within the HCR-20V3 may result in the risk 
assessment being unbalanced (Rogers, 2000), and the need for a 
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concurrent additional tool such as the SAPROF is imperative.  Future 
research may wish to consider whether the inclusion of protective factors 
in risk assessment strategies improves predictive accuracy, and more 
specifically the impact on predictive accuracy if the SAPROF was used in 
conjunction with the HCR-20V3. 
 This critique demonstrates the importance of ensuring an evidence 
base when selecting a risk assessment tool.  Failure to do so could result 
in negative consequences for the individual being assessed (e.g. longer 
detention) and the wider population (e.g. financial implications).   
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Abstract 
This review systematically examined the research literature on the 
inclusion of protective factors in violence risk assessment tools.  It 
investigated the predictive accuracy of the violence risk assessment tools 
recommended for use in forensic mental health services in the NHS 
(service specification no. C03/S/a; NHS Commissioning Board, 2013), 
and whether the inclusion of protective factors improved the risk 
assessment process.  Following PRISMA guidelines, research investigating 
the predictive validity of the Historical Clinical Risk-20 (HCR-20V2; 
Webster, Douglas, Eaves, & Hart, 1997, and HCR-20V3; Douglas, Hart, 
Webster, & Belfrage, 2013), the Structured Assessment of Protective 
Factors (SAPROF; de Vogel, de Ruiter, Bouman, & de Vries Robbe, 2012), 
and the Short Term Assessment of Risk and Treatability (START; 
Webster, Martin, Brink, Nicolls, & Desmarais, 2004) in a population of 
adult male offenders, with a primary diagnosis of mental illness or 
personality disorder, a history of violence, and an outcome measure of 
future violent behaviour or re-offending was included.  A total of 11,847 
participants were investigated in 44 studies, and the HCR-20 was the 
most widely evaluated tool.  The SAPROF was found to have the highest 
level of predictive validity with a mean AUC of .74, followed by the HCR-
20 with a mean AUC of .72.  The START had the lowest level of predictive 
validity with a mean AUC of .70.  It was difficult to establish with any 
certainty whether the inclusion of protective factors improved the risk 
assessment process, but the combined use of the HCR-20 with the 
SAPROF improved predictive accuracy, promoting the inclusion of 
protective factors.   
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3.1. Introduction 
3.1.1. Background 
This review systematically examined the research literature on the 
inclusion of protective factors in violence risk assessment tools.  It 
investigated the predictive accuracy of the violence risk assessments 
tools which are recommended for use in forensic mental health services 
in the National Health Service (NHS), and whether the inclusion of 
protective factors improves the risk assessment process.   
Assessing and managing the risk of violence in individuals with 
mental illness who have also offended is essential in forensic mental 
health services (Wilson, Desmarais, Nicholls, & Brink, 2010).  Clinicians 
are often under pressure from expectations of the general public to 
predict and manage risk, but they are also required to consider the best 
interests of the individual being assessed, and develop positive risk 
management strategies (Whittington et al., 2013).  In forensic mental 
health services this means integrating the risk of reoffending with 
appropriate interventions to manage and reduce this risk, otherwise 
known as ‘risk-needs assessment’ (Andrews, Bonta, & Hodge, 1990).  
This allows for resources such as supervision and treatment to be 
allocated appropriately, and for individuals to be managed in the least 
restrictive environment.   
A number of violence risk assessment instruments have been 
developed.  In the NHS’s forensic mental health services it is 
recommended that the HCR-20 (HCR-20V2; Webster, Douglas, Eaves, & 
Hart, 1997, and HCR-20V3; Douglas, Hart, Webster, & Belfrage, 2013), 
the Structured Assessment of Protective Factors (SAPROF; de Vogel, de 
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Ruiter, Bouman, & de Vries Robbe, 2012), and the Short Term 
Assessment of Risk and Treatability (START; Webster, Martin, Brink, 
Nicolls, and Desmarais, 2004) are all used (service specification no. 
C03/S/a; NHS Commissioning Board, 2013).    
The HCR-20 is a comprehensive set of professional guidelines for 
the assessment and management of violence risk.  The measure assists 
professionals to evaluate a person’s likelihood of future violence, and 
determine the most appropriate treatment and management strategies.  
It was first developed in 1995 (Webster, Eaves, Douglas, & Wintrup, 
1995), updated in 1997 (HCR-20V2; Webster et al., 1997), and it was 
further updated in 2013 (HCR-20V3; Douglas et al., 2013).     
The SAPROF is a structured assessment guideline developed for 
use in combination with a reliable and valid violence risk assesment tool,  
such as the HCR-20.  It documents and quantifies the presence or 
absence of protective factors.  The tool also offers guidelines for future 
treatment and risk management.   
The START likewise assesses risk of future violence, but also 
evaluates other related risks such as self-neglect.  In addition to 
appraising risk, it is designed as a tool to help structure regular clinical 
assessment in terms of evaluation, monitoring, and treatment planning.  
The START is considered a short-term risk assessment (up to three 
months; Webster et al., 2004), whereas the HCR-20 and SAPROF are 
used as long-term risk assessments (between six and 12 months; 
Douglas et al., 2013, and de Vogel et al., 2012). 
Traditionally violence risk assessment tools have focused on the 
assessment of risk factors, but there is increasing evidence to suggest 
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protective factors should be included when assessing the risk of future 
violent behaviour (for example, Miller, 2006).   Of the risk assessment 
tools suggested for use within the NHS, the SAPROF assesses the 
presence of protective factors, whereas the START evaluates the 
presence of both protective factors and risk factors.  The HCR-20 follows 
the traditional route of assessing the presence of risk factors alone. 
The predictive accuracy of risk assessment tools is most commonly 
evaluated using Receiver Operating Characteristic (ROC) analysis 
(Mossman, 2013).  The ROC yields an Area Under the Curve (AUC) which 
represents the probability that a randomly chosen actually violent person 
will score greater than a randomly chosen non-violent person (Swets, 
1988).    Table 3.1 shows the classification of effect size (Rice & Harris, 
2005), and compares AUC and Cohen’s d (1969). 
 
Table 3.1 
 
AUC and Cohen’s d effect size comparisons and classifications 
AUC Cohen’s d Classification 
0.556 0.200 Small 
0.639 0.500 Moderate 
0.714 0.800 Large 
 
Whether using prospective or retrospective research designs, the 
HCR-20 has been established as one of the best validated violence risk 
assessments (Singh, Fazel, Gueorguieva, & Buchanan, 2014).  Douglas, 
Shaffer, Blanchard, Guy, Reeves, and Weir (2014) found that across 
forensic psychiatric samples, the predictive validity of the HCR-20 V1 and 
V2 AUC values ranged between .42 (Schaap, Lammers, & de Vogel, 
2009) and .89 (McDermott, Quanbeck, Busse, Yastro, & Scott, 2008).  
Research exploring the predictive validity of the HCR-20V3 has found 
54 
 
 
 
AUC values ranging between .70 (Doyle et al., 2014) and .75 (de Vogel, 
van den Broek, & de Vries Robbé, 2014).   
The predictive validity of the START has been investigated to a 
lesser degree and recent research has reported modest AUC values of .63 
(Quinn, Miles, & Kinane, 2013), .59 (Troquete et al., 2014), and .65 
(Whittington et al., 2014).  Research exploring the predictive validity of 
the SAPROF is even more limited.   De Vries Robbé, de Vogel, and de Spa 
(2011) found the SAPROF to have good predictive validity for absence of 
violent reconvictions in the short (1 year), medium (3 years), and long 
term (11 years), with AUC values of .85, .80, and .74 respectively.  They 
also found that creating a new measure where violence risk is balanced 
by protective factors by subtracting the SAPROF total score from the 
HCR-20 total score (overall total score of risk and protection index; ORP 
index), yielded better predictive validity than using the HCR-20 on its 
own (de Vries Robbé et al., 2011).  This serves to highlight the argument 
that ‘risk-only evaluations are inherently inaccurate’ (Rogers, 2000, p. 
589). 
 
3.1.2. Summary of existing reviews 
A scoping search found no published systematic reviews 
investigating the inclusion of protective factors in violence risk 
assessment tools, although a number of systematic reviews exploring the 
use of violence risk assessments using the HCR-20, were found.  For 
example, Singh, Grann, and Fazel (2011) conducted a systematic review 
and meta-regression comparing violence risk assessment tools.  They 
found a median AUC value of .70 for the HCR-20.  Published reviews 
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including investigation of the SAPROF and START were not identified.  
Most recently, a systematic review of risk assessment strategies for 
populations at high risk of engaging in violent behaviour was identified 
(Whittington et al., 2013), investigating which risk assessment tools have 
the highest level of predictive validity for a violent outcome.  There were 
16 studies that investigated the predictive validity of the HCR-20, and 
found a mean AUC value of .69 (Whittington et al., 2013).  
 Whittington et al. (2013) declare that for a risk assessment tool to 
be effective a number of elements should be present, including the 
recognition of protective factors.  This highlights the emerging presumed 
importance of protective factors when completing violence risk 
assessments but does not identify their impact on predictive accuracy. 
 
3.1.3. Aims and objectives 
The aim of this review was to examine systematically the research 
literature on the inclusion of protective factors in violence risk 
assessment tools.  It investigated the predictive accuracy of violence risk 
assessment tools used in forensic mental health services in the NHS; the 
HCR-20, the SAPROF, and the START.  It compared the predictive 
accuracy of these tools to establish whether the inclusion of protective 
factors improves the risk assessment process. 
 
3.2. Method 
Evidence for the predictive accuracy of the HCR-20, the SAPROF, 
and the START was assessed by conducting a systematic review of 
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published and unpublished resources.  The review followed the PRISMA 
guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009). 
 
3.2.1. Identification of studies 
3.2.1.1. Search strategy: sources of literature 
The sources of literature are outlined in table 3.2.  Electronic 
bibliographic databases and gateways were searched in an attempt to 
identify all relevant publications.  Grey literature and the reference lists 
of previous reviews and retrieved resources were also searched, and 
further attempts to identify studies were made by contacting experts in 
the field.  These sources were specified as previous systematic reviews in 
the area of violence risk assessment found them appropriate (for 
example, Singh et al., 2011).  The search included both published and 
unpublished resources, and those obtained in a foreign language were 
noted.   
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Table 3.2 
 
Data sources 
Source Database Search 
completed 
Electronic 
bibliographic 
databases 
EBSCOhost: Cumulative Index to Nursing 
and Allied Health Literature (CINAHL) 
09th March 2015 
OVID: PsycINFO (1806 to March Week 1 
2015) 
09th March 2015 
OVID: Embase (1980 to 2015 Week 10) 09th March 2015 
OVID: MEDLINE (R) (1946 to March Week 1 
2015) 
09th March 2015 
ProQuest: Applied Social Sciences Index and 
Abstracts (ASSIA) 
09th March 2015 
Web of Science (Science Citation Index 
Expanded (SCI-EXPANDED), Social Sciences 
Citation Index (SSCI), Arts and Humanities 
Citation Index (A&HCI), Conference 
Proceedings Citation Index – Science (CPCI-
S), Conference Proceedings Citation Index – 
Social Science and Humanities (CPCI-SSH)) 
(Timespan = 2000-2015) 
11th March 2015 
Gateways Cochrane Library 09th March 2015 
Campbell Library 11th March 2015 
Grey 
literature 
sources 
Google Scholar 
 
11th March 2015 
Reference 
lists from 
identified 
reviews 
 
A search of reference lists of resources which 
met the inclusion criteria took place 
 
14th April 2015 
Contact with 
experts 
 
Michiel de Vries Robbe (Van der Hoeven 
Kliniek, Utrecht) 
14th April 2015 
Dr Vivienne De Vogel (Van der Hoeven 
Kliniek, Utrecht) 
14th April 2015 
Dr Kevin Douglas (Simon Fraser University, 
Canada) 
14th April 2015 
Dr Christopher Webster (Simon Fraser 
University, Canada) 
14th April 2015 
 
3.2.1.2. Search strategy: search terms 
The search strategy was broad and not restricted to a single type 
of study.  The search was limited to references published from the year 
2000 onwards, as the first violence risk assessment including the 
evaluation of protective factors was developed in 2004 (START; Webster 
et al., 2004).  The following outlines the search terms applied to all 
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databases, and this was modified to meet the requirements of each 
database (see appendix 3.A): 
 
(forensic mental health patient/offender) 
AND 
(HCR-20/SAPROF/START) 
AND 
(predictive validity/area under curve) 
 
3.2.1.3. Data management 
EndNote (bibliographic software) was used during the review 
process to manage the data. 
 
3.2.2. Study selection (inclusion and exclusion criteria) 
After identification of studies using the search strategy described, 
all duplicate references were identified and removed, and all irrelevant 
references were excluded by screening the reference titles.  The inclusion 
criteria (see table 3.3) were applied to the remaining resources in two 
stages.  In stage 1 two reviewers (the researcher and a research 
assistant with experience of completing violence risk assessment tools) 
applied the inclusion criteria to the titles and abstracts of all remaining 
references.  Full-text papers of any titles and abstracts considered 
relevant by either reviewer were obtained, and their relevance was again 
assessed using inclusion criteria (stage 2).  See appendix 3.B for the full 
inclusion and exclusion form used at both stages.  References that did 
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not meet the criteria were excluded and their details were recorded 
alongside the reasons for exclusion.   
 
Table 3.3 
Inclusion criteria 
Population Adult males with a diagnosis of mental illness and/or personality 
disorder, and a history of violent behaviour 
Exposure HCR-20V2, HCR-20V3, START, SAPROF  
Outcome HCR-20/START/START vulnerabilities/SAPROF: Actual, 
attempted, threatened harm to others/self 
SAPROF/START strengths: Absence of actual, attempted, 
threatened harm to others/self 
 
The violence risk assessment tools selected for inclusion in this 
review have primarily been validated for use in an adult male sample (de 
Vogel et al., 2012).  For this reason, research based solely on a female or 
adolescent sample was excluded.  Research conducted using samples 
without a diagnosis of mental illness (MI) or personality disorder (PD) 
were excluded because it would not reflect the population found within 
forensic mental health services.   
To investigate the predictive validity of the specified violence risk 
assessment tools two outcomes were identified: i) actual, attempted, 
threatened harm to others/self; and ii) absence of actual, attempted, 
threatened harm to others or self.  This reflects that the HCR-20V2, HCR-
20V3, START, and the SAPROF (used with either the HCR-20V2 or HCR-
20V3) assess likelihood of future violence, while the SAPROF used 
independently assesses absence of future violence.  Actual, attempted, 
threatened harm to others or self was considered to be self-reported or 
observed aggression or violence towards others or self, violent 
reoffending, violent reconviction, violent recidivism, or readmission due 
to violence.  Violence to self was included as research conducted by 
60 
 
 
 
Abidin et al. (2013) had found the HCR-20, SAPROF, and START to be 
predictive of self-harm (to varying degrees). 
All quantitative study designs were included.  Qualitative study 
designs were not included as they would not have reported a measure of 
predictive validity.  To reduce publication bias, no initial limits were set 
on language, despite the researcher lacking resources to translate non-
English language studies within the time constraints.  Details of these 
studies were recorded (see figure 3.1), but they were excluded from the 
review, as were any references which were un-obtainable despite 
contacting the author.  Those studies focused on the HCR-20V2 which 
were included in the systematic review conducted by Whittington et al. 
(2013) were excluded to avoid double counting.   
 
3.2.3. Quality assessment 
The quality of the remaining references was assessed using 
adapted checklists from the Critical Appraisal Skills Programme (CASP; 
CASP, 2013; see appendices 3.C and 3.D).  Adaptations included 
specifying the violence risk assessment tools used, a clear definition of 
the outcome measure, and an appropriate measure of predictive validity 
(for example, AUC value).  The quality assessment was completed by the 
researcher.  To aid consistency of the process, 20% of the references 
were independently assessed by a second reviewer (a research assistant 
with experience of completing violence risk assessment tools).  An intra-
class correlation coefficient (ICC) of .98 (95% confidence interval = .92 – 
1.00) was achieved between the two assessors for this data set, which 
falls in the excellent range (Fleiss, 1986). 
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3.2.4. Data extraction 
 Following the quality assessment, data were extracted from all 
included studies using a data extraction form (see appendix 3.E).  Data 
to be extracted included sample size, risk assessment tool, outcome 
measure, length of follow-up, base rate, and predictive validity.  Due to 
time constraints it was not possible to contact the authors of relevant 
resources if there were missing data or additional data required, 
therefore this information was recorded as ‘unknown’.  To reduce errors 
or inconsistences the researcher repeated the data extraction process, 
and cross-checked both sets of extracted data.  Following completion of 
the data extraction tables the data were reported using the process of 
narrative synthesis (Boland, Cherry, & Dickson, 2014). 
 
3.3. Results 
3.3.1. Quantity of research available 
 The search identified 5,947 citations.  Following removal of 566 
duplicates, and 5,148 irrelevant references, 233 references remained for 
screening using the inclusion and exclusion criteria.  During stage 1 
screening 137 references were excluded on the basis that their title and 
abstract did not meet the inclusion criteria.  This resulted in 96 
references being retained for stage 2 screening.  After applying the 
inclusion criteria to the full-texts of the remaining references (stage 2), 
34 references were excluded; 12 did not have the specified population, 
the exposure was not as required in 15, and 6 were excluded due to the 
study design.  One reference was excluded as it was a dissertation, and 
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the studies within were already included in the review.  The full-texts of 
three references were excluded because they could not be obtained 
despite author contact, and six non-English language references were 
excluded.  A further thirteen references were excluded due to being 
included in a previously completed systematic review (Whittington et al., 
2013).  Following contact with experts in the field, three additional 
references were included, and a further one reference was obtained via 
hand searching of reference lists of previous reviews and retrieved 
resources.  Subsequently 44 references were included.  The results of the 
study selection stage have been reported using a PRISMA diagram 
(Moher et al., 2009), see figure 3.1.  Appendices 3.F, 3.G, 3.H, and 3.I 
outline reasons for exclusion in regards to each reference. 
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Figure 3.1. Identification of included studies 
ASSISA: 114, Campbell: 0, CINAHL: 
720, Cochrane: 678, EMBASE: 103, 
Google Scholar: 107, Medline: 3322, 
PsycINFO: 582, Web of Science: 321, 
TOTAL: 5947 
566 references 
excluded - 
duplicates 
5148 references 
excluded - 
irrelevant 
233 references 
included 
137 references 
excluded - did not 
meet the inclusion 
criteria (stage 1 - 
titles/abstracts 
screened) 
96 references 
included 
34 references excluded - did not meet the 
inclusion criteria (stage 2 - full text 
screened).  Population (n = 12), 
exposure (n = 15), study design (n = 6), 
dissertation; repeated studies (n = 1) 
9 references excluded - not accessible in 
timeframe (6 x non-English language (2 
x Dutch, 2 x French, 1 x Greek, and 1 x 
Czech), 3 x unobtainable despite author 
contact)  
13 references excluded - in 
previously completed systematic 
review (HCR-20) 
4 additional references  
included (1 x hand 
searched from 
reference list, 3 x 
identified via expert) 
44 references 
included 
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3.3.2. Quality assessment 
 All included studies were assessed for quality.  Quality scores 
ranged between 28 and 47 for cohort studies (maximum score achievable 
was 66), with a mean of 38.5 (SD = 4.9), and between 47 and 50 for 
case control studies (maximum score achievable was 74) with a mean of 
48.5 (SD = 2.1).  Appendices 3.J and 3.K detail the results of the quality 
assessment process. 
The majority of the studies were cohort designs (n = 42), and 29 
of these employed a prospective study design (73%).  Two studies were 
case control designs, and both were prospective studies.  The suitability 
of the follow-up period was guided by the time frames for update 
recommended by the authors of the tools; for the HCR-20 and SAPROF 
follow-up period greater than 12 months was considered good, whereas 
for the START a follow-up period greater than 3 months was considered 
good.  More than half of the studies had a follow-up period which was 
considered suitable (66%), whereas 9% were determined to have an 
unsuitable follow-up period (less than 6 months for the HCR-20 and 
SAPROF, and less than 1 month for the START).  Participants lost during 
the follow-up period were reported in 23% of studies, though 93% of 
studies did not discuss the implications of lost participants.  Table 3.4 
outlines further details of study design and follow-up periods. 
 In terms of selection bias 28 studies (64%) utilised a large number 
of participants (n ≥ 100), 20% used a sample recruited across more than 
one site, and 39% included all participants who were available.  This 
highlights a particular area for improvement in relation to recruiting 
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larger samples, across different sites, and including all relevant 
participants. 
 Measurement bias was considered for the exposure construct (risk 
assessment tool), and the outcome (the presence or absence of actual, 
attempted, threatened harm to others/self).  The risk assessment tool 
was clearly stated in all studies, and the assessor rating the risk 
assessment tool was blind to the outcome in 27% of studies, although it 
was unclear if this was the case in another 70% of studies.  The risk 
assessment tool manual defines the level of training assessors should 
receive prior to completion, and this was reflected in 66% of studies.  
The manual also recommends the assessments should be completed 
using more than two sources of information (file review, interview with 
patient/offender, interview with those who know patient/offender).  This 
was reflected in 16% of studies.  Many used two sources (34%) or one 
source (32%).  Consensus rating was used in 14% of studies (where the 
assessment is completed by more than one assessor who agree a rating).  
Inter-rater reliability was assessed in 50% of studies and found to be 
excellent in 82% of those studies.   
Measurement bias in terms of the outcome was considered in 
relation to whether it was clearly defined, and whether the outcome 
measure reflected the defined outcome.  This was found to be the case in 
89% and 23% of studies respectively.  The assessor of outcome was 
reported to be blind to the exposure in 20% of studies but it was unclear 
in 70%.  Missing information was only discussed in 9% of studies.  The 
quality of future research could be improved by following 
recommendations of the tool’s authors in terms of completing the 
66 
 
 
 
assessments, ensuring the assessor is blind to the outcome and exposure 
(and that it is clearly reported), ensuring the defined outcome is reliable 
and valid, and making sure missing information is considered and dealt 
with appropriately. 
 The results were clearly reported in all studies, as was predictive 
validity, and the majority of studies reported outcome base rates (91%).  
Construct validity was considered in 36% of studies, and confounding 
factors considered in 50% of studies.  The results were considered to fit 
with other available evidence in the majority of studies (82%), and the 
implications for practice were discussed in 73% of studies.  The 
discussion and consideration of confounding factors would be an area of 
improvement for the quality of future research studies.   
 
3.3.3. Study characteristics 
Table 3.4 outlines the characteristics of each study.  Some studies 
investigated more than one risk assessment tool, and as such the HCR-
20V2 was investigated in 31 studies, the HCR-20V3 in three studies, the 
SAPROF in eight studies, and the START in 15 studies.  Additional risk 
assessment tools were investigated in 18 of the studies as comparators, 
but the results of these were not discussed within this review.  The HCR-
20V2 was the most widely evaluated tool, which indicates it has been the 
most robustly tested.  The HCR-20V3, SAPROF, and START are relatively 
newer tools, and as such have not been the focus of research to the 
same degree.  Half of the studies examining the SAPROF were completed 
by the authors of the tool or researchers affiliated with them, as such 
author bias was present.  Similarly 42% of research investigating the 
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predictive validity of the START was completed by the authors (or those 
affiliated with) of the tool. 
Included studies were conducted in 18 different countries.  The 
United Kingdom (England, Northern Ireland, Scotland, and Wales) 
accounted for the majority of studies (34%).  The studies investigating 
the HCR-20V2 used participants from the broadest range of countries.  
The research focused on the SAPROF used participants primarily from the 
Netherlands (50%), while research investigating the START used 
participants primarily from Canada (47%).  This is a reflection of research 
being completed by the authors of the assessment tool; 50% of research 
conducted on the SAPROF was completed by the tools authors, and 42% 
of START research was completed by the tools authors.  This highlights 
author bias in the research. 
 For all included studies the research settings comprised inpatient 
(43%), community (46%), or both inpatient and community (11%) 
contexts.  For the HCR-20V2 more than half of the studies were 
conducted in the community (52%); all research investigating the HCR-
20V3 was completed in the community.  SAPROF research was primarily 
conducted in the community (50%), whilst 74% of START research was 
using inpatient samples. 
As mentioned in the quality assessment, the majority of studies 
were cohorts which employed a prospective approach.  Overall 44 studies 
the follow-up period ranged from 30 days to 11 years.  In terms of the 
HCR-20V2 and HCR-20V3, the follow-up period ranged from 6 months to 
11 years, and 6 months to 36 months respectively.  The follow-up period 
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for the SAPROF ranged from 6 months to 11 years, and from 30 days to 
12 months for the START. 
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Table 3.4 
 
Study characteristics 
Risk tool Reference Additional 
assessment 
Country Setting Study design Follow-up 
HCR-20V2 Abidin et al. (2013)  Ireland Inpatient Prospective 6 months 
 Arbach-Lucioni et al. (2011) PCL-SV Spain Inpatient Prospective 12 months 
 Barber-Rioja et al. (2012) PCL-SV USA Community Retrospective 12 months 
 Chu et al. (2011a)  Australia Inpatient Retrospective 6 months 
 Coid et al. (2009) PCL-R 
VRAG 
RM2000 
OGRS-II 
England and Wales Community Prospective M 1.97 years 
 Coid et al. (2011) PCL-R 
VRAG 
England and Wales Community Prospective M 1.97 years 
 Coid et al. (2013) VRAG 
OGRS-II 
England and Wales Community Prospective M 1.97 years 
 Coupland (2015) VRS Canada Inpatient and community Retrospective M 9.7 years 
 de Borba Telles et al. (2012) PCL-R Brazil Inpatient Prospective 12 months 
 de Vries Robbé & de Vogel (2011) PCL-R Netherlands Inpatient Prospective 12 months 
 de Vries Robbé et al. (2011)  Netherlands Community Retrospective 36 months 
 de Vries Robbé et al. (2013)  Netherlands Community Retrospective M 11 years 
 de Vries Robbe et al. (2014)  Netherlands Inpatient Prospective 12 months 
 Dernevik et al. (2002)  Sweden Inpatient Prospective 12 months 
 Desmarais et al. (2012) PCL-SV Canada Inpatient Retrospective 12 months 
 Dolan and Blattner (2010)  England Community Retrospective 12 months 
 Doyle et al. (2012) VRAG 
VRS 
England Community Prospective 5 months 
 Gray et al. (2011a)  England and Wales Community Retrospective 24 months 
 Ho et al. (2013)  China Community Prospective 12 months 
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Risk tool Reference Additional 
assessment 
Country Setting Study design Follow-up 
 Langton et al. (2009) VRS 
Static-99 
RM200 
PCL-R 
England Inpatient Prospective M 570 days 
 McDermott et al. (2008) PLC-R USA Inpatient Prospective M 2.5 years 
 Michel et al. (2013)  Canada 
Finland 
Germany 
Sweden 
Community Prospective 24 months 
 Neves et al. (2011) PLC-R Portugal Community Prospective M 13 months 
 O’Shea et al. (2014)  England Inpatient Prospective 3 months 
 Pedersen et al. (2010)  Denmark Community Retrospective M 6 years 
 Pedersen et al. (2012)  Denmark Inpatient and community Prospective M 21 months 
 Snowden et al. (2010) VRAG England and Wales Community Retrospective 24 months 
 Troquete et al. (2014)  Netherlands Community Prospective 6 months 
 Viljoen (2014)  Canada Community Prospective 12 months 
 Vojt et al. (2013)  Scotland Inpatient and community Prospective M 31 months 
 Wilson et al. (2013)*  Canada Inpatient Prospective 12 months 
HCR-20V3 de Vogel et al. (2014)  Netherlands Community Retrospective 36 months 
 Doyle et al. (2014)  England and Wales Community Prospective 12 months 
 Strub et al. (2014) HCR-20V2 Canada Community Prospective 6-8 months 
SAPROF Abidin et al. (2013) ^      
 Barnard-Croft (2014)  England and Wales Community Prospective 12 months 
 Coupland (2015) ^      
 de Vries Robbé & de Vogel (2011) ^      
 de Vries Robbé et al. (2011) ^      
 de Vries Robbé et al. (2013) ^      
 de Vries Robbe et al. (2014) ^      
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Risk tool Reference Additional 
assessment 
Country Setting Study design Follow-up 
 Viljoen (2014) ^ PCL-R     
START Abidin et al. (2013) ^      
 Braithwaite et al. (2010)  Canada Inpatient Prospective 30 days 
 Chu et al. (2011a) ^ LSI-R SV 
PCL-R 
VRAG 
    
 Chu et al. (2011b)  Australia Inpatient Retrospective 1 month 
 Desmarais et al. (2010)  Canada Inpatient and community Prospective 12 months 
 Desmarais et al. (2012) ^      
 Gray et al. (2011b)  Wales Inpatient Prospective M 114 days 
 Nicholls et al. (2006)  Portugal Inpatient and community Prospective 12 months 
 Nonstad et al. (2010)  Canada Inpatient Prospective 3 months 
 Quinn et al. (2013)  England Inpatient Retrospective 6 months 
 Troquete, et al. (2014)^      
 Viljoen (2014)      
 Whittington, et al. (2014)  England Inpatient Prospective 30 days 
 Wilson et al. (2010)*  Canada Inpatient Prospective 12 months 
 Wilson et al. (2013) *^      
Note.  Additional risk assessment tools: LSI-R SV (Level of Service Inventory – Revised Short Version; Andrews & Bonta, 1998), OGRS-II (Offenders 
Group Reconviction Scale – II; Copas & Marshall, 1998; Taylor, 1999), PCL-R (Psychopathy Checklist – Revised; Hare, 2003), PCL-SV (Psychopathy 
Checklist – Short Version; Hart, Cox, & Hare, 1995), RM2000 (Risk Matrix 2000; Thornton, 2005; Thornton et al., 2003), Static-99; (Hanson & 
Thornton, 2000; Harris, Phenix, Hanson, & Thornton, 2003), VRAG (Violence Risk; Quinsey, Harris, Rice, & Cormier, 1998), and VRS (Violence Risk 
Scale; Wong & Gordon, 2006). 
*case control study. 
^ data described above under different risk assessment tool. 
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3.3.3.1. Participant characteristics 
The participant characteristics of all included references can be 
found in tables 3.5 and 3.6.  There were a total of 11,847 participants 
investigated, and all studies were treated as separate pieces of research.  
It appeared the same sample was used in 3 studies (Coid et al., 2009, 
2011, and Coid, Ullrich, & Kallis, 2013), although different risk 
assessment tools were examined.  The same samples were also used in 
Wilson, Desmarais, Nicholls, and Brink, (2010) and Wilson, Desmarais, 
Nicholls, Hart, and Brink (2013), again examining different risk 
assessment tools.  The smallest sample size was 30 (Wilson et al., 2010, 
2013), and the largest sample size was 1,657 (Coid et al., 2009).   
All samples were at least 60% male, and 16 studies used samples 
which were 100% male.  The mean age of the samples ranged from 31 
years old to 47 years old, this information was unclear in 1 study.  The 
percentage of participants who had a history of violence ranged from 
18% to 100%, though this information was unclear in 23 studies.  The 
percentages of participants with a diagnosis of MI ranged from 5% to 
100% (unclear in 15 studies).  Finally, the percentages of participants 
with a diagnosis of PD ranged from 0.7% to 98% (unclear in 13 studies).  
The main reason for information being unclear was that a history of 
violent behaviour, MI, and PD were often divided into different categories 
(for example, murder and arson, or schizophrenia and mood disorders), 
and the participants frequently fell into more than one category, resulting 
in it being impossible to separate this data into the categories required by 
the review.   
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Table 3.5 
 
Participant characteristics 
Risk tool Reference Sample 
size 
% 
male 
M age % history of 
violence 
% diagnosis of MI % diagnosis of PD 
HCR-20V2 Abidin et al. (2013) 100 94 40 Unknown 100 Unknown 
 Arbach-Lucioni et al. (2011) 78 74 43 Unknown 90 10 
 Barber-Rioja, et al. (2012) 131 69 37 Unknown 10 Unknown 
 Chu et al. (2011a) 66 80 34 44 85 20 
 Coid et al. (2009)a 1657 82 31 Unknown Unknown 73 
 Coid et al. (2011) a 1353 100 31 Unknown 44 74 
 Coid et al. (2013) a 1396 100 31 Unknown Unknown Unknown 
 Coupland (2015) 178 100 38 Unknown 30 76 
 de Borba Telles et al. (2012) 68 100 43 Unknown 59 15 
 de Vries Robbé & de Vogel (2011)  245 100 Unknown 60 Unknown Unknown 
 de Vries Robbé et al. (2011)  105 100 31 Unknown 19 83 
 de Vries Robbé et al. (2013)  188 100 32 100 15 66 
 de Vries Robbe et al. (2014) 185 79 41 70 53 89 
 Dernevik et al. (2002) 54 89 34 100 69 Unknown 
 Desmarais et al. (2012) 120 100 38 80 Unknown Unknown 
 Dolan and Blattner (2010) 72 87 36 64 73 31 
 Doyle et al. (2012) 114 62 40 18 55 4 
 Gray et al. (2011a) 890 100 38 Unknown Unknown 18 
 Ho et al. (2013) 220 75 44 99 Unknown 5 
 Langton et al. (2009) 44 100 34 89 Unknown Unknown 
 McDermott et al. (2008) 238 86 47 86 100 98 
 Michel et al. (2013) 248 96 38 57 82 22 
 Neves et al. (2011) 258 87 35 73 5 2 
 O’Shea et al. (2014) 505 69 40 Unknown Unknown Unknown 
 Pedersen et al. (2010) 107 100 36 94 Unknown 18 
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Risk tool Reference Sample 
size 
% 
male 
M age % history of 
violence 
% diagnosis of MI % diagnosis of PD 
 Pedersen et al. (2012) 81 100 36 96 Unknown 9 
 Snowden et al. (2010) 1016 85 32 Unknown 77 18 
 Troquete et al. (2014) 310 94 40 Unknown 93 69 
 Viljoen (2014) 102 61 47 22 100 34 
 Vojt et al. (2013) 109 100 39 Unknown 93 7 
 Wilson et al. (2013) b 30 100 37 73 87 Unknown 
HCR-20V3 de Vogel et al. (2014) 86 100 32 100 21 62 
 Doyle et al. (2014) 387 89 38 (median) Unknown Unknown Unknown 
 Strub et al. (2014) 106 69 34 Unknown 82 Unknown 
SAPROF Abidin et al. (2013) ^       
 Barnard-Croft (2014) 409 89 38 Unknown 89 6 
 Coupland (2015) ^       
 de Vries Robbé & de Vogel (2011) ^       
 de Vries Robbé et al. (2011) ^       
 de Vries Robbé et al. (2013) ^       
 de Vries Robbe et al. (2014) ^       
 Viljoen (2014) ^       
START Abidin et al. (2013) ^       
 Braithwaite et al. (2010) 34 79 44 Unknown Unknown 21 
 Chu et al. (2011a) ^       
 Chu et al. (2011b) 50 76 35 Unknown 86 20 
 Desmarais et al. (2010) 119 90 39 64 85 Unknown 
 Desmarais et al. (2012) ^       
 Gray et al. (2011b) 44 64 40 Unknown Unknown 14 
 Nicholls et al. (2006) 137 89 38 Unknown 100 .7 
 Nonstad et al. (2010) 47 83 36 Unknown 100 15 
 Quinn et al. (2013) 80 74 38 96 Unknown 13 
 Troquete et al. (2014)^       
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Risk tool Reference Sample 
size 
% 
male 
M age % history of 
violence 
% diagnosis of MI % diagnosis of PD 
 Viljoen (2014) ^       
 Whittington et al. (2014) 50 88 39 Unknown Unknown Unknown 
 Wilson et al. (2010)b 30 100 37 73 87 Unknown 
 Wilson et al. (2013) b^       
Note.  a same sample used across studies. 
b same sample used across studies. 
^ data described above under different risk assessment tool. 
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Table 3.6 
 
Participant characteristics dependent on the risk assessment tool studied 
 
3.3.3.2. Outcome characteristics 
Table 3.7 details the defined outcome, and the average base rates.  
The studies included in the review utilised a number of different 
outcomes to investigate the predictive validity of the risk assessment 
tools.  The most common outcomes, as defined in each study, were 
violence (13 studies) and aggression (12 studies).  Base rates were 
reported in all but 2 studies, and were often divided into categories 
dependent on follow-up periods, and sub-levels of the defined outcome.  
The reported base rates ranged between 11% and 73%.  In terms of the 
HCR-20V2, the reported base rates ranged between 11% and 73%, and 
for the HCR-20V3 it was between 23% and 34%.  The base rates ranged 
between 11% and 53% for the SAPROF, and between 15% and 65% for 
the START.  The problem of comparing base rates for differing outcomes 
should be acknowledged.  For example, studies investigating the SAPROF 
used absence of violence as an outcome which is likely to produce a 
much higher base rate than an outcome of presence of violence, 
increasing the possibility for true positives regardless of the accuracy of 
the assessment tool (Conway & Murrie, 2007). 
  
 HCR-20V2 HCR-20V3 SAPROF START 
n studies 31 3 8 15 
Total participants 10,628 579 1,412 1,319 
% male 84 86 90 85 
n studies 100% male 14 0 4 3 
M age range 31 – 47 32 - 38 31 - 47 34 - 47 
% history of violence range 18 – 100 100 22 – 100 22 - 96 
% diagnosis of MI range 5 – 100 21 – 82 19 – 100 85 - 100 
% diagnosis of PD range 2 - 98 62 5 - 89 0.7 - 69 
77 
 
 
 
Table 3.7 
 
Outcome characteristics 
Risk tool Resference Outcome Average base rate 
HCR-20V2 Abidin et al. (2013) Adverse events 7.1 per 10,000 patient-days at risk 
 Arbach-Lucioni et al. (2011) Aggression 54% 
 Barber-Rioja et al. (2012) Re-incarceration and non-compliance 43% 
 Chu et al. (2011a) Violence 29% 
 Coid et al. (2009) Reconviction 27% 
 Coid et al. (2011)  Reconviction 29% 
 Coid et al. (2013) Reconviction 25% 
 Coupland (2015) Institutional and community recidivism 53% 
 De Borba Telles et al. (2012) Violent and/or anti-social behaviour 73% 
 de Vries Robbé & de Vogel (2011)  Violence Unknown 
 De Vries Robbé et al. (2011)  Recidivism 19% 
 De Vries Robbé et al. (2013)  Recidivism 30% 
 De Vries Robbe et al. (2014) Aggression 11% 
 Dernevik et al. (2002) Violence 57% 
 Desmarai, et al. (2012) Aggression 55% 
 Dolan and Blattner (2010) Failure (readmission or reconviction) 56% 
 Doyle et al. (2012) Violence 25% 
 Gray et al. (2011a) Reconviction 15% 
 Ho et al. (2013) Violence 27% 
 Langton et al. (2009) Aggression 39% 
 McDermott et al. (2008) Physical aggression 25% 
 Michel et al. (2013) Any aggressive behaviour 18% 
 Neves et al. (2011) Recidivism 35% 
 O’Shea et al. (2014) Aggressive and violent incidents 61% 
 Pedersen et al. (2010) Recidivism 65% 
 Pedersen et al. (2012) Aggression and recidivism 43% 
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Risk tool Resference Outcome Average base rate 
 Snowden et al. (2010) Reconviction 12% 
 Troquete et al. (2014) Violent and criminal behaviour, and 
START definition  
21% 
 Viljoen (2014) Aggression 48% 
 Vojt et al. (2013) Violent incident and reconviction 25% 
 Wilson et al. (2013)  Institutional violence 50% 
HCR-20V3 De Vogel, et al. (2014) Violent reconviction Unknown 
 Doyle et al. (2014) Violence 23% 
 Strub et al. (2014) Violence 34% 
SAPROF Abidin et al. (2013)^   
 Barnard-Croft (2014) Violence 29% 
 Coupland (2015) ^   
 de Vries Robbé & de Vogel (2011) ^   
 De Vries Robbé et al. (2011) ^   
 De Vries Robbé et al. (2013) ^   
 De Vries Robbe et al. (2014) ^   
 Viljoen (2014) ^   
START Abidin et al. (2013) ^   
 Braithwaite et al. (2010) Challenging behaviour 48% 
 Chu et al. (2011a) ^   
 Chu et al. (2011b) Aggression 15% 
 Desmarais et al. (2010) Aggression 44% 
 Desmarais et al. (2012) ^   
 Gray et al. (2011b) Aggression 36% 
 Nicholls et al. (2006) Aggression 65% 
 Nonstad et al. (2010) Violent incidents (physical) 35% 
 Quinn et al. (2013) Aversive incidents 165 aversive incidents 
 Troquete et al. (2014) ^   
 Viljoen (2014) ^   
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Risk tool Resference Outcome Average base rate 
 Whittington, et al. (2014) Aggression 52% 
 Wilson et al. (2010) Institutional violence 50% 
 Wilson et al. (2013) ^   
Note.  ^ data described above under different risk assessment tool.
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3.3.4. Results data synthesis 
Inter-rater reliability was primarily investigated using intra-class 
correlations, where the critical values are: ICC ≥ .75 = excellent, ICC 
between .60 and < .75 = good, and ICC between .40 and .60 = 
moderate (Fleiss, 1986).  Table 3.8 outlines the inter-rater reliability for 
each study, and the mean inter-rater reliability data for each risk tool are 
displayed in table 3.9.  Full results can be found in appendix 3.L.  Inter-
rater reliability ranged between .41 for the overall risk rating on the 
START (Viljoen, 2014), and .98 for the HCR-20V2 (Coid et al., 2009, 
2011, and Coid, Ullrich, & Kallis, 2013).  Overall, the HCR-20V3 had the 
highest inter-rater reliability with a mean of .88 (.83-.92), and the START 
had the lowest with a mean of .75 (.41-.91), however this is still in the 
excellent range. 
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Table 3.8 
 
Results: Inter-rater reliability and AUC values 
Risk tool Reference Inter-rater 
reliability 
Follow-up AUC 
HCR-20V2 Abidin et al. (2013)  6 months .88* 
 Arbach-Lucioni et al. (2011)  1-4 months .75* 
   5-8 months .69* 
   9-12 months .77* 
 Barber-Rioja et al. (2012) ICC = .90 12 months .75* 
 Chu et al. (2011a)  1 month .73* 
   3 months .74* 
   6 months .61* 
 Coid et al. (2009) ICC = .98 M 1.97 years .68* 
 Coid et al. (2011)  ICC = .98 M 1.97 years .67 
 Coid et al. (2013) ICC = .98 M 1.97 years .62* 
 Coupland (2015) ICC = .94* M 9.7 years .65* 
 De Borba Telles et al. (2012)  12 months .78* 
 de Vries Robbé & de Vogel 
(2011)  
 12 months .79* 
 De Vries Robbé et al. (2011)   12 months .81 
   24 months .77 
   36 months .68 
 De Vries Robbé et al. (2013)  ICC= .74 12 months .84 
   36 months .73 
   Long term .64 
 De Vries Robbe et al. (2014)  12 months .78* 
 Dernevik et al. (2002)  12 months .71* 
 Desmarais et al. (2012)  12 months .79* 
 Dolan and Blattner (2010)  12 months .86 
 Doyle et al. (2012) ICC= .88* 5 months .68 
 Gray et al. (2011a) r = .80 24 months .69* 
 Ho et al. (2013) ICC = .37 6 months .72* 
   12 months .69* 
 Langton et al. (2009)  12 months .59* 
   Full period .69* 
 McDermott et al. (2008) ICC = .97 6 months .77* 
   Full period .64* 
 Michel et al. (2013) ICC = .73* 6 months .67* 
   12 months .71* 
   18 months .71 
   24 months .72* 
 Neves et al. (2011)  M 12.82 
months 
.82* 
 O’Shea et al. (2014)  3 months .66* 
 Pedersen et al. (2010) ICC = .90 M 6 years .74* 
 Pedersen et al. (2012)  M 21 months .68* 
 Snowden et al. (2010) ICC = .80 24 months .70* 
 Troquete et al. (2014)  3 months .59* 
   6 months .60* 
 Viljoen (2014) ICC = .80 6 months .53* 
   12 months .70* 
 Vojt et al. (2013)  M 31 months .63* 
 Wilson et al. (2013)  ICC = .88 3 months .86 
   6 months .81 
   9 months .74 
   12 months .85* 
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Risk tool Reference Inter-rater 
reliability 
Follow-up AUC 
HCR-20V3 De Vogel et al. (2014) ICC = .83 12 months .77 
   24 months .75 
   36 months .67 
 Doyle et al. (2014) ICC = .92 6 months .73 
   12 months .70 
 Strub et al. (2014)  4-6 weeks .75* 
   6-8 months .67* 
SAPROF Abidin et al. (2013) r = .83 6 months .81* 
 Barnard-Croft (2014) ICC > .90 6 months .73* 
   12 months .72* 
 Coupland (2015)  ICC = .77 M 9.7 years .65* 
 de Vries Robbé & de Vogel 
(2011) 
 12 months .79* 
 De Vries Robbé et al. (2011)  ICC = .88 12 months .85 
   24 months .80 
   36 months .74 
 De Vries Robbé et al. (2013)  ICC = .79 12 months .85 
   36 months .75 
   Long term .73 
 De Vries Robbe et al. (2014)   12 months .75* 
 Viljoen (2014)  ICC = .75 6 months .59* 
   12 months .61* 
START Abidin et al. (2013)  r = .77* 6 months .70* 
 Braithwaite et al. (2010)  30 days .62* 
 Chu et al. (2011a)   1 month .76* 
   3 months .81* 
   6 months .76* 
 Chu et al. (2011b)  1 month .74* 
 Desmarais et al. (2010) ICC = .87 12 months .74* 
 Desmarais et al. (2012)  ICC = .91* 12 months .79* 
 Gray et al. (2011b)  M 114 days .58* 
 Nicholls et al. (2006)  12 months .70* 
 Nonstad et al. (2010)  3 months .77* 
 Quinn et al. (2013)  1 month .63* 
   3 months .58* 
   6 months .56* 
 Troquete et al. (2014)  ICC = .57* 3 months .59* 
   6 months .62* 
 Viljoen (2014)  ICC = .41* 6 months .61* 
   12 months .61* 
 Whittington et al. (2014)  30 days .65* 
   M 231 days .72* 
 Wilson et al. (2010) ICC = .88* 3 months .72* 
   6 months .81* 
   9 months .71* 
   12 months .77* 
 Wilson et al. (2013)  ICC = .88* 3 months .74* 
   6 months .81* 
   9 months .71* 
   12 months .80* 
ORP index Coupland (2015)  M 9.7 years .65* 
de Vries Robbé & de Vogel 
(2011) 
ICC = .80 12 months .82* 
De Vries Robbé et al. (2011)  12 months .85 
  24 months .81 
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Risk tool Reference Inter-rater 
reliability 
Follow-up AUC 
  36 months .72 
De Vries Robbé et al. (2013)  12 months .87 
  36 months .76 
   Long term .70 
 De Vries Robbe et al. (2014)  12 months .79* 
 Viljoen (2014)  6 months .57* 
   12 months .61* 
Note.  * mean ICC/AUC. 
 
The predictive validity of each risk assessment tool was 
investigated using area under the curve statistics (AUC; see table 3.1).  
Many studies investigated the predictive validity at a variety of follow-up 
periods, and differing outcome categories, and some studies also 
differentiated between MI diagnoses.  Table 3.8 details the AUC data for 
each study.  Where multiple outcome or diagnostic categories were used, 
a mean AUC value is reported.  The full results can be found in appendix 
3.L.  Table 3.9 displays the mean AUC values for each risk tool.   
Overall, AUC values ranged between .53 (HCR-20V2; Viljoen, 
2014), and .88 (HCR-20V2; Abidin et al., 2013).  The SAPROF was found 
to have the highest level of predictive validity, with a mean AUC value of 
.74 (range .59 - .85), followed by the HCR-20V2 and HCR-20V3 which 
both had a mean AUC value of .72 (range .53 - .88, and .76 - .77 
respectively), all had a large effect size, though the START had the 
lowest level of predictive validity with a mean AUC value of .70 (range 
.56 - .81), which was a moderate effect size.  For studies focused on the 
SAPROF 79% had AUC values producing a large effect size, followed by 
the HCR-20V3 and the START, with 57% of studies resulting in large 
effect size AUC values, and 54% of studies focused on the HCR-20V2 had 
large effect size AUC values.  Studies focused on the START had the most 
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AUC values producing a small effect size (32%), and studies focused on 
the SAPROF had the least (2%). 
In terms of follow-up periods the HCR-20V2, HCR-20V3, SAPROF, 
and START were all most predictive between 6-12 months (M AUC = .74, 
.73, .74, and .71 respectively).   
The SAPROF’s ORP index was investigated in 6 studies.  Inter-rater 
reliability was reported in one study and was in the excellent range (.80).  
The level of predictive validity as reported by the AUC value ranged 
between .57 and .87, with a mean AUC value of .74.  AUC values 
producing large effect sizes were reported in 70% of studies, the 
remainder produced 10% and 20% moderate and small effect sizes 
respectively.  In terms of follow-up periods, predictive validity was 
highest between 6-12 months (M AUC = .75).   
A meta-analysis of the data generated in this systematic review 
was considered.  Although the homogeneity of the included sample 
supports the completion of a meta-analysis, the high clinical 
heterogeneity of the outcome measures contradicts this.  The outcome 
measure was operationalised differently in all studies.  For example, the 
outcome of ‘violence’ is different from ‘any aggressive behaviour’ as an 
outcome which may include acts such as verbal aggression.  In addition, 
the studies investigating the SAPROF, and some of those examining the 
START, used absence of violence as an outcome rather than presence of 
violence which would have been used when investigating the HCR-20.  
Therefore a meta-analysis was not conducted. 
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Table 3.9 
 
Results: Mean data for each risk tool 
Risk tool No. of studies 
Mean quality score 
(range) 
Mean sample size 
(range) 
Mean inter-rater reliability 
(range) 
Mean follow-up, months 
(range) 
Mean AUC 
(range) 
HCR-20V2 31 39 (28-47) 331 (30-1657) .85 (.37-.98) 16 (1-120) .72 (.53-.88) 
HCR-20V3 3 39 (29-46) 193 (86-387) .88 (.83-.92) 14 (1-36) .72 (.67-.77) 
SAPROF 8 42 (28-47) 189 (102-409) .82 (.75-.88) 26 (6-120) .74 (.59-.85) 
START 15 39 (31-50) 88 (30-310) .75 (.41-.91) 6 (1-12) .70 (.56-.81) 
ORP index 6 41 (28-47) 167 (102-245) .80 18 (6-120) .74 (.57-.87) 
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3.4. Discussion 
The search strategy identified 53 references which satisfied the 
inclusion criteria.  Of these, 13 references had been included in a 
previous systematic review and were subsequently excluded.  
Consequently 40 references obtained from the search strategy were 
included in the review.  Contacting professionals in the field and hand 
searching the reference lists of included resources revealed four further 
references.  This allowed confidence in the search strategy, and it can be 
concluded that all relevant research was included in this systematic 
review.  The HCR-20 is one of the most commonly used SPJ tools, and is 
reportedly one of the best validated violence risk assessments (Singh et 
al., 2014); it was therefore no surprise that the majority of references 
obtained during the search focused on the HCR-20.  Similarly, the 
SAPROF is the newest violence risk assessment, and as such resulted in 
the fewest research studies. 
The aim of this review was to examine systematically the research 
literature on the inclusion of protective factors in violence risk 
assessment.  It investigated the predictive accuracy of the violence risk 
assessment tools which are recommended for use in forensic mental 
health services in the NHS (HCR-20, SAPROF, and START), and compared 
the predictive accuracy of these tools to establish whether the inclusion 
of protective factors improves the risk assessment process.   
The HCR-20, which assesses risk factors, and the SAPROF, which 
assesses protective factors, demonstrated good predictive validity with a 
large effect size, while the START, which assesses both risk and 
protective factors, demonstrated moderate predictive validity with a 
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moderate effect size in relation to prediction of future violence (according 
to the classifications defined by Rice & Harris, 2005).  These results 
suggest that the violence risk assessment tools recommended for use in 
forensic mental health services in the NHS have predictive validity. 
In line with previous systematic reviews, for example Whittington 
et al. (2013) and Singh et al. (2011), the HCR-20 was found to have 
good predictive validity.  There continues to be limited research 
investigating the value of protective factors, with fewer research studies 
focused on the SAPROF and the START.  Overall, the SAPROF was found 
to have greater predictive validity (in predicting absence of violence) than 
the HCR-20 (in predicting presence of violence), with a mean AUC value 
of .74, and 79% of studies demonstrating AUC values with a large effect 
size.  This compares to a mean AUC of .72 for the HCR-20V2 and HCR-
20V3, with 54% and 57% of studies demonstrating AUC values with a 
large effect size respectively.  While the START was found to have lower 
predictive validity than the HCR-20 (mean AUC value = .70), 57% of 
studies demonstrated AUC values with a larger effect size which is similar 
to that obtained from the HCR-20.  These mixed results suggest it is 
difficult to establish whether the inclusion of protective factors improves 
the risk assessment process.   
The results observed support the research of de Vries Robbé et al. 
(2011), who found that instruments assessing violence risk which 
included protective factors had better predictive validity than using a 
negative risk-based HCR-20 alone.  When the HCR-20 and SAPROF were 
used together to create a total score of risk and protection (the ORP 
index), the overall predictive validity was higher than when the HCR-20 
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was used alone (mean AUC value = .74).  This is a small increase, and 
both values fall in the large effect range, but it further evidences that the 
inclusion of protective factors improves the predictive accuracy of 
violence risk assessment tools.  However, thus far, it is difficult to 
support the argument that to assess the risk of future violence accurately 
both risk and protective factors need to be considered (Rogers, 2000), 
when the predictive accuracy of risk assessments focused purely on risk 
factors do not differ dramatically from those which include protective 
factors.   
Overall, the methodological quality of the studies included was 
acceptable.  Strengths included the use of prospective study designs in 
the majority of research studies.  Some researchers have stated that 
because the primary aim of a risk assessment is to predict future 
violence, prospective study designs are more appropriate when 
investigating predictive validity (Caldwell, Bogat, & Davidson, 1988).  
Recommendations made by the risk assessment tools’ authors in terms of 
follow-up periods, and assessors training requirements were followed in 
the majority of research studies, and inter-rater reliability was excellent.   
Limitations and areas for improvement include problems in regard 
to sample selection, measurement bias, and author bias.  The included 
studies highlight the need to recruit larger samples and those which are 
more representative of the defined population.  Many studies included 
participants from just one psychiatric unit or excluded some participants, 
due to lack of capacity to consent for example.  The implications of 
excluded and lost participants were rarely discussed.  This is particularly 
pertinent when investigating violence risk assessment tools, as the 
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reason for participant loss for example, may be that they were moved 
due to an increase (or decrease) in their violent behaviour or relapse of 
their illness, and had this been included in the results of the study it may 
have had an impact on its outcome.  Similarly, few studies discussed 
missing information in terms of the exposure measure or the outcome 
criterion.  Finally, confounding factors were rarely discussed or 
considered in the included studies.  For example, it could be argued that 
the reason for reduced predictive validity is because the assessment 
classified an individual at high risk of future violence, and as such, an 
increased level of management and supervision was put in place 
(Andrews & Bonta, 2007), subsequently reducing the opportunity for 
future violence. 
The current systematic review has a number of strengths.  The 
search strategy was comprehensive, and reflected all relevant research.  
To reduce bias in the study selection stage, two reviewers completed 
stage 1 of applying the inclusion criteria, and the quality assessment was 
also completed by two reviewers, yielding an ICC of .98 for inter-rater 
reliability.  Publication bias was reduced by including unpublished 
resources such as theses.   
In terms of limitations, language bias may have been present due 
to 17% of studies being excluded on the basis of language or due to the 
full text being unavailable.  All studies included in the review were 
treated as separate studies, despite there being evidence some samples 
overlapped, and it is possible further studies overlapped but were not 
identified.  This possible double counting may have resulted in an over-
estimation of the number of participants included in this review.   
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Additionally, due to time constraints it was not possible to contact 
the authors of relevant resources if there were missing data, which may 
have had implications in terms of the studies included, particularly in 
relation to the defined population.  The data extraction was completed by 
a single reviewer (the researcher) which may have resulted in errors or 
inconsistencies.  However this was minimised by the reviewer repeating 
the data extraction process, and cross-checking that both sets of 
extracted data were the same.   
Author bias should be acknowledged.  Half of the research 
investigating the predictive accuracy of the SAPROF was completed by 
the authors (or those affliated with) of the tool.  Similarly 42% of 
research investigating the predictive validity of the START was completed 
by the authors (or those affiliated with) of the tool. 
Despite the inclusion criteria specifying an outcome of ‘violent 
behaviour’, each study operationalised violence outcome differently.  For 
example, using official reconviction data is different from ‘any aggression 
behaviour’.  The outcome may result in an under-estimation of violent 
behaviour, as it does not include that which is not registered or 
documented.  In addition, the outcomes differed for studies investigating 
the SAPROF (and some examining the START) as they assessed absence 
rather than presence of violence.  This affects the base rate which would 
have been much higher for absence of violence, increasing the 
opportunity for true positives independent of the accuracy of the 
assessment tool (Conway & Murrie, 2007).  Future studies may wish to 
take into consideration these limitations to improve the quality of 
research in this area. 
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The findings of this systematic review can be tentatively 
generalised to adult males with a diagnosis of mental illness or 
personality disorder, who have a history of violent behaviour, for whom 
this review was directed.  Many of the studies included a small 
percentage of females, which may have skewed the results.  In some 
studies the data regarding diagnosis was not clear, which may have had 
a similar effect.  In terms of whether the findings can be generalised to 
forensic mental health services within the NHS, much of the research was 
conducted in Western countries, and approximately a third of the studies 
were completed in the United Kingdom (n = 14), supporting 
generalisation. 
 
3.4.1. Implications for practice 
Caution should be used when applying the findings of this review 
to professional practice.  When completing research into the predictive 
validity of violence risk assessment tools, researchers tend to focus 
purely on the total scores achieved on the tools; however, these total 
scores are not used within professional practice.  The risk assessment, 
and final risk judgement is made integrating clinical and structured 
professional judgement evidence (for example, Douglas et al., 2013); 
predictive validity based purely on the total scores may not be reflective 
of the level of risk identified by the clinician. 
The findings support the continued use of the HCR-20, the 
SAPROF, and the START in forensic mental health settings within the 
NHS.  However, it could be questioned why three violence risk 
assessment instruments are utilised instead of just one.  The SAPROF 
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was found to have the greatest predictive validity in terms of absence of 
violence, but it cannot be used independently of another validated risk 
assessment tool.  The START had the lowest level of predictive validity, 
lying below the large effect size classification, indicating it may not be 
suitable for use in practice, and it could be withdrawn.   
Yet the START evaluates a number of different areas of risk, not 
just violence.  The authors of the HCR-20 (Douglas et al., 2013) and 
SAPROF (de Vogel et al., 2012) recommend they are used as ‘long term’ 
risk assessment tools, whilst the START proposes to be a ‘short term’ risk 
assessment tool (Webster et al., 2004).  Both of which are arguments for 
the START’s continued use.  The results of the systematic review found 
optimum predictive validity found between the 6 and 12 month follow-up 
period when using the SAPROF and HCR-20V3, but the START displayed 
better predictive validity between the 6 and 12 month follow-up period, 
rather than follow-up periods below 6 months.  This has implications for 
the use of the START as a short term risk assessment tool, and future 
research may wish to explore further its predictive validity at shorter 
follow-up periods (between 1 and 3 months), rather than focusing on 
follow-up periods of 6 months and above. 
 
3.4.2. Conclusions 
In conclusion, this systematic review examined the research 
literature on the inclusion of protective factors into violence risk 
assessment.  It investigated the predictive accuracy of the violence risk 
assessments tools which are recommended for use in forensic mental 
health services in the NHS, and found the HCR-20 and SAPROF 
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predictively valid (presence and absence of violence respectively), 
producing a large effect size (the START a moderate effect size), 
suggesting they have adequate predictive validity.  It was difficult to 
establish with any certainty whether the inclusion of protective factors 
improves the risk assessment process, but it appeared the use of the 
HCR-20 and SAPROF together, creating an overall total score of risk and 
protection, improved predictive accuracy for future violence, supporting 
the inclusion of protective factors.   
The predictive accuracy of violence risk assessments focused 
purely on risk factors do not differ dramatically from those which include 
protective factors.  This invites questioning of the value of protective 
factors as inherently worthy.  However, the argument remains that in 
practice neglect of protective factors can result in individuals with mental 
illness, who have offended, being classed as at a higher risk of violent 
behaviour than is appropriate (Rogers, 2000).  In addition, and thinking 
about it from the point of view of the patient, treatment to reduce violent 
reoffending should not focus purely on reducing risk factors which can be 
demoralising and demotivating (Miller, 2006), but also on increasing and 
maintaining protective factors which serves for a more positive focus for 
the individual to build upon (Rogers, 2000). 
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The Structured Assessment of Protective Factors for Violence 
Risk: a prospective validation study of psychiatric inpatients 
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Abstract 
The aim this research study was to explore the value of protective factors 
in the assessment of violence risk.  The use of the Structured Assessment 
of Protective Factors (SAPROF; de Vogel, de Ruiter, Bouman, & de Vries 
Robbé, 2009b) was explored to allow for a greater understanding of the 
effectiveness of its application in forensic inpatient settings.  The validity 
and reliability of the SAPROF as an assessment tool was investigated 
across a number of domains to evaluate whether the inclusion of 
protective factors improves predictive accuracy of violence risk 
assessment tools.  A prospective cohort research design and quantitative 
analysis were employed.  The total follow-up period was six months, and 
the sample consisted of 108 inpatients in low and medium secure forensic 
services.  Information from the SAPROF, HCR-20 V3, and START 
assessments was collected, and evidence of absence and presence of 
violence obtained.  The SAPROF was found to have good internal 
reliability, concurrent, construct, and discriminative validity.  The SAPROF 
demonstrated good predictive accuracy for absence of violence (AUC = 
.75), and results suggested its predictive abilities were superior to the 
HCR-20V3 (AUC = .68) in predicting violence, and the START (AUC = 
.64) in predicting presence and absence of violence, although not 
significantly better.  Combining the use of the SAPROF with the HCR-
20V3 significantly increased the predictive accuracy for presence of 
violence.  The SAPROF was found to have incremental validity over the 
HCR-20V3 and the START, suggesting there is additional value in the 
consideration of protective factors in the assessment of violence risk.   
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4.1. Introduction 
4.1.1. Background 
In forensic mental health services violence risk assessment and 
management is central to effective care and treatment (Wilson, 
Desmarais, Nicholls, & Brink, 2010).  A number of violence risk 
assessment tools have been developed to create a structured and 
consistent approach, but there is no ‘gold standard’ when it comes to 
choosing the correct instrument (NICE Guidelines, 2005).  Traditionally, 
tools have focused on the assessment of risk factors, but there is 
increasing evidence to suggest protective factors should be included (for 
example, Miller, 2006), and individual’s strengths emphasised 
(Department of Health; DoH, 2007a).   
The National Health Service (NHS) recommend the Historical 
Clinical Risk - 20 (HCR-20 V2; Webster, Douglas, Eaves, & Hart, 1997; 
HCR-20V3; Douglas, Hart, Webster, & Belfrage, 2013), the Structured 
Assessment of Protective Factors (SAPROF; de Vogel, de Ruiter, Bouman, 
& de Vries Robbe, 2012), and the Short Term Assessment of Risk and 
Treatability (START; Webster, Martin, Brink, Nicolls, & Desmarais, 2004) 
are used as violence risk assessment tools (service specification no. 
C03/S/a; NHS Commissioning Board, 2013).   The HCR-20 follows the 
traditional route of assessing the presence of risk factors, whereas the 
SAPROF assesses the presence of protective factors, and the START 
evaluates the presence of both protective factors and risk factors.   
This research study focused on the use of the SAPROF, specifically 
it’s predictive abilities for absence of violence, in comparison to the HCR-
20V3 and the START (which predict presence of violence).  The SAPROF 
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is a structured assessment guideline developed for use in combination 
with a reliable and valid violence risk assesment tool,  such as the HCR-
20.  It aims to balance the risk assessment of future violent behaviour by 
documenting and quantifying the presence or absence of protective 
factors such as empathy, leisure activities, and social network (de Vogel 
et al., 2012).   
ROC analysis is the most common method used to investigate the 
predictive accuracy of risk assessment tools (Mossman, 2013).  The ROC 
yields an Area Under the Curve (AUC), and in risk assessment this 
represents the probability a randomly chosen violent individual will score 
greater than a randomly chosen non-violent individual on the measure 
(Swets, 1988).  Since the SAPROF aims to identify protective factors 
against violence risk, research investigating its predictive accuracy tends 
to use absence of violence as the outcome, which contrasts with 
traditional investigation of the predictive accuracy of violence risk 
assessment tools where presence of violence is used as the outcome.   
Systematic review of the literature identifed just eight studies 
exploring the predictive validity of the SAPROF.  Half of these studies 
were completed by the authors of the SAPROF or researchers affiliated 
with them, as such author bias is present strengthening the justification 
for further research.   
Research was primarily conducted in community settings outside of 
the United Kingdom (UK), demostrating a need for further research to be 
conducted in NHS inpatient forensic mental health services.   Only one 
study was completed in England and Wales, but it used a community 
sample.  Using a prospective cohort study, Barnard-Croft (2014) 
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investigated the ability of the SAPROF to predict non-violent outcomes in 
participants discharged from a medium secure setting, comparing the 
instrument across differing diagnostic groups.  Strong significant 
correlations were found between higher scores on the SAPROF and non-
violent outcomes.  It was able to significantly predict non-violent 
outcomes for particpants with a primary diagnosis of serious mental 
illness (AUC = .78 and .69, at 6 and 12 months respectively).  However, 
it was unable to significantly predict non-violent outcomes for 
participants with a primary diagnosis of personality disorder, or a co-
morbid diagnosis of personality disorder. 
Other research completed in community settings found AUC values 
for predictive validity of absence of violence between .59 (Viljoen, 2014) 
and  .85 (de Vries Robbé, de Vogel, & de Spa, 2011, and de Vries Robbé, 
de Vogel, Wever, Douglas, & Nijman, 2014).   
In a Dutch inpatient setting, de Vries Robbé and de Vogel (2011) 
found good predictive validity for absence of violent (AUC = .77) and 
sexual (AUC = .81) offences.  They found comparable results for the 
predictive validity of the HCR-20 for presence of violent (AUC = .74) and 
sexual (AUC = .85) offences.  Also in a Dutch inpatient setting, a 
prospective investigation of the difference in dynamic risk and protective 
factors between different stages in treatment, and the predictive validity 
of the SAPROF and HCR-20 for aggressive incidents during clinical 
treatment, found total scores on the SAPROF increased as treatment 
progressed and HCR-20 total scores decreased.  Good significant 
predictive validity was found for the SAPROF for absence of aggressive 
incidents (AUC = .76) and the HCR-20 for presence of aggressive 
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incidents (AUC = .77; De Vries Robbé, de Vogel, Wever, Douglas, & 
Nijman, 2014).   
Outside of the Netherlands, Abidin, Davoren, Naughton, Gibbons, 
Nulty, and Kennedy (2013) compared the SAPROF with previously 
validated risk assessments, and prospectively tested its ability to predict 
absence of violence or self harm in a secure hospital setting in Ireland.  
They found total scores on the SAPROF had strong negative correlations 
with the HCR-20, and predicted absence of violence (AUC = .85) and 
absence of self harm (AUC = .77).   
In Canada, Coupland (2015) investigated the predictive validity of 
the SAPROF for absence of community and institutional recidivism.  
Significant predictive validity for absence of conviction of violent offences 
pre-treatment (AUC = .64), post-treatment (AUC = .65), at the point of 
release (AUC = .71), and for absence of violent offences which did not 
result in conviction (AUC = .70, .71, and .75 respectively) were found.  
The SAPROF was not found to significantly predict absence of institutional 
recidivism. 
De Vries Robbé et al. (2011) investigated the predictive validity of 
a new measure where risk factors were balanced by protective factors.  
They developed the ‘Overall Total Score of Risk and Protection Index 
(ORP index) by subtracting the SAPROF total score from the HCR-20 total 
score.  This measure had better predictive validity for violent 
reconvictions in the community than the HCR-20, and this has been 
supported by other researchers where the AUC values have ranged 
between .64 and .87 (for example, de Vries Robbé et al., 2013, and 
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Viljoen, 2014).  This construct has not been investigated in a NHS 
inpatient forensic mental health service. 
Four studies have investigated the additional value of using the 
SAPROF in addition to the HCR-20, studying the incremental validity of 
the tools.  De Vries Robbé et al. (2013) found significantly improved 
predictive validity for presence of violence in the three year and long-
term follow-up periods, but not the one year follow-up period.  
Conversely Abidin et al. (2013) found the SAPROF had a significant 
interactive effect with the dynamic factors on the HCR-20, but not the 
tool as a whole.  It was concluded the SAPROF was not consistently 
better than the HCR-20 when predicting adverse events, but it has the 
advantage of covering a wider context of behaviours.  Viljoen (2014) 
found mixed results, reporting a significant improvement, specifically for 
presence of verbal and sexual aggression, but no improvement in the 
area of predicting presence of general violence.  Similarly, Coupland 
(2015) found the SAPROF did not add value at the pre- and post-
treatment stage, however at the point of release good incremental 
validity was found.  Again, none of these studies were completed in the 
UK and the majority used community settings. 
The research to date suggests the SAPROF has good predictive 
validity as an absence of violence risk assessment tool, and results 
consistently report higher levels of predictive validity than the HCR-20, 
particularly when using the ORP index.  However, there are conflicting 
results in terms of incremental validity, and whether using the SAPROF 
and the HCR-20 together improves the risk assessment process.  There 
are currently no published data replicating  the validity of the SAPROF as 
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applied to a UK inpatient sample.  More specifically, its validity has not 
been investigated in a NHS inpatient forensic mental health service, 
where it has been compared to that of the HCR-20V3, and the 
incremental validity of the conjunctive use of the SAPROF and HCR-20V3 
has been explored.   
The authors of the SAPROF state it can be used with both male and 
female individuals (de Vogel et al., 2012).  However, only half of 
published research includes female participants, and only one of those 
explicitly investigated gender differences in the validity of the SAPROF 
(Viljoen, 2014).  Viljoen (2014) found the SAPROF did not significantly 
predict any of the outcome variables for female participants, indicating a 
need for further research to explore the applicability of the SAPROF as a 
risk assessment tool for use with women. 
Similarly previous research has not explicitly investigated the 
application of the SAPROF as a risk assessment tool to individuals with a 
diagnosis of learning disability, focusing instead on mental illness and 
personality disorder (for example, Barnard-Croft, 2014).  Presence of 
intelligence is considered a protective factor in the SAPROF (de Vogel et 
al., 2012), and some of the items may be more difficult to attain for an 
individual with a learning disability, for example self-control and work.  In 
2010/11, only 6.6% of adults with learning disabilities were reported to 
be in some form of paid employment (Foundation for People with 
Learning Disabilities).  This suggests individuals with a diagnosis of 
learning disability may be negatively discriminated against by the 
SAPROF. 
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Finally, research supporting the applicability of the SAPROF to 
individuals in differing stage of their treatment, for example level of 
hospital security, stage of recovery, and length of admission remains in 
its infancy.  Given the aim of inpatient admission to forensic services is to 
manage and reduce risk (Andrews & Bonta, 2007) it can be assumed that 
as individuals move through their care pathway the SAPROF assessment 
should identify an increased number of protective factors.  This is 
supported by research completed by de Vries Robbé, de Vogel, and de 
Spa (2011) who found presence of dynamic protective factors increased 
following engagement in treatment. 
 
4.1.2. Aims and objectives 
The aim of this research study was to explore the value of 
protective factors in the assessment of violence risk.  The use of the 
SAPROF was explored to allow for a greater understanding of the 
effectiveness of its application in forensic inpatient settings.  The validity 
and reliability of the SAPROF as an assessment tool was investigated 
across a number of domains to evaluate whether the inclusion of 
protective factors improves predictive accuracy of violence risk 
assessment. 
The objective of this research study was to examine whether the 
SAPROF, in comparison to the HCR-20V3 and START, is a reliable and 
valid assessment tool in terms of: 
 
1. Internal reliability:  Is the SAPROF consistent within itself? 
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2. Concurrent validity:  Is the SAPROF (assessing absence of 
violence) related to the: 
a. HCR-20V3 (assessing presence of violence)? 
b. START (assessing presence and absence of violence)?  
3. Construct validity: Are patients’ total SAPROF scores 
representative of associated of levels of protection (absence of 
violence) in one month, three month, and six month follow-up 
periods?   
4. Predictive validity: Do total SAPROF scores prospectively 
accurately predict absence of violence in a NHS inpatient forensic 
mental health service, in one month, three month, and six month 
follow-up periods?   
5. Incremental validity.  Does the use of the SAPROF with the HCR-
20V3 improve predictive accuracy for presence of violence in a 
NHS inpatient forensic mental health service, in one month, three 
month, and six month follow-up periods?   
6. Discriminative validity:  Does the total SAPROF score discriminate 
between: 
a. Gender? 
b. Patients in different levels of security?   
c. Patients with differing diagnoses?   
d. Patients at different stages of their care pathway?   
e. Patients with regard to their length of stay in forensic 
inpatient settings?   
 
In line with the research questions, the hypotheses are as follows: 
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1. The SAPROF will have good internal reliability. 
2.  
a. Total SAPROF scores will be significantly negatively 
correlated with total HCR-20V3 scores. 
b. Total SAPROF scores will be significantly positively correlated 
with total START strength scores, and total SAPROF scores 
will be significantly negatively correlated with total START 
vulnerability scores. 
3. There will be a significant positive correlation between higher total 
SAPROF scores and increased absence of violence (number of 
violent incident free days). 
4. Total SAPROF scores will significantly predict absence of violence 
(number of violent incident free days). 
5. Combining the use of the SAPROF with the HCR-20V3 will 
significantly increase the predictive accuracy of presence of 
violence. 
6.  
a. There will be no significant difference in total SAPROF scores 
between genders. 
b. Total SAPROF scores for patients in low secure units will be 
significantly higher than those in medium secure units. 
c. Total SAPROF scores for patients with mental illness will be 
significantly higher than those with learning disability. 
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d. Total SAPROF scores for patients on pre-discharge and 
rehabilitation wards will be significantly higher than those on 
acute wards.  
e. There will be a significant positive correlation between total 
SAPROF scores and patients with a longer length of 
admission. 
 
4.2. Method 
4.2.1. Study design 
A prospective cohort research design using quantitative analysis 
was employed.  The total follow-up period was six months, with one and 
three months durations included.  Data was collected as part of a service 
delivery evaluation.   
 
4.2.2. Setting 
 Four forensic hospitals offering local inpatient provision to service 
users whose offending behavior and mental health needs require they are 
detained in secure conditions under the Mental Health Act (MHA; 1983, 
2007 amendments) were involved.  Each service specialised in the 
assessment, treatment, and rehabilitation of adults with complex needs.  
The services were a medium secure unit (MSU) for adult men and 
women.  It had 65 beds over five wards providing different levels of care 
(acute, sub-acute, rehabilitation, and pre-discharge).  Of the 65 beds, 16 
were for women.  A low secure unit (LSU) for adult men, providing 20 
beds, with 15 beds located on a low intensity unit (rehabilitation care), 
and five beds within a high dependency unit (acute care).  A LSU for 
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adult men with a learning disability, with 20 beds over two wards which 
offered different levels of care (acute and rehabilitation), and a 12 bed 
inpatient service (pre-discharge) for male patients with a learning 
disability.   
 
4.2.3. Participants 
 All inpatients assessed prospectively during the period 01 May 
2014 to 31 May 2015 were included in the sample (N = 108).  Patients 
were excluded if their length of stay post assessment was shorter than 
the follow-up period.  For example, patients with a length of stay post-
assessment of three months were excluded from the six month follow-up, 
but included in the one and three month follow-ups.  As such, 108 
participants were included in the one and three month follow-up and 100 
participants were included in the six month follow-up. 
 
4.2.4. Criterion measures 
The SAPROF (de Vogel et al., 2012) evaluates the presence of 17 
internal, motivation, and external protective factors as three subscales 
(see table 4.1).  These subscales were referred to as SAPROF/I, 
SAPROF/M, and SAPROF/E respectively.  Two of the factors are static.  
The factors are coded on a three point scale, based on the degree to 
which the protective factor is present: ‘no’ (0); ‘perhaps’ (1); and ‘yes’ 
(2).  The presence of key items (a protective effect that is already 
present) and goal items (a protective effect which may occur after 
intervention) are established.  The assessor gives a final judgement 
which reflects the extent of protection which can be ‘low’; ‘moderate’; or 
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‘high’.  The SAPROF gives an integrative final risk judgement which 
combines and weighs the risk and protective factors.  Key items, goal 
items, the final judgement, and integrative final risk judgement were not 
included for the purposes of this research.  The total SAPROF score was 
utilised for the purpose of analysis by summing the presence of the 17 
factors (maximum score 34). 
 
 
Table 4.1 
 
Factors in the SAPROF 
Internal factors  Motivational factors  External factors  
1. Intelligence (static) 
2. Secure attachment in 
childhood (static) 
3. Empathy 
4. Coping 
5. Self-control 
 
6. Work 
7. Leisure activities 
8. Financial management 
9. Motivation for treatment 
10. Attitudes towards 
authority 
11. Life goals 
12. Medication 
13. Social network 
14. Intimate 
relationship 
15. Professional care 
16. Living 
circumstances 
17. External control 
 
 
The HCR-20V3 (Douglas et al., 2013) is a comprehensive set of 
professional guidelines for the assessment and management of violence 
risk.  It assists professionals estimate a person’s likelihood of future 
violence, and consider the most appropriate treatment and management 
strategies.  The HCR-20V3 allows for the evaluation of the presence (and 
relevance) of 20 violence risk factors in the areas of historical, clinical, 
and risk management over three subscales (see table 4.2).  These 
subscales were referred to as HCR-20/H, HCR-20/C, and HCR-20/R 
respectively.  The historical factors are static, and the clinical and risk 
management items are dynamic.  The presence of factors is coded using 
a three level response format: ‘no’ (0); ‘possibly’ (1); and ‘yes’ (2).  The 
risk factors relevance with respect to the development of future risk 
management strategies are judged, and also coded on a three level 
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scale: ‘low’; ‘moderate’; or ‘high’.  There is the option to rate a final risk 
judgement following completion of the assessment (low, medium, and 
high).  Risk factor relevance and the final risk judgement were not 
included for the purposes of this research.  The total HCR-20 score was 
utilised for the purpose of analysis by summing the presence of the 20 
factors (maximum score 40). 
The HCR-20 has been established as one of the best validated 
violence risk assessments using both prospective and retrospective 
research designs (Singh, Fazel, Gueorguieva, & Buchanan, 2014).  
Research exploring the predictive validity of the HCR-20 V3 has found 
AUC values ranging between .70 (Doyle, Coid, Archer-Power, Dewa, 
Hunter-Didrichsen, Stevenson, & Shaw, 2014) and .75 (de Vogel, van 
den Broek, & de Vries Robbé, 2014).   
 
Table 4.2 
 
Factors in the HCR-20V3  
Historical items 
Problems with… 
Clinical items 
Problems with… 
Risk management items 
Problems with… 
H1. Violence 
H2. Other anti-social 
behavior 
H3. Relationships 
H4. Employment 
H5. Substance use 
H6. Major mental 
disorder 
H7. Personality disorder 
H8. Traumatic 
experiences 
H9. Violent attitudes 
H10. Treatment or 
supervision response 
C1. Insight 
C2. Violent ideation or 
intent 
C3. Symptoms of major 
mental illness 
C4. Instability 
C5. Treatment or 
supervision response 
R1. Professional services 
and plans 
R2. Living situation 
R3. Personal support 
R4. Treatment or 
supervision response 
R5. Stress or coping 
 
The START (Webster, Martin, Brink, Nicholls, & Desmarais, 2004) 
is a further set of guidelines designed to evaluate mental disorder, 
monitor progress, plan treatment, and begin the process of estimating 
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future risk to self and others.  In addition to assessing risk of violence it 
aims to inform decision making in terms of self-harm, suicide, 
unauthorised leave, substance abuse, self-neglect, and victimization.  
There are 20 dynamic factors (with two optional case specific items) 
which are considered in terms of strengths (protective factors) and 
vulnerabilities (risk factors; see table 4.3).  This differentiation was 
referred to as START/S and START/V respectively.  The factors are coded 
on a three point scale: minimally present (0); moderately present (1); or 
maximally present (2).  Key and critical items can be selected, where a 
key item reflects a prominent strength, and a critical item identifies a 
factor which needs specific attention in treatment planning and 
supervision.  Consideration of these factors allows for a specific risk 
estimate of ‘low’, ‘moderate’, or ‘high’ to be made for each area of risk.  
The key and critical items, and the specific risk estimates were not 
included for the purposes of this research.  Total START/S and START/V 
scores were utilised for the purpose of analysis by summing the presence 
of the 20 factors (maximum score 40 respectively). 
The predictive validity of the START has been investigated to a 
lesser degree than the HCR-20, but recent research has reported lower 
AUC values, for example, .63 (Quinn, Miles, & Kinane, 2013), .59 
(Troquete, van den Brink, Beintema, Mulder, van Os, Schoevers, & 
Wiersma, 2014), and .65 (Whittington, Bjorngaard, Brown, Nathan, 
Noblett, & Quinn, 2014).   
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Table 4.3 
 
Factors in the START 
Strengths and vulnerabilities  
1. Social skills 11. Social support 
2. Relationships 12. Material resources 
3. Occupational 13. Attitudes 
4. Recreational 14. Medication adherence 
5. Self-care 15. Rule adherence 
6. Mental state 16. Conduct 
7. Emotional state 17. Insight 
8. Substance use 18. Plans 
9. Impulse control 19. Coping 
10. External triggers 20. Treatability 
  
 
4.2.5. Outcome measures 
The outcome measure to investigate the validity of the SAPROF 
and START/S was absence of violence (AoV), whereas for the HCR-20V3 
and START/V it was presence of violence (PoV).   
 
4.2.5.1. AoV 
Defined as the absence of ‘actual, attempted, or threatened 
infliction of bodily harm of another person’ (Douglas et al., 2013, p. 2) or 
self.  AoV was measured by determining the total number of violent 
‘incident free’ days for each participant.  A day was classed as ‘incident 
free’ if there were no recorded violent incidents on that day.  The 
maximum total number of violent ‘incident free’ days possible post 
assessment was 30, 91, and 183 at the one, three, and six month follow-
up periods respectively.  Violence to self was included as research 
conducted by Abidin et al. (2013) had found the HCR-20, SAPROF, and 
START to be predictive of self-harm (to varying degrees).  A distinction 
was made between externalised and internalised violence as absence of 
violent harm-to-others (A/HO) and harm-to-self (A/HS). 
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4.2.5.2. PoV.   
Defined as the presence of ‘actual, attempted, or threatened 
infliction of bodily harm of another person’ (Douglas et al., 2013, p. 2) or 
self.  PoV was measured by determining the total number of violent 
‘incident’ days for each participant.  It was classed as an ‘incident’ if 
there were recorded violent incidents on that day.  For research purposes 
if more than one violent incident occurred on the same day they were 
treated as a separate violent ‘incident’ day.  For example, three violent 
incidents occurring on the same day were the equivalent of three violent 
‘incident’ days (the unit of measure is days, not the incidents 
themselves).  A distinction was made between externalised and 
internalised violence as presence of violent harm-to-others (A/HO) and 
harm-to-self (A/HS).  
 
4.2.6. Procedure 
All assessments were completed routinely as part of a patient’s 
admission.  The SAPROF and the HCR-20V3 were completed on a six 
monthly basis by qualified psychologists, who conducted an exhaustive 
review of background documents, discussion with individuals who knew 
the person being assessed, and completed a clinical interview with the 
person being assessed.  The START was updated every three months by 
members of the multidisciplinary team (MDT; nursing staff, medical 
professionals, psychologists, occupational therapists, and social workers) 
who discussed and agreed ratings.  All persons implementing the tools 
were trained in their use.  This information was stored electronically in 
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the patient’s case file, and the scores based on the ratings given were 
transferred into a database for analysis by the researcher.  The SAPROF’s 
ORP index was calculated by subtracting the total SAPROF score from the 
total HCR-20V3 score. 
The follow-up periods began from the date their assessment was 
completed.  Violent incident follow-up data was obtained from 
information recorded on Incident Reporting Information System (IRIS; 
the local procedure for recording all incidents) and documented Risk 
Incidents on RiO (the patient administration system).  Any member of 
staff could complete an IRIS form, and all incidents of violence were 
included.  Any member of staff could record a Risk Incident on RiO, and 
incidents documented as ‘abuse’, ‘aggressive’, ‘assault actual – 
perpetrator’, ‘assault threat – perpetrator’, ‘self-harm actual’, ‘self-harm 
threat’, ‘suicide’, and ‘violent’ were included. The researcher collated the 
data and calculated the total number of violent ‘incident free’ and 
‘incident’ days.   
The researcher transferred all data to a SPSS (statistical package 
for the social sciences) database for further analysis.   
 
4.2.7. Ethical considerations 
The study was approved by local governance procedures, including 
local NHS Trust and Service Level permissions.  All data was stored 
securely and anonymously to ensure confidentiality. 
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4.2.8. Statistical methods 
 Analysis was conducted using SPSS 22.0 for Windows.  Cronbach’s 
alpha was used to measure internal reliability.  Cronbach’s alpha yields a 
coefficient () ranging between 0 (no correlation, therefore no internal 
consistency) and 1 (perfect correlation, therefore complete internal 
consistency).  Usually a result of .80 and above implies an acceptable 
level of internal reliability (Bryman, 2012).   
Pearson’s correlation coefficient was used to investigate concurrent 
validity.  Good concurrent validity would be suggested if significant 
relationships between the SAPROF and the HCR-20V3 and the START 
were found.  Pearson’s correlation coefficient was also used to investigate 
construct validity.  Good construct validity would be suggested if 
significant relationships between the risk assessment tool and relevant 
outcome were found.  A correlation (r) between .1 and .3 indicates a 
small effect, between .3 and .5 indicates a medium effect, and .5 or 
greater indicates a large effect (Cohen, 1988).   
Sensitivity and specificity, and positive predictive power (PPP) and 
negative predictive power (NPP) were calculated to examine true positive 
and true negative predictive abilities of each tool.  Table 4.4 outlines the 
definitions of these.  To calculate these values, the optimal cut-off point 
of the ROC curve was identified (Hart, Webster, & Menzies, 1993) using 
Clinical Calculator 1 (VassarStats).  For the SAPROF and START/S scores 
below the cut-off were considered to have low levels of protection (high 
risk), and scores above the cut-off were considered to have high levels of 
protection (low risk; optimal cut-off point = 17 and 16 for SAPROF and 
START/S respectively).  For the HCR-20V3 and START/V, scores below 
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the cut-off were considered to have low levels of risk, and scores above 
the cut–off were considered to have high levels of risk (optimal cut-off 
point = 35 and 28 for the HCR-20V3 and START/V respectively). 
 
Table 4.4 
 
Definitions of sensitivity, specificity, PPP, and NPP 
Test SAPROF or START/S HCR-20V3 or START/V 
Sensitivity Percentage of non-violent 
individuals correctly identified as 
having high levels of protection. 
Percentage of violent 
individuals correctly identified 
as having high levels of risk. 
   
Specificity Percentage of violent individuals 
correctly identified as having low 
levels of protection. 
Percentage of non-violent 
individuals correctly identified 
as having low levels of risk. 
   
PPP Non-violent individuals correctly 
identified as ‘high protection’. 
Violent individuals correctly 
identified as ‘high risk’ 
   
NPP Violent individuals correctly 
identified as ‘low protection’. 
Non-violent individuals 
correctly identified as ‘low 
risk’ 
 
ROC analysis was used to investigate predictive validity.  When 
evaluating the AUC values generated by ROC analysis, significant AUC’s 
show the risk assessment tool significantly predicts absence or presence 
of violent incidents during the specified follow-up period, and the actual 
AUC value indicates how strong the effect was.  Rice and Harris (2005) 
suggest AUC’s above .56 should be considered small effects, AUC’s above 
.64 as medium effects, and AUC’s above .71 as large effects.  Therefore 
AUC values of a greater value and significance indicate greater predictive 
ability. StAR (statistical comparison of ROC curves; Vergara, 
Norambuena, Ferrada, Slater, & Melo, 2008) was used to allow 
comparison of significance.   
A multiple regression (hierarchical, enter) analysis was conducted 
to investigate incremental validity of the protective measures.  Multiple 
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regression yields a correlation (R) between multiple independent 
variables and a dependent variable.  The amount of variance the 
independent variables have is indicated (R2).  The associated F-ratio 
represents the improvement in prediction resulting from the regression.  
If this value is greater than 1 improvement is greater than any 
inaccuracy within the model, and the significance of this is calculated.  A 
coefficient (β) demonstrates the individual contribution of each 
independent variable and their significance is specified. 
An independent-samples t-test was conducted to determine if there 
were significant differences in protection levels between genders, level of 
security, and diagnosis.  Logistic regression (binominal, enter) was used 
to determine if SAPROF outcome can be predicted by gender, level of 
security, and diagnosis.   One-way Analysis of Variance (ANOVA) was 
used to determine if there were significant differences in protection levels 
between stages of care pathway.  Post hoc comparisons were corrected 
using the Bonferroni test.  Due to skewed distribution, Spearman’s rank-
order correlation coefficient was calculated to determine if there were 
significant differences between protection levels of patients in regard to 
their length of admission. 
 
4.3. Results 
4.3.1. Participants and descriptive data 
 The sample comprised 108 participants (93 men, 15 women) with 
a mean age of 40.21 years (SD = 13.2).  The average length of 
admission at the time of assessment was 908.17 days (SD = 975.77), 
which equated to 2.69 years.  The ethnicity of most participants was 
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White-British (80%).  The typical diagnosis (as defined by information 
recorded in H6 of the HCR-20V3) was schizophrenia (51%).  Slightly 
more than half of participants were detained in conditions of medium 
security (56%) and the remainder in low security (45%).  The majority 
were detained under sections 37 and 41 (44%) of the Mental Health Act 
(1983; 2007).  Most participants were in the acute stage of their care 
pathway (42%), followed by the rehabilitation stage, and the pre-
discharge stage.  The most common recorded index offence (H1 of the 
HCR-20V3) was assault (35.2%), followed by arson, then sexual assault.  
For full details of the participants please see table 4.5.   
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Table 4.5 
 
Participant data 
 N (%) 
Gender Male = 93 (86.1) 
Female = 15 (13.9) 
Ethnicity White-British = 86 (79.6) 
Asian or Asian British-Indian = 3 (2.8) 
Mixed-White and Black Caribbean = 2 (1.9) 
Other = 17 (15.8) 
Diagnosis Schizophrenia or Paranoid Schizophrenia = 55 (50.9) 
Schizo-Affective Disorder = 9 (8.3) 
Depression = 4 (3.7) 
Personality Disorder = 2 (1.9) 
Bi-Polar Disorder = 1 (.9) 
Learning Disability = 16 (14.8) 
Autistic Spectrum Disorder = 3 (2.8) 
Learning disability and Schizophrenia = 7 (6.5) 
Undiagnosed = 6 (5.6) 
Section of Mental 
Health Act  
(1983; 2007) 
 
S3 = 27 (25) 
S37 = 15 (13.9) 
S37/41 = 48 (44.4) 
S47/49 = 8 (7.4) 
S48/49 = 5 (4.6) 
Other = 5 (5.4) 
Level of security Low secure = 48 (44.4) 
Medium secure = 60 (55.6) 
Stage of Care 
Pathway 
Acute = 45 (41.7) 
Rehabilitation = 43 (39.8) 
Pre-Discharge = 20 (18.5) 
Index Offence Murder = 4 (3.7) 
Assault (including wounding, ABH, and GBH) = 38 (35.2) 
Arson = 12 (11.1) 
Aggravated burglary = 4 (3.7) 
Rape = 6 (5.6) 
Sexual assault = 10 (9.3) 
Other sexual offence = 6 (5.6) 
Other = 25 (25.86) 
Age (years) M = 40.21, SD = 13.2 (range = 19 - 89) 
Length of Admission 
(days) 
M = 980.93, SD = 974.8 (range = 59 – 4582) 
 
The SAPROF and START were completed for all 108 patients.  The 
HCR-20V3 was completed for 97 of these patients, the remaining 11 
patients having had a Risk of Sexual Violence Protocol (RSVP; Hart, 
Kropp, Laws, Klaver, Logan, & Watt, 2003) due to their having a sexual 
index offence.  This data was excluded from analyses.  Table 4.6 outlines 
the descriptive data. 
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Table 4.6 
 
Risk assessment descriptive data and internal reliability  
 N M SD Internal reliability 
SAPROF  108 18.79 5.02 .80 
SAPROF/I   4.32 2.40 .70 
SAPROF/M   7.55 3.00 .75 
SAPROF/E   6.93 .93 .23 
ORP index 97 7.35 10.13  
     
HCR-20V3 97 26.24 5.99 .78 
HCR-20/H   14.87 3.04 .60 
HCR-20/C   6.01 2.60 .75 
HCR-20/R   5.40 2.54 .70 
     
START 108    
START/S   21.09 6.75 .91 
START/V   22.90 7.89 .91 
 
4.3.2. Internal reliability 
Table 4.6 displays the results.  The SAPROF total score was found 
to be highly reliable ( = .80).   Removal of any items, except ‘secure 
attachment in childhood’ and ‘external control’ resulted in a lower 
Cronbach’s alpha.  Removal of ‘secure attachment in childhood’ and 
‘external control’ led to a small improvement in internal reliability ( = 
.81 respectively), so there was no value in removing these items.  The 
SAPROF/I and SAPROF/M total scores had good levels of reliability ( = 
.70 and .75 respectively) compared to SAPROF/E total score.  Despite the 
low reliability of SAPROF/E total score removal of related items did not 
result in a large increase in the overall internal reliability of the SAPROF 
total score ( = .81).  Comparison using the Feldt test (1969) found the 
SAPROF total score was not significantly more reliable than the HCR-
20V3 total score (p = .32), but the START/S and START/V total scores 
were significantly more reliable than the SAPROF total score (p < .001). 
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4.3.3. Concurrent validity 
Table 4.7 displays the results of the correlation analysis (Pearson’s 
r).  There was a significant negative correlation between the SAPROF and 
HCR-20V3 total scores (r = -.64, n = 97, p < .001), and this was a large 
effect.  The scatter graph for this result in figure 4.1 displays the 
correlation.  There was a significant positive correlation between the ORP 
and HCR-20V3 total score (r = .918, n = 97, p < .001), also a large 
effect.    
There was a significant positive correlation between the SAPROF 
total score and the START/S total score (r = .52, n = 108, p < .001), a 
large effect, and there was a significant negative correlation between the 
SAPROF total score and the START/V total score (r = -.44, n = 108, p < 
.001), a medium effect.  The ORP and START/V total score positively 
correlated (r = .375, n = 97, p < .001) with a medium effect, and there 
was a significant negative correlation with START/S total score (r = -
.408, n = 97, p < .001), again a medium effect.   
These results suggest the SAPROF total score has good concurrent 
validity, and is related to the HCR-20V3 total score and START total 
score.  However, it is also possible that the similarity of some of the 
items across the instruments may have confounded these results, for 
example, self-control (SAPROF), instability (HCR-20V3), and impulse 
control (START).  The relationship of the ORP to the HCR-20V3 total 
score is stronger than the SAPROF’s total score relationship; however it is 
likely this is due to the contribution of the HCR-20V3’s score to its 
development (HCR-20V3 total score minus SAPROF total score). 
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Table 4.7 
 
Relationship between SAPROF and other risk assessment tools 
 SAPROF SAPROF/I SAPROF/M SAPROF/E ORP 
     (n = 97) 
HCR-20V3  
(n = 97) 
-.64** -.61** -.51** -.25* .92** 
HCR-20/H -.36** -.39** -.27* -.10 .60** 
HCR-20/C -.56** -.53** -.49** -.09 .73** 
HCR-20/R -.51** -.43** -.40** -.38** .71** 
      
START  
(n = 108) 
    (n = 97) 
START/S .52** .29* .57** .26* -.41** 
START/V -.44** -.31* -.42** -.21* .38** 
*significant at the p < 0.01 level 
**significant at the p < 0.001 level 
 
 
 
 
Figure 4.1.  Scatter graph to show the correlation between SAPROF and HCR-
20V3  
 
4.3.4. Construct validity 
Descriptive statistics for AoV and PoV within a 6 month period can 
be seen in table 4.8.  On average, patients were AoV (absence of 
violence) on 99% of the days, and so PoV (presence of violence) was low 
frequency.   At the one, three, and six month follow-up 83%, 75%, and 
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62% of participants were AoV respectively.  At the one, three, and six 
month follow-up 86%, 79%, and 68% of participants were A/HO 
respectively (94%, 92%, and 88% of participants were A/HS 
respectively).  Taking the mode and range into account the scope of AoV 
varies between patients, with some being free from violent incidents, and 
others having multiple violent incidents.   
 
Table 4.8 
 
Descriptive statistics of absence or presence of violent incidents over a 6 month 
period 
 M SD Mode Range 
AoV 181.47 3.84 183 161 – 183 
A/HO 181.96 2.68 183 167 - 183 
A/HS 182.52 2.30 183 162 - 183 
     
PoV 1.53 3.84 0 0 – 22 
P/HO 1.05 2.68 0 0 – 16 
P/HS .48 2.30 0 0 – 21 
Note.  AoV = Absence of violence, A/HO = Absence of harm-to-others, A/HS = 
Absence of harm-to-self, PoV = Presence of violence, P/HO = Presence of harm-
to-others, P/HS = Presence of harm-to-self. 
 
Good construct validity is suggested if significant relationships 
between the risk assessment tool and AoV or PoV were found.  Table 4.9 
displays the results of the Pearson’s correlation analysis.  The SAPROF 
total score and ORP were significantly positively correlated with AoV and 
PoV respectively at all follow-ups, and significantly positively correlated 
with A/HO and P/HO respectively at the one and six month follow-ups.  
There was a significant positive correlation between the SAPROF total 
score and A/HS at the three and six month follow-ups.  The ORP did not 
correlate with P/HS at any follow-up period.  These were all small effects.  
The SAPROF/I total score was significantly correlated with all outcomes at 
all follow-ups (small and medium effects), except A/HS at the one month 
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follow-up.  The SAPROF/E total score was not significantly correlated with 
AoV at any of the follow-ups, and SAPROF/M total score was only 
significantly correlated with AoV at the 6 month follow-up. 
The SAPROF total score and ORP held stronger construct validity 
than the HCR-20V3 total score, which was only correlated with PoV at the 
six month follow-up.  The HCR-20V3 total score correlations with P/HO 
were comparable to the SAPROF total score and ORP, with significant 
positive correlations at the one and six month follow-ups.  There were no 
significant correlations between the HCR-20V3 total score and P/HS at 
any follow-up, which was weaker than the SAPROF total score but 
comparable to the ORP.  The HCR-20/H total score and HCR-20/R total 
score were not significantly correlated with any of the outcomes at any 
follow-up.  The HCR-20/C total score was significantly correlated with PoV 
and P/HO at all follow-ups, but not with P/HS at any follow-up.  As with 
the SAPROF total score and ORP, all effects were small. 
The SAPROF total score and ORP held stronger construct validity 
than the START/S total score, which was not correlated with any outcome 
measures at any follow-up period.  There was a small significant positive 
correlation between the START/V total score and PoV at all follow-ups, 
which is comparable to the SAPROF total score and ORP.  There were no 
significant correlations between START/V total score and P/HO at any 
follow-up which is weaker than the SAPROF total score and ORP.  There 
were significant correlations between START/V total score and P/HS at 
the three and six months follow-up, which is comparable to the SAPROF 
total score but stronger than the ORP.  Again all effects were small. 
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These results suggest the SAPROF total score (and the ORP) hold 
good construct validity, and overall the SAPROF total score is slightly 
more superior to the HCR-20V3 and the START total scores.  However, it 
should be noted that using r as a guide, all effect sizes for all risk 
assessment tools were small, and comparing the high base rate of AoV to 
the low base rate of PoV may be problematic (Conroy & Murrie, 2007).  
In addition, the problem of multiple comparisons and the increased 
chance of false positives should be acknowledged (Abdi, 2007).
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Table 4.9 
 
Relationship between risk assessment tools and AoV / PoV 
Follow-up 1 month 3 months 6 months 
 
n 
AoV or 
PoV 
A/HO or 
P/HO 
A/HS or 
P/HS 
n 
AoV or 
PoV 
A/HO or 
P/HO 
A/HS or 
P/HS 
n 
AoV or 
PoV 
A/HO or 
P/HO 
A/HS or 
P/HS 
SAPROF 108 .22* .22* 0.15 108 .20* 0.15 .17* 100 .26** .21* .19* 
SAPROF/I 108 .26** .25* 0.13 108 .24** .25** .18* 100 .33** .30** .20* 
SAPROF/M 108 0.15 0.15 0.11 108 0.13 0.08 0.13 100 .17* 0.14 0.13 
SAPROF/E 108 0.03 0.03 0.1 108 -0.03 -0.11 0.07 100 0.01 -0.08 0.11 
ORP 97 .21* .21* 0.12 97 .20* 0.67 0.15 90 .24* .21* 0.15 
HCR-20V3 97 0.16 .17* 0.06 97 0.16 0.16 0.1 90 .18* .18* 0.09 
HCR-20/H 97 0.03 0.08 -0.02 97 0.05 0.08 -0.02 90 0.08 0.13 -0.01 
HCR-20/C 97 .19* .26** 0.03 97 .22* .24* 0.11 90 .22* .24* 0.08 
HCR-20/R 97 0.14 0.05 0.14 97 0.1 0.04 0.14 90 0.12 0.04 0.15 
START/S 108 -0.01 -0.04 0.04 108 0.05 0.01 0.07 100 0.08 0.04 0.09 
START/V 108 .17* 0.1 0.14 108 .20* 0.13 .19* 100 .22* 0.13 .22* 
Note.  AoV = Absence of violence, A/HO = Absence of harm-to-others, A/HS = Absence of harm-to-self, PoV = Presence of violence, P/HO 
= Presence of harm-to-others, P/HS = Presence of harm-to-self. 
*significant at the p < 0.05 level (one-tailed) 
**significant at the p < 0.01 level (one-tailed) 
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4.3.5. Predictive validity 
Use of correlation analysis to investigate the predictive accuracy of 
violence risk assessment tools has been criticised due to its reliance on 
base rates (prevalence of violence) or selection ratios (proportion of 
individuals predicted to be violent; for example, Cohen, 1969).  Base 
rates are particularly problematic in this research due to the comparison 
of a high level base rate of absence of violence (resulting in a higher 
likelihood of true positives independent of the assessment tool) to a low 
level base rate of presence of violence.  It is common to use sensitivity 
and specificity, and positive and negative predictive power to explore 
predictive accuracy (Baldessarini, Finkelstein, & Arana, 1983).  Table 
4.10 shows how the SAPROF and ORP compare to the HCR-20V3 and the 
START.  At the six month follow-up, the sensitivity, specificity, PPP, and 
NPP of the SAPROF was 82%, 61%, 78%, and 67% respectively for AoV.  
However, as can be seen for A/HS and P/HS, these methods have also 
been criticised for similar reasons as correlation analysis (Rice & Harris, 
1995). 
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Table 4.10 
 
Sensitivity, specificity, PPP, and NPP for the risk assessment tools 
6 months SAPROF ORP HCR-20V3 START/S START/V 
AoV / PoV      
Sensitivity .82 .61 .12 .88 .48 
Specificity .61 .75 .95 .30 .82 
PPP .78 .59 .57 .68 .62 
NPP .67 .77 .65 .59 .73 
      
A/HO / P/HO      
Sensitivity .79 .14 .11 1.00 .46 
Specificity .61 .98 .94 0 .79 
PPP .82 .80 .43 .69 .50 
NPP .57 .72 .70 - .77 
      
A/HS / P/HS      
Sensitivity 1 0 .01 1 .46 
Specificity 0 1 .99 .10 .79 
PPP .89 - .50 .90 .50 
NPP - .89 .90 1 .77 
Note.  AoV = Absence of violence, A/HO = Absence of harm-to-others, A/HS = 
Absence of harm-to-self, PoV = Presence of violence, P/HO = Presence of harm-
to-others, P/HS = Presence of harm-to-self. 
 
Rice and Harris (1995) suggest ROC analysis is the superior 
method for evaluating the accuracy of risk assessment tools because the 
AUC is independent of selection ratios and base rates.  Table 4.11 
displays the results of the ROC analysis for each risk assessment tool and 
absence or presence of violent incidents.  The ROC curve for each risk 
assessment tool and relevant outcome at the 6 month follow-up period is 
shown in figures 4.2 and 4.3.  AUC values ranged from .67 to .75 for the 
SAPROF total score predicting absence of violence, from .56 to .75 for the 
ORP predicting presence of violence, from .47 to .69 for the HCR-20V3 
total score predicting presence of violence, and from .44 to .78 for the 
START total score predicting both absence and presence of violence. 
At the one and six month follow-ups the SAPROF total score had 
significant large predictive abilities for AoV, A/HO and A/HS.  Significant 
medium predictive abilities at the three month follow-up were found for 
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AoV and A/HO.  Medium predictive ability at the three month follow-up 
for A/HS was found, but this was not significant.  Predictive ability for 
AoV was most accurate at the 6 month follow-up, and for A/HO and A/HS 
it was most accurate at the one month follow-up.  For AoV and A/HO the 
SAPROF total score was found to be significantly more accurate than the 
START/S total score (p < .001 and p = .01 respectively).  There were no 
other significant differences between the predictive accuracy of the 
SAPROF total score and HCR-20V3 or START total scores. 
The ORP had significant large predictive abilities for PoV at the 
three and six month follow-ups, and significant medium predictive 
abilities at the one month follow-up.  It also had significant large 
predictive abilities for P/HO at the one and six month follow-ups, and 
significant medium predictive abilities at the three month follow-up.  
Predictive ability for all outcomes was most accurate at the 6 month 
follow-up.  For PoV the ORP was found to be significantly more accurate 
than the HCR-20V3 total score (p = .02) and the START/S total score (p 
= .02).  For P/HO the ORP was significantly more accurate than the 
START/S total score (p = .03).  There were no other significant 
differences between the predictive accuracy of the ORP and HCR-20V3 or 
START total scores.   
These results suggest the SAPROF total score and the ORP have 
good predictive validity, and overall are superior to the HCR-20V3 and 
START total scores.  At the 6 month follow-up for AoV, the SAPROF total 
score was significantly more predictively accurate than the START/S total 
score, whereas for PoV, the ORP was significantly more predictively 
accurate than the HCR-20V3 and START/S total scores.  
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Table 4.11 
 
ROC analysis for each risk assessment tool and absence or presence of violent incidents 
 SAPROF ORP HCR-20V3 START/S START/V 
Follow-up AUC 95% CI AUC 95% CI AUC 95% CI AUC 95% CI AUC 95% CI 
1 month           
AoV / PoV .74** .63 - .85 .70** .57 - .83 .63 .50 - .77 .48 .32 - .64 .62 .48 - .75 
A/HO / P/HO .74** .63 - .85 .72** .60 - .84 .67* .52 - .80 .44 .27 - .62 .57 .42 - .72 
A/HS / P/HS .83* .70 - .97 .56 .28 - .85 .47 .20 - .74 .65 .38 - .92 .68 .42 - .94 
           
3 months           
AoV / PoV .70** .58 - .82 .71** .59 - .82 .67* .55 - .78 .50 .37 - .62 .64* .52 - .76 
A/HO / P/HO .69** .57 - .82 .70** .58 - .81 .67* .55 - .78 .48 .34 - .62 .61 .48 - .74 
A/HS / P/HS .67 .52 - .82 .64 .48 - .81 .59 .41 - .77 .61 .45 - .78 .73* .58 - .87 
           
6 months           
AoV / PoV .75*** .65 - .85 .75*** -65 - .86 .68** .57 - .79 .59 .47 - .70 .68** .57 - .80 
A/HO / P/HO .72** .61 - .82 .73*** .62 - .84 .69** .58 - .80 .55 .43 - .67 .63* .51 - .75 
A/HS / P/HS .71* .58 - .85 .64 .48 - .79 .55 .37 - .72 .66 .51 - .80 .78** .65 - .91 
Note.  CI = Confidence interval, AoV = Absence of violence, A/HO = Absence of harm-to-others, A/HS = Absence of harm-to-self, PoV = 
Presence of violence, P/HO = Presence of harm-to-others, P/HS = Presence of harm-to-self. 
*significant at the p < 0.05 level (two-tailed) 
**significant at the p < 0.01 level (two-tailed) 
***significant at the p< 0.001 level (two-tailed) 
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Figure 4.2. ROC curve for risk assessment tools and AoV at 6 month follow-up 
period 
 
 
 
 
Figure 4.3. ROC curve for risk assessment tools and PoV at 6 month follow-up 
period 
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4.3.6. Incremental validity 
 Table 4.12 shows the results of the multiple regression analysis for 
the use of the SAPROF in addition to the HCR-20V3 when predicting 
presence of violence.  In the first step of the hierarchical multiple 
regression the HCR-20V3 total score was entered.  For six month follow-
up this model was not significant (F (1, 88) = 3.06; p = .08), and 
explained only 3% of the variance in violent incidents.  After entry of the 
SAPROF total score at step two the total variance explained by the model 
overall was 7%, and was significant (F (2, 87) = 3.21; p < .05).  The 
introduction of the SAPROF total score explained an additional 4% 
variance in violent incidents, after controlling for the HCR-20V3 total 
score (R2 change = .04; F(1, 87) = 3.28; p = .07).  In the final model 
the SAPROF total score was the better predictor (β = .24, p = .07), 
compared to the HCR-20V3 total score (β = .03, p = .82) but the effect 
was trend only.  At the one and three month follow-ups there was no 
significant effect. 
These results indicate that using the SAPROF total score in addition 
to the HCR-20V3 total score significantly increases the prediction of 
violence at the six month follow-up.  Interestingly, neither the HCR-20V3 
nor SAPROF total scores were found to be predictive when used 
independently.  There was no impact of incremental validity at the one 
and three month follow-ups. 
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Table 4.12 
 
Hierarchical regression of SAPROF and HCR-20V3 
Follow-up      ANOVA Coefficients 95% confidence interval 
  R R2 R2 change F change df F B SE β t Lower Upper 
1 month              
Model 1 HCR-20V3 .16 .03 .03 2.46 95(1) 2.46       
Model 2 HCR-20V3        .00 .02 .02 .18 -.04 .05 
 SAPROF .23 .05 .03 2.68 94(2) 2.59 .05 .03 .21 1.64 -.10 .10 
              
3 months              
Model 1 HCR-20V3 .16 .03 .03 2.60 95(1) 2.60       
Model 2 HCR-20V3       .02 .05 .05 .36 -.09 .13 
 SAPROF .22 .05 .02 1.98 94(2) 2.30 .09 .06 .18 1.41 -.04 .21 
              
6 months              
Model 1 HCR-20V3 .18 .03 .03 3.06 88(1) 3.10       
Model 2 HCR-20V3       .02 .09 .03 .23 -.16 .20 
 SAPROF .26 .07 .04 3.28 87(2) 3.21* .19 .10 .24 1.81 -.02 .39 
*significant at the p < 0.05 level 
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4.3.7. Discriminative validity 
4.3.7.1. Gender 
Table 4.13 compares the mean SAPROF scores by gender using an 
independent subjects t-test.  Female patients had higher levels of 
protection overall, and male patients had higher levels of risk in terms of 
the ORP.  However, there were no significant differences in SAPROF 
scores between gender.   
The results of the logistic regression are shown in table 4.14.  A 
test of the full model against a constant only model was not statistically 
significant, indicating the SAPROF total score did not reliably distinguish 
between gender (2 = 1.12, p = .29, df = 1).  The model explained 2% 
(Nagelkerke’s R2) of the variance in gender, and correctly classified 
86.1% of cases (100% for male and 0% for female).  The Wald criterion 
demonstrated the SAPROF total score was not a significant predictor of 
absence of violence.   
To summarise, levels of protection as determined by the SAPROF 
total score and levels of risk as determined by the ORP do not differ 
between gender, and the SAPROF total score cannot be predicted by 
gender.  These results suggest the SAPROF total score does not 
discriminate between genders. 
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Table 4.13 
 
Independent-samples t-test of SAPROF between genders 
 Male (n = 93) Female (n = 15)    95% confidence interval 
 M (SD) M (SD) t df M difference Lower Upper 
SAPROF 18.58 (4.97) 20.07 (5.37) -1.06 106 -1.49 -4.26 1.28 
SAPROF/I 4.27 (2.35) 4.67 (2.77) -.59 106 -.40 -1.73 .93 
SAPROF/M 7.38 (2.99) 8.60 (2.90) -1.48 106 -1.22 -2.87 .42 
SAPROF/E 6.95 (.96) 6.80 (.78) .56 106 .146 -.37 .66 
ORP  8.11 (9.82) 3.20 (11.09) 1.75 95 4.91 -.68 10.50 
 
 
 
 
 
 
Table 4.14 
 
Logistic regression for SAPROF and gender (N = 108) 
           95% confidence interval 
  MI LD % correct Predictor B SE Wald’s 2 df Exp(B) Lower Upper 
Step 0 MI 93 0 100.0 Constant -1.83 .28 43.00* 1 .16   
 LD 15 0 0         
 Overall %   86.1         
             
Step 1 MI 93 0 100.0 SAPROF .06 .06 1.13 1 1.06 .95 1.18 
 LD 15 0 0         
 Overall %   86.1         
*significant at the p < 0.001 level  
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4.3.7.2. Level of security 
Table 4.15 outlines the mean SAPROF scores for each level of 
security, and the results of the t-test.  Patients in the medium secure unit 
(MSU) reported higher levels of protection.  Patients in the low secure 
unit (LSU) had higher levels of risk in terms of the ORP.  Patients in the 
LSU had significantly lower scores on the SAPROF, and patients in the 
LSU had significantly higher scores for the ORP.   
The results of the logistic regression are shown in table 4.15.  A 
test of the full model against a constant only model was statistically 
significant, indicating the SAPROF total score reliably distinguished 
between patients in LSU and patients in MSU (2 = 14.87, p < .001, df = 
1).  The model explained 17% (Nagelkerke’s R2) of the variance in level 
of security, and correctly classified 63.9% of cases (58.3% for LSU and 
68.3% for MSU).  The Wald criterion demonstrated the SAPROF total 
score was a significant predictor of absence of violence, and increasing 
SAPROF scores were associated with an increased likelihood of being in 
an MSU. 
These results suggest the SAPROF total score had good 
discriminative validity in terms of level of security as it judged patients in 
conditions of medium security had a higher level of protection than 
patients in low security.  It was able to discriminate between protection 
levels, and the ORP discriminated between risk levels, of patients in 
different levels of security.  In addition SAPROF total score was predicted 
by level of security.   
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Table 4.15 
 
Independent-samples t-test of SAPROF between different levels of security 
 LSU (n = 48) MSU (n = 60)    95% confidence interval 
 M (SD) M (SD) t df M difference Lower Upper 
SAPROF 16.79 (3.40) 20.38 (5.55) -4.14** 100  -3.59 -5.31 -1.87 
SAPROF/I 3.08 (1.82) 5.32 (2.35) -5.41** 106  -2.22 -3.05 -1.41 
SAPROF/M 6.83 (2.44) 8.12 (3.29) -2.31* 105  -1.28 -2.38 -.19 
SAPROF/E 6.90 (.59) 6.95 (1.14) -.32 92 -.54 -.39 .28 
        
 (n = 38) (n = 59)      
ORP 12.61 (6.35) 3.97 (10.69) 4.99** 95 8.64 5.20 12.08 
*significant at the p < 0.05 level 
**significant at the p < 0.001 level 
 
 
 
Table 4.16 
 
Logistic regression SAPROF and level of security (N = 108) 
           95% confidence interval 
  LSU MSU % correct Predictor B SE Wald’s 2 df Exp(B) Lower Upper 
Step 0 LSU 0 48 0 Constant .22 .19 1.33 1 1.25   
 MSU 0 60 100.0         
 Overall %   55.6         
             
Step 1 LSU 28 20 58.3 SAPROF  .17 .05 12.16* 1 1.18 1.08 1.30 
 MSU 19 41 68.3         
 Overall %   63.9         
*significant at the p < 0.001 level 
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4.3.7.3. Diagnosis 
Table 4.17 outlines the mean SAPROF scores for each diagnosis, 
and the results of the t-test.  Patients with mental illness (MI) had higher 
levels of protection.  Patients with learning disability (LD) had higher 
levels of risk in terms of the ORP.  Patients with MI had significantly 
higher scores on the SAPROF compared to patients with LD, and patients 
with MI had significantly lower ORP scores compared to patients with LD.   
The results of the logistic regression are shown in table 4.18.  A 
test of the full model against a constant only model was statistically 
significant, indicating the SAPROF total score reliably distinguished 
between patients with MI and patients with LD (2 = 12.36, p < .001, df 
= 1).  The model explained 20% (Nagelkerke’s R2) of the variance in 
diagnosis and correctly classified 72.2% of cases (91% for MI and 23.3% 
for LD).  The Wald criterion demonstrated the SAPROF total score was a 
significant predictor of absence of violence, and increasing SAPROF 
scores were associated with a decreased likelihood of having a diagnosis 
of LD. 
These results suggest the SAPROF total score showed good 
discriminative validity in terms of diagnosis as it judged patients with a 
diagnosis of MI to have higher levels of protection than patients with LD.  
It was able to discriminate between protection levels, and the ORP 
discriminated between risk levels, of patients with MI and patients with 
LD.  In addition SAPROF total score was predicted by diagnosis.
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Table 4.17 
 
Independent-samples t-test of SAPROF between different diagnoses 
 MI (n = 78) LD (n = 30)    95% confidence interval 
 M (SD) M (SD) t df M difference Lower Upper 
SAPROF 19.91 (.59) 15.87 (.57) 4.96* 87 4.04 2.42 5.67 
SAPROF/I 5.15 (.25) 2.17 (.21) 9.10* 97 2.99 2.34 3.61 
SAPROF/M 7.81 (.36) 6.87 (.45) 1.47 106 .94 -.33 2.21 
SAPROF/E 6.95 (.12) 6.87 (.12) .41 106 .08 -.32 .48 
ORP  5.05 (1.17) 15.18 (1.07) -6.38* 72 -10.13 -13.29 -6.97 
*significant at the p < 0.001 level 
 
 
 
 
 
 
Table 4.18 
 
Logistic regression for SAPROF and diagnosis (N = 108) 
           95% confidence interval 
  MI LD % correct Predictor B SE Wald’s 2 df Exp(B) Lower Upper 
Step 0 MI 78 0 100.0 Constant -.6 .22 19.78* 1 .39   
 LD 30 0 0         
 Overall %   72.2         
             
Step 1 MI 71 7 91.0 SAPROF -.20 .06 12.36* 1 .82 .73 .91 
 LD 23 7 23.3         
 Overall %   72.2         
*significant at the p < 0.001 level
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4.3.7.4.  Stage of care pathway 
Table 4.19 displays the mean SAPROF scores for the stage of care 
pathway and the results of the ANOVA.  Patients in the acute stage had 
the lowest levels of protection, and patients in the rehabilitation stage 
had the highest.  Patients in the rehabilitation stage had the lowest levels 
of risk as determined by the ORP, and patients in the acute stage had the 
highest.   
 
Table 4.19 
 
One-way between subjects ANOVA of the SAPROF between differing stages of 
care pathway  
 Acute 
(n = 45) 
M (SD) 
Rehabilitation 
(n = 43) 
M (SD) 
Pre-Discharge 
(n = 20) 
M (SD) 
df f 
SAPROF 17.29 (5.49) 20.21 (4.62) 19.10 (3.89) 2 (105) 3.97* 
SAPROF/I 4.16 (2.42) 4.81 (2.51) 3.65 (1.95) 2 (105) 1.83 
SAPROF/
M 
6.40 (3.09) 8.42 (2.65) 8.25 (2.77) 2 (105) 6.22* 
SAPROF/E 6.73 (1.16) 6.98 (.67) 7.25 (.79) 2 (105) 2.28 
ORP 9.61 (10.09) 4.22 (9.58) 8.38 (10.20) 2 (94) 3.08 
*significant at the p < 0.05 level 
 
There was a significant effect of the stage of care pathway on the 
SAPROF (F(2, 105) = 3.97, p < .05).  Post hoc comparisons corrected 
using the Bonferroni test indicated that the mean score for the acute 
stage SAPROF total score was significantly lower compared to the 
rehabilitation stage SAPROF total score (mean difference = -2.92, p < 
.05). However, the pre-discharge stage SAPROF total score did not 
significantly differ from the acute and rehabilitation stage SAPROF total 
scores. 
There was a significant effect of the stage of care pathway on the 
SAPROF/M total score (F(2, 105) = 6.22, p < .01).  Post hoc comparisons 
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corrected using the Bonferroni test indicated the mean score for the 
acute stage SAPROF/M total score was significantly lower compared to 
the rehabilitation stage SAPROF/M total score (mean difference = -2.02, 
p < .01).  However, the pre-discharge stage SAPROF/M total score did 
not significantly differ from the rehabilitation and acute stage 
SAPROF/M’s total score. 
There was marginal yet significant effect of the stage of care 
pathway on the ORP (F(2, 94) = 3.08, p = .051).  Post hoc comparisons 
corrected using the Bonferroni test indicated that the mean score for the 
acute stage ORP was significantly higher compared to the rehabilitation 
stage ORP. However, the pre-discharge stage ORP did not significantly 
differ from the acute and rehabilitation stage ORP’s.  
These results suggest that the SAPROF total score discriminates 
between protection levels, and the ORP discriminates between risk levels, 
of patients at differing stages.  Specifically the results suggest the 
SAPROF total score and ORP can discriminate between acute and 
rehabilitation stages, although not between pre-discharge and 
acute/rehabilitation stages.   
 
4.3.7.5. Length of admission 
As shown in table 4.4, there was huge variation in the patient’s 
length of admission (m = 980.93 days, SD = 974.8, range = 59 – 4582 
days).  The Spearman’s rank-order correlation coefficient showed there 
was no correlation between length of admission and the SAPROF total 
score or ORP.  The results show the SAPROF total score cannot 
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distinguish between patients in regard to their length of admission in 
forensic inpatient settings alone. 
 
4.4. Discussion 
The aim this research study was to explore the value of protective 
factors in the assessment of violence risk.  The use of the SAPROF was 
examined to allow for a greater understanding of the effectiveness of its 
application in forensic inpatient settings.  The validity and reliability of 
the SAPROF as an assessment tool was investigated across a number of 
domains to evaluate whether the inclusion of protective factors improves 
predictive accuracy of violence risk assessment tools. 
The SAPROF total score was found to have good internal reliability 
supporting hypothesis one.  Good internal reliability means each 
protective factor within the SAPROF contributes to determining levels of 
protection.  Internal reliability of the SAPROF/E total score was very low, 
suggesting external factors contribute to a lesser degree; however it is 
likely this is due to three out of five factors being rated similarly due to 
the homgeniety of the sample in terms of professional care, living 
circumstances, and external control, rather than a true deficit of the 
internal reliability for this scale.  Removal of these items did not result in 
a great improvement to the overall internal reliability.  This is comparible 
to research conducted by Abidin et al. (2012) and  Coupland (2015) who 
reported high levels internal reliability ( = .88 and  = .87 - .89 
respectively).  Therefore use of the SAPROF, with 20 items across three 
scales, as a reliable assessment tool is supported. 
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Hypothesis two was supported, as the SAPROF total score was 
found to have good concurrent validity.  This means significant 
correlations with other risk assessments tools were found, and suggests 
the SAPROF total score was related to previously validated tools (HCR-
20V3 and START).  Abidin et al. (2012) also found significant correlations 
between the SAPROF and the START, and de Vries Robbé et al. (2014) 
found significant correlations between the SAPROF total score and the 
HCR-20V3 total score.  Vijolen (2014) found similar results with 
significant correlations between SAPROF total scores and HCR-20 and 
START/V total scores, however, conversely significant correlations were 
not found between the SAPROF and START/S total scores.  This 
strengthens the evidence for the use of the SAPROF as a tool which 
proposes to estimate levels of protection in the violence risk assessment 
and management process.   
The SAPROF total score demonstrated good construct validity 
supporting hypothesis three.  Significant positive correlations between 
the SAPROF total score and absence of violence were found, suggesting 
patients’ SAPROF assessments are representative of their protective 
factors.  This is supportive of previous research completed (for example,  
de Vries Robbé et al., 2011, and  Barnard-Croft, 2015).  Therefore the 
SAPROF measures what it claims to be measuring, and this study can 
endorse its use as an assessment of protective factors in the violence risk 
assessment and management process.  The SAPROF total score was 
found to be superior to the HCR-20V3 and START total scores in terms of 
construct validity, which further endorses its use. 
142 
 
 
 
The SAPROF total score demonstrated good predictive validity 
supporting hypothesis four. This means SAPROF total scores significantly 
predicted the outcome, and suggests SAPROF assessments accurately 
predict absence of violence.  The AUC value found for absence of violence 
at the 6 month follow-up period (.82) was comparable to previous 
research using the same timescale, for example, Abidin et al. (2013) and 
Barnard-Croft (2014) reported AUC values of .81 and .73 respectively, 
although greater than that found by Viljoen (2014) who reported an AUC 
of .59 at the 6 month follow-up period.  It is possible these differences 
could be a result of the differing samples and settings, and also outcomes 
operationalised differently.   
The SAPROF total score was also found to have superior predictive 
accuracy for absence of violence than the HCR-20V3 and START total 
scores had for presence of violence.  These findings are supportive of the 
existing body of research into the predictive validity of the SAPROF for 
absence of violence (for example, de Vries Robbé et al., 2011), and 
further support its use in the violence risk assessment and management 
process.  The SAPROF/M and SAPROF/E total scores were not 
representative of absence of violence at any of the follow-ups, suggesting 
that internal factors are more important protectors against violence than 
motivational or external factors.  This study is also supportive of previous 
research which has demonstrated the SAPROF can be utilised to assess 
the risk of harm to self (Abidin et al., 2013).  The HCR-20V3 does not 
appear to capture the risk of self-harm, and as such the use of the 
SAPROF as an additional assessment would be supported if this risk were 
suspected.   
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Combining the use of the SAPROF total score with the HCR-20V3 
total score significantly increased the predictive accuracy for presence of 
violence, supporting hypothesis five.  This means use of the SAPROF in 
addition the HCR-20V3 improved the accuracy of the risk assessment 
relative to using the HCR-20V3 as a lone assessment.  These results add 
to the mixed findings of existing research (for example de Vries Robbé et 
al., 2013 and Abidin et al., 2013), but suggest the SAPROF positively 
influences risk assessment and can be used in addition to the HCR-20V3 
to improve the process. 
In terms of discriminative ability the SAPROF total score was 
unable to discriminate between genders, supporting hypothesis six (a).  
This suggests males and females achieved similar results on the SAPROF, 
and as such it appears suitable for use with both genders as 
recommended by the tools authors (de Vogel et al., 2012).  However, it 
is possible these results were due to the limited number of females in the 
sample, rather than a true reflection of the SAPROF’s inability to 
distinguish between genders.  Rumgay (2004) suggests women may 
respond differently to protective factors.  Further research is required to 
establish whether males and females do indeed have the same protective 
factors against violence, much the same as further research is needed 
into whether risk factors are the same.   
The SAPROF total score had good discriminative validity in terms of 
level of security for the participant.  This means it was able to 
discriminate between protection levels (and the ORP discriminated 
between risk levels) of patients in different levels of security.  However 
hypothesis six (b) was not supported; it was expected those in the LSU 
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would have higher levels of protection due to the admission criteria, 
which would result in those referred to MSU’s having higher levels of risk 
than those referred to LSU’s (Andrew & Bonta, 2007).  It is possible this 
result could be due to the support and supervision offered in conditions of 
medium security which inherently result in higher levels of protection 
(service specification no. C03/S/a; NHS Commissioning Board, 2013). 
The SAPROF total score showed good discriminative validity in 
terms of diagnosis and supported hypothesis six (c), as it was able to 
discriminate between protection levels of patients with MI and patients 
with LD, and found that patients with MI have higher levels of protection.  
As a result, it is possible patients with a diagnosis of LD need a higher 
level of support to enable development of more protective factors.  It is 
possible that due to their learning disability, criterion for protection such 
as intelligence, self-control, and financial management, can never really 
be met, and therefore may generally have lower levels of protection, 
highlighting the need for external measures to manage risk or a specialist 
instrument for this population.  Further investigation is required in this 
area as applicability of the SAPROF as an assessment tool of protectives 
in individuals with a learning disability has not been conducted 
previously. 
The SAPROF total score showed good discriminative validity in 
terms of care pathway stages.  This means it was able to discriminate 
between protection levels of patients in the acute and rehabilitation 
stages of their care pathway.  However, it was unable to discriminate 
between the pre-discharge and rehabilitation or acute stages.  Hypothesis 
six (d) was therefore only partly supported.  Surprisingly, patients in the 
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pre-discharge stage had lower levels of protection than those in the 
rehabilitation stage.  This may be because as patients are approaching 
discharge thoughts turn towards how they will present in the community, 
and as such, levels of protection may fall because the support of 
professionals in all areas reduces.  Three out of five factors on SAPROF/E 
are rated positively present due to detention in hospital and will 
automatically reduce following discharge.   
The SAPROF total score did not show discriminative validity in 
terms of length of stay.  This means the SAPROF was unable to 
distinguish between patients in regard to their length of admission in 
forensic inpatient settings.  As such hypothesis number six (e) was 
rejected.  As with stage of care pathway it is possible that the protection 
offered by detention in hospital over-rules protection in other areas. 
The discriminative validity results in terms of care pathway and 
length of admission are in contrast with research conducted by de Vries 
Robbé et al. (2014), who found SAPROF total scores increased through 
their care pathway.  It is possible differing support systems in the 
Netherlands where this research was complete may explain the 
differences in the results. 
 
4.4.1. Study limitations 
 Although low and medium secure settings were included, these 
results found may not generalise to other settings.  The outcomes may 
not be applicable to community settings as factors leading to inpatient 
violence may be different from those resulting in community violence.  
The sample was relatively homogenous, only had a small percentage of 
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females (14%), and even fewer diagnosed with a personality disorder 
(2%), and the results may not be generalizable to these populations.  In 
addition, there were very few ethnic minorities which may not be 
reflective of the number in forensic mental health services in general.   
The study size and follow-up length may have been insufficient; a 
longer follow-up may have generated a higher base rates.  However, in 
practice it is recommended risk assessments are updated on a regular 
basis due to the dynamic nature of risk (Douglas et al., 2013), and 
therefore the 6 month follow-up is reflective of this.  Replication in other 
settings and populations with a variety of follow-up periods may be 
useful.   
Due to the study design, the analysis of inter-rater reliability was 
not possible, and the researcher was not blind to the assessment 
information when collecting the follow-up data.  Both these factors may 
have impacted on the results of the research, and future investigations 
may wish to conduct such work blind to clinical information. 
The use of total scores on each of the assessment tools and 
calculated optimal cut-off scores is a noteworthy limitation of this 
research.  In practice the final judgement ratings of low, medium, and 
high are utilised by professionals to guide their assessment of level of 
protection (and risk; Douglas et al., 2013).  However, it was not possible 
to investigate this construct as the setting used for research did not 
consistently utilise the final judgement ratings.  Future research should 
consider using the final judgement ratings in addition to the total scores. 
 A further limitation may be the method of gathering outcome data 
which may have been influenced by bias.  It was local policy for all 
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violent incidents to be reported via IRIS forms and risk incidents recorded 
on RiO, and we can be reasonably confident that these outcomes are 
representative of all incidents of violence.  However, it is a subjective 
decision made by professionals as to the threshold criteria which results 
in an incident being reported.  Some incidents may not have been 
captured by this measure, and so the index behaviour may be an under-
representation of the actual phenomenon.  In addition, as patients move 
through their care pathway they are likely to be supervised to a lesser 
degree, and incidents may go more un-noticed.  Conversely, if patients 
are considered to have low levels of protection and high levels of risk, 
they are likely to be more closely supervised, with enhanced 
management plans, which are likely to result in fewer opportunities (and 
lower motivation) to engage in violent behaviour.  This may have had an 
impact on the base rates of absence and presence of violence reported.   
In terms of base rates, due to the use of absence of violence 
(SAPROF and START) and presence of violence as outcomes (HCR-20V3 
and START), the base rates for each outcome were extremely different 
(99% versus 1% respectively) which may be problematic.  Investigation 
of high base rates is likely to produce higher incidences of the 
investigated construct (absence of violence) being identified independent 
of the usefulness of the tool (Conroy & Murrie, 2007). 
 Finally, self-harm was included in the outcome as a form of 
violence as research conducted by Abidin et al. (2013) had found the 
HCR-20, SAPROF, and START to be predictive of self-harm (to varying 
degrees).  However, it is not generally considered violent behaviour and 
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is not included in the definition of violence in the HCR-20V3 (Douglas et 
al., 2013).   
  
4.4.2. Implications for practice 
In practice, professionals want to know whether the individual they 
are assessing is at risk of future violence, not whether a group of 
individuals are at risk, and there is criticism of the use of AUC analyses to 
investigate the use of violence risk assessment tools on this basis (Cooke 
& Michie, 2013).  There are suggestions that AUC values can be subject 
to over-optimistic interpretations (Sjöstedt & Grann, 2002), and 
Szmukler, Everitt, and Leese (2012) state ‘even a highly statistically 
significant AUC is of limited value in clinical practice’ (p. 895).  In reality 
the ‘scores’ on violence risk assessment tools are not employed, nor used 
to predict future violence.  The instruments are used to guide formulation 
and management plans.  The resultant AUC values are irrelevant to 
practice (Hart & Cooke, 2013).  Despite this, research such as the current 
study is important to add to empirical evidence and recommendations for 
best clinical practice (Cooke & Michie, 2013).  This is one of the first 
piece of research investigating the reliability and validity of the SAPROF 
in an English inpatient sample, and enhances the evidence base for its 
application in this area. 
The SAPROF was found to predict the absence of violence in a 
patients admission, and as such can be used as an evaluation of 
protective factors, alongside risk factors, in the process of violence risk 
assessment.  This research provides corroborative evidence for the 
continued use of the SAPROF in forensic mental health settings.  It 
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supports the recommendation that use of the SAPROF enhances the risk 
assessment process, and improves the validity of a risk factor focused 
assessment such as the HCR-20V3 (de Vogel et al., 2012).  The use of 
the SAPROF in addition to the HCR-20V3 is supportive of the strengths 
based approach recommended by the DoH (2007a). 
Due to the SAPROF’s higher level of predictive accuracy (for 
absence of violence) than the HCR-20V3 and START, it could be argued 
the SAPROF could be used instead of these tools.  However it was not 
designed for this purpose, it was developed as a complimentary 
assessment to be used alongside the HCR-20V3 to allow for a more 
balanced assessment, and it could be argued that disregard of risk 
factors would tip the balance in the other direction, and may result in a 
less comprehensive assessment.  Although this is not reflected in the 
results, which support assessment of only protective factors to evaluate 
violence risk. 
The SAPROF’s ORP index also achieved good concurrent, construct, 
predictive, and discriminative validity.  It was found to be significantly 
more predictive for presence of violence than the HCR-20V3, and is 
supportive of previous studies using the method (for example, De Vries 
Robbé et al., 2014).  This advocates the use of a measure where violence 
risk is balanced by protective factors (de Vries Robbé et al., 2011); this is 
a research concept, and it is difficult to comprehend how this can be 
applied in practice.  The ORP is based on substracting the SAPROF total 
score from the HCR-20 total score, and as discussed, ‘scores’ are not 
used in practice. 
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4.4.3. Conclusions 
The aim of this research study was to explore the value of 
protective factors in the assessment of violence risk.  The validity and 
reliability of the SAPROF as an assessment tool was investigated across a 
number of domains to evaluate whether the inclusion of protective 
factors improves predictive accuracy of violence risk assessment tools.  It 
was found to have good internal reliability, and good concurrent, 
construct, predictive, incremental, and discriminative validity.  The 
SAPROF was found to have enhanced construct and predictive validity 
over the HCR-20V3, suggesting there is value considering protective 
factors when attempting any assessment of violence risk.   
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Chapter Five 
 
 
 
The Importance of a Strengths-Based Approach to Collaborative 
Risk Assessment and Risk Management: A research case study 
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Abstract 
The aim of this case study was to explore the impact of psycho-education 
on a patient’s motivation to engage in treatment and interventions to 
manage risk.  The main objective was to establish whether risk 
assessment tools, which follow a strengths-based approach and focus on 
protective factors, have a positive impact on motivation to change when 
used in the collaborative risk assessment and management process.  Risk 
management should be positive, collaborative, and strengths-based 
(Department of Health; DoH, 2007a).   To enable recovery and 
rehabilitation individuals need to develop insight in to the risks related to 
their offending behaviour and mental illness (Birchwood, Spencer, & 
McGovern, 2000).  In addition, individuals need to develop insight into 
the need for change, and it is essential for this to happen before effective 
interventions can take place (Bordin, 1979).  Effective collaborative risk 
assessment and management may encourage insight into offending 
behaviour and mental illness to develop (Horstead & Cree, 2013).  The 
case reviewed was a patient who took part in a ten week, collaborative 
risk assessment and risk management, psycho-education group 
programme.  Motivation to change was measured using the University of 
Rhode Island Change Assessment (URICA; McConnaughy, Prochaska, & 
Velicer, 1983) after the patient viewed the team’s ratings on the 
Historical Clinical Risk-20 Version 3 (HCR-20V3; Douglas, Hart, Webster, 
& Belfrage, 2013), Structured Assessment of Protective Factors (SAPROF; 
de Vogel, de Ruiter, Bouman, & de Vries Robbe, 2012), and Short Term 
Assessment of Risk and Treatability (START; Webster, Martin, Brink, 
Nicolls, & Desmarais, 2004).  The results were compared to establish if 
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one assessment increased motivation more than the others.  Readiness 
to change increased after viewing the HCR-20V3 and the SAPROF; 
however reliable and clinically significant change was not indicated.   
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5.1. Introduction 
5.1.1. Background 
The purpose of risk assessment and risk management in forensic 
mental health services is to balance the risk of reoffending with 
appropriate interventions to manage and reduce risks.  This is known as 
a ‘risk-needs assessment’ (Andrews, Bonta, & Hoge, 1990).  It allows for 
least restrictive management proportionate to the level of risk and 
recommendation of the most appropriate intervention and support 
(Department of Health; DoH, 2007a).   
Risk management should be positive, collaborative, and strengths-
based (DoH, 2007a).   Positive risk management acknowledges ‘risk can 
never be completely eliminated’; and that risk management plans will 
contain decisions associated with risk (DoH, 2007a; p. 10).  It is 
suggested that individuals should be supported to take reasonable risks, 
taking into account independence, well-being, and choice (DoH, 2007b).  
Collaborative risk management between the individual, carer, and 
professional entails developing a therapeutic relationship based on 
warmth, empathy, and a sense of trust, where the risk management 
process is explained at the earliest opportunity (DoH, 2007a).  This 
allows for the development of a collaborative risk management plan in an 
open and transparent environment, which encourages the individual to 
have more autonomy over their care and treatment (Ryan & Deci, 2000).  
In terms of strengths-based risk management, Rapp and Goscha (2006) 
suggest when an individual’s strengths are acknowledged, in addition to 
their vulnerabilities, and strategies to address problems are built around 
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their positive skills, the individual feels more able to cope, resulting in 
more effective risk management. 
To enable recovery and rehabilitation individuals need to develop 
insight into the risks associated with their offending behaviour and 
mental illness (Birchwood, Spencer, & McGovern, 2000).  In addition, 
individuals need to develop insight into the need for change, and it is 
essential for this to happen before effective interventions can take place 
(Bordin, 1979).  Effective collaborative risk assessment and risk 
management may allow for insight into offending behaviour and mental 
illness to develop (Horstead & Cree, 2013).  In contrast, if individuals are 
excluded from the risk assessment process this may result in mistrust of 
professionals, rejection or denial of risk issues, and possibly strengthen 
any cognitive distortions regarding their risk (Horstead & Cree, 2013).  
This is unlikely to create conditions supportive of change. 
Prochaska and DiClemente (1986) developed the Stages of Change 
model which proposed four levels; pre-contemplation, contemplation, 
action, and maintenance.  This was later updated to include 
determination (see figure 5.1; Prochaska & Velicer, 1997).  It was 
suggested that if you can identify an individual’s stage of change, you 
can develop interventions which are most appropriate to meeting their 
needs, and in turn they can move through the stages.  It could be argued 
that collaborative risk assessment and risk management may increase 
insight into the need to change, and enable movement through the 
stages of change (Prochaska & Velicer, 1997).  If an individual is aware 
of their risks and protective factors, and the impact they have, it is 
156 
 
 
 
possible they may be more motivated to engage in interventions to help 
manage risk and maintain protection (Bordin, 1979).   
 
 
 
 
Figure 5.1.  Stages of change model (adapted from Prochaska & Velicer, 1997) 
 
To facilitate collaborative risk assessment and risk management, 
current best practice recommends the process should be explained as 
soon as possible (DoH, 2007a), and this could take the form of psycho-
education.  This is deemed to be an important and ethically crucial aspect 
of treatment for individuals with mental illness (Bauml, Frobose, 
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Action  
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they plan to change 
Maintenance  
Continuing the 
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Enter 
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at any stage 
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Kraemer, Rentrop, & Pitschel-Walz, 2006), and it has been reported that 
educating patients about their illness can increase coping strategies and 
awareness of relapse indicators (Aho-Mustonen, Miettinen, Koivisto, 
Timonen, & Raty, 2008).  It inherently follows that the same could be 
applied to risk assessment and risk management.  Psycho-education may 
need to include the definition of risk and risk management (including the 
difference between risk and protective factors), the purpose of risk 
management, and how it relates to treatment planning.  There should be 
a focus on developing strengths, using positive treatment and 
interventions to further enhance the motivation of the individual and 
inspire a lifestyle free from offending (Horstead & Cree, 2013).   
Psycho-education may also include information on the types of risk 
assessment used. In conditions of medium security it is recommended 
the Historical Clinical Risk Management - 20 (HCR-20V3; Douglas, Hart, 
Webster, & Belfrage, 2013) is used to assess potential risk of violence 
(service specification no. C03/S/a; NHS Commissioning Board, 2013).  
The HCR-20V3 evaluates the presence and relevance of risk factors, and 
uses these to formulate risk of violence and develop management plans.   
Due to its focus on risk factors the HCR-20V3 does not explicitly follow 
the strengths-based process recommended.  Protective factors are 
considered in so much as they contribute to the formulation and the risk 
management plan; however there is no guidance in terms of how to 
identify protective factors.   
It has been argued that collaborative risk management based 
solely on a focus on risk factors may be detrimental to individuals, as it 
can be demoralising and demotivating (Miller, 2006).  To balance the risk 
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assessment and risk management process, taking into account risk 
factors and protective factors (Laub & Lauritsen, 1994), the Structured 
Assessment of Protective Factors (SAPROF; de Vogel, de Ruiter, Bouman, 
& de Vries Robbe, 2012), and the Short Term Assessment of Risk and 
Treatability (START; Webster, Martin, Brink, Nicolls, & Desmarais, 2004) 
are also recommended for use as risk assessment tools in medium secure 
services (service specification no. C03/S/a; NHS Commissioning Board, 
2013).  The SAPROF evaluates the presence of protective factors to 
assess risk of future violence, thus focusing on the individual’s strengths.  
The START assesses risk of future violence, but also evaluates other 
related issues such as self neglect, and it considers the presence of both 
strengths (protective factors) and vulnerabilities (risk factors).   
There are a number of theories which support an emphasis on 
strengths and protective factors in the process of risk assessment and 
risk management.  The Theory of Reasoned Action (TRA; Fishbien & 
Azjen, 2010) claims one of the strongest predictors of behaviour is 
intention.  This is predicted by the attitude an individual holds towards 
the behaviour (behavioural beliefs), what the individual thinks others 
believe about the behaviour (normative beliefs), and the extent the 
individual believes they can control the behaviour (control beliefs).  The 
more positive these beliefs are towards the behaviour, the more likely the 
individual is to perform it.  In terms of reducing likelihood of offending 
the TRA suggests individuals would have negative attitudes towards 
offending, good social support which would disapprove of offending, and 
confidence in their ability not to offend.  These elements could be viewed 
as protective factors or strengths.  However, it should be noted that the 
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TRA assumes rationality and cognition are all that is needed to change 
behaviour, and this is not always the case (Kippax & Crawford, 1993). 
The Good Lives Model (GLM) of offender rehabilitation (Ward and 
Stewart, 2003) is another theory supporting the use of protective factors 
in risk assessment and risk management.  The GLM approach is based on 
the assumption that capabilities and strengths in people should be built 
on in order to reduce their risk of reoffending.  It suggests that 
individuals offend because they are attempting to achieve a valued 
outcome in their life, but their route to this often involves harmful and 
antisocial behaviours due to vulnerabilities within the individual and their 
environment.  Intervention and treatment is viewed as something which 
should add to the individual’s strengths, rather than something which 
removes or manages a problem.  This could be achieved through 
employment, leisure activities, and social integration.  Solution-Focused 
Treatment (SFT; De Jong & Berg, 2008) follows the same tenet where 
individuals are encouraged to explore and build on positive personal 
goals.  Andrews, Bonta, and Wormith (2011) argue that despite the 
popularity of the positive, strength—based focus of the GLM, it actually 
adds very little to the overarching theory of offender rehabilitation, the 
risk, need, and responsivity model (RNR; Andrews & Bonta, 2006) of 
offender assessment and treatment.  This model suggests that to reduce 
the risk posed by offenders the treatment should be proportional to the 
risk, focused on the need (factors related to the offending), and delivered 
in a way that is responsive to the individual’s abilities.   
Strength-based risk management can also be enhanced by 
external and environmental factors.  For example, detention or inpatient 
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treatment not only reduces the opportunity of offend, but offers support 
from professionals which may be emotional and practical, including 
motivational work.  Control theory (Cochran, Wood, & Arneklev, 1994) 
suggests external factors can be seen as important socialisation methods 
which discourage offending behaviour.  This is extremely important for 
individuals who have not yet developed personal internal strengths, or for 
those who may not be able to. 
A review of the literature did not identify any research that has 
explored the use of risk assessment tools which assess the presence of 
protective factors (such as the SAPROF), and the impact on an 
individual’s motivation to change (and engage in treatment).  However, it 
could be inferred that if a strengths-based approach improves motivation, 
a risk assessment following the strengths-based approach would do so 
also.   
Case studies appear to have been neglected in forensic mental 
health literature, possibly due to misunderstandings regarding their 
scientific value and rigour (Robinson, 2012).  They are useful for 
investigating experiences at an individual level, allowing for greater 
understanding, theory development, and analytical generalisation (Yin, 
2003).  Perhaps most importantly, case studies allow for ‘real-life’ 
situations to be scrutinised and for views to be tested as they unfold in 
practice (Flyvbjerg, 2006).  Davies, Howells, and Jones (2007) report it 
can be difficult to apply the results of larger studies, such as cohort 
studies or randomised control trials, to individuals in forensic mental 
health services, due to limited focus and generic conclusions.  Case 
studies are particularly important in terms of formulation (Kreis & Cooke, 
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2012).  Formulation is an important part of risk assessment and risk 
management, and provides an individualised and comprehensive view of 
the individual’s needs and risks (and strengths), which then guides 
intervention (Cooke, 2010).  This is something which is difficult to 
explore in large scale research. 
 
5.1.2. Aims and objectives 
A collaborative risk assessment and risk management training 
group programme for patients was introduced in a regional medium 
secure unit in May 2015.  The aim of this case study was to explore the 
impact of the training on a patient’s motivation to engage in treatment, 
and interventions to manage risk.  The main objective was to establish 
whether risk assessment tools which follow a strengths-based approach 
and focus on protective factors, in comparison to those which focus on 
risk factors alone, have a positive impact on motivation to change (in 
terms of the Stages to Change model, Prochaska and DiClemente, 1986) 
when used in the collaborative risk assessment and risk management 
process.  It was hypothesised that strengths-based collaborative risk 
assessment and management would have a positive impact on motivation 
to change. 
 
5.2. Method 
5.2.1. Setting 
This was conducted in a medium secure unit (MSU) for adult men 
and women.  The service aims to offer local inpatient provision to service 
users whose offending behaviour and mental health needs require they 
162 
 
 
 
are detained under the Mental Health Act (MHA; 1983, 2007 
amendments) in secure conditions.  It specializes in the assessment, 
treatment, and rehabilitation of adults with complex needs.  It provides 
65 beds, and has five wards which provide different levels of service to 
meet the patient’s needs (acute, sub-acute, rehabilitation, and pre-
discharge care).  Of the 65 beds, 16 are for women (acute, rehabilitation, 
and pre-discharge care). 
 
5.2.2. Case introduction  
The case reviewed was a patient who took part in a ten week 
collaborative risk assessment and risk management psycho-education 
programme.  For the purposes of this case study and to maintain 
anonymity, the patient will be referred to as ‘Mr O’.  Mr O was a 63 year 
old British Caucasian male.  He was detained under sections 37 and 41 of 
the Mental Health Act (1983; 2007 amendments).  His diagnosis was 
bipolar affective disorder.  The index offence was grievous bodily harm 
(GBH) with intent against a woman previously unknown to him.   
Mr O was born in a small village in the South East of England, and 
he grew up with his mother and father.  He had one brother who was five 
years older.  Mr O reports he had a happy childhood, and there are no 
reports or evidence of traumatic experiences during this period.  His 
father worked as an agricultural worker before moving on to a 
horticultural nursery, and his mother was employed as a farm worker.   
Mr O reports being bullied whilst at primary school, but this 
stopped when he went to secondary school.  He did well at school, and 
left at the age of 16 years old, obtaining employment as a trainee 
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draftsman and designer.  He remained in this position for 12 months, but 
had to leave due to the company going out of business.  He worked as a 
landscape gardener for 14 months, but his employer was unable to keep 
him on due to the employment of a new worker who could drive, unlike 
Mr O.  Between 1970 and 1976 Mr O worked for various construction 
companies as a labourer.  During this period he gained a number of skills 
which allowed him to become a self-employed builder.  In 1976 he began 
working in a colliery, where he remained until 1984 when he was made 
redundant as the coal mine closed.  Mr O returned to his career as a self-
employed builder until 1995, when he began training to become a 
registered general nurse.  He graduated in 1998 and embarked on a 
career in general nursing, first working  on general medical wards at a 
local hospital, followed by employment in a hospice where he continued 
working until 2012.  His employment ended following an incident where 
he was unable to get home from the hospice due to poor weather.  He 
had attempted to contact the director on a number of occasions, as 
transport had been guaranteed in such circumstances.  The director did 
not like Mr O’s persistence, and wrote to him the next day to dismiss 
him.  The dismissal was challenged, and Mr O was able to continue 
working, although he did not return to the hospice.  He once again 
returned to building work, and continued nursing on an agency basis. 
Mr O’s father died in 1980 at the age of 65 years old.  He died 
from lung cancer and secondary liver cancer.  His brother died two years 
later of leukaemia.  In 1996 Mr O’s mother died following an overdose of 
amitriptyline with whiskey.  He reports his mother suffered from 
depression which he believes started after the death of his father, and 
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was exacerbated by the death of his brother.  Mr O reports he had made 
a number of attempts to have his mother reviewed by the general 
practitioner, but they had not been prepared to visit her at home. 
Mr O married his wife in 1971, and they remain together.  His wife 
had a daughter from a previous relationship, and they had a son together 
in 1984 following a period of 12 years during which they had been trying 
to conceive.  Their son was diagnosed with Asperger’s Syndrome. 
 Mr O had a history of depression and anxiety which appeared to 
related to post traumatic stress disorder (PTSD), following a transient 
ischaemic attack which was the result of a motorbike accident in 2006.  His 
symptoms were managed in the community, and he had no admissions to 
psychiatric services.  Mr O reported that his symptoms of anxiety appeared 
to have become progressively worse since November 2013, and affected 
his ability to concentrate and remember things.  He described ‘stomach 
knots’ and shaking which would get worse when he tried to do something, 
for example leave the house.   In 2014 it was queried whether he was 
suffering from bipolar disorder due to the cyclical nature of his illness.  Mr O 
reported suffering from low mood and depressive episodes with periods of 
elated mood where he would become energetic, over confident, and 
reckless.  
Prior to Mr O’s arrest for the index offence there was no recorded 
history of psychosis.  At the time of his offence Mr O has reported 
experiencing auditory command hallucinations from a male voice that he 
refers to as ‘Mr Fox’.  Mr O reported he was taught by a ‘Mr Fox’ at 
school, and feels this is the foundation of the voice.  He reported feeling 
frightened to disobey the instructions that the voice gave him.  He was 
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unsure how long he had been hearing the voice for, but did not think it 
had been present for longer than a few months.  Prior to the index 
offence the voice had instructed him to harm someone.  At the time of 
the intervention it was unclear whether the offence was in response to a 
delusional system or whether it was an impulsive act. 
There was no evidence of violent or anti-social behaviour before 
the index offence, which occurred in January 2014, when Mr O was 
convicted of GBH with intent, following an allegation that he had stabbed 
a 21 year old female shop worker without provocation.  Mr O reportedly 
had no connection with the victim prior to the incident. 
Mr O was admitted to the acute ward at the MSU in February 2014 
following assessment in prison.  During his early he was diagnosed as 
suffering from a severe depressive episode with psychotic features, and 
bipolar affective disorder.  He continued to refer to ‘Mr Fox’, and his 
physical health deteriorated as he stopped eating and had limited fluid 
intake.  Emergency treatment with electroconvulsive therapy (ECT) was 
implemented due to a high risk of suicide, and deterioration in his 
physical state.  Subsequently Mr O’s mental state improved, and during 
his 18 month admission he progressed through the care pathway.  At the 
time of the current assessment, intervention, and evaluation Mr O 
resided on the pre-discharge ward. 
 
5.2.3. Measures 
The HCR-20V3 (Douglas et al., 2013) is a comprehensive set of 
professional guidelines for the assessment and management of violence 
risk.  The HCR-20V3 assists professionals to evaluate a person’s 
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likelihood of future violence and determine appropriate treatment and 
management strategies.  The HCR-20V3 allows for the appraisal of the 
presence (and relevance) of 20 key violence risk factors.  These are 
organized into three areas: historical, clinical, and risk management.  The 
historical factors are static, whereas the clinical and risk management 
items are dynamic.  The complete list is shown in table 4.2.  The 
presence of factors is coded using a three level response format: ‘yes’ the 
factor is definitely or conclusively present; ‘possible’ the factor is possibly 
or partially present, or the risk factor is present, but the information is 
weak, contradictory, or inconclusive; ‘no’ the factor is absent, or the 
professional perceives no evidence the factor is present.  The assessor 
should judge the relevance of factors with respect to the development of 
future risk management strategies.  Relevance is also coded on a three 
level scale: ‘low’ the factor is of low relevance to the individual’s risk for 
violence; ‘moderate’ the factor is relevant to some degree; ‘high’ the 
factor is present and its role in causing violence or impairing the 
effectiveness of risk management strategies is likely to be substantial.  
There is the option to rate a final risk judgement following completion of 
the assessment (low, medium, and high).   
The SAPROF (De Vogel et al., 2012) was developed to complement 
the risk assessment of future violent behaviour in offenders and forensic 
psychiatric patients.  It is a structured assessment guideline  designed for 
use in combination with a reliable and valid violence risk assesment tool,  
such as the HCR-20V3 (Douglas et al., 2013).  It aims to document and 
quantify the presence or absence of 17 protective factors in three areas: 
internal, motivation, and external (see table 4.1).  All but two of the 
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criteria (intelligence and secure attachment in childhood) are dynamic.  
The factors are coded on a three point scale based on the degree to 
which the protective factor is present.  ‘No’ means the protective factor is 
not present; ‘perhaps’  means the factor may be present but there is no 
conclusive evidence, or the factor is present only to some extent; ‘yes’ 
means the protective factor is definitely or clearly present.  There is also 
the option to rate factors in regard to key items (a protective effect that 
is already present), and goal items (a protective effect which may occur 
after intervention).  After rating the presence of the protective factors the 
assessor gives a final judgement which reflects the extent of ‘protection’.  
‘Low’ indicates there is little or no protection, ‘moderate’ refers to a 
moderate degree of protection, and ‘high’ indicates there is a high degree 
of protection.  The SAPROF gives an integrative final risk judgement 
which combines and weighs the risk and protective factors.   
The START (Webster et al., 2004) is a set of guidelines designed to 
evaluate mental disorder, monitor progress, plan treatment, and begin 
the process of estimating future risk to self and others.  In addition to 
assessing risk of violence it aims to inform decision making in terms of 
self-harm, suicide, unauthorised leave, substance abuse, self-neglect, 
and victimization.  There are 20 dynamic factors (with two additional case 
specific items) which are considered as strengths (protective factors) and 
as vulnerabilities (risk factors).  These are outlined in table 4.3.  The 
factors are coded on a three point scale; maximally present, moderately 
present, and minimally present.  Key and critical items can also be 
selected, where a key item reflects a prominent strength and a critical 
item identifies a factor which needs specific attention in treatment 
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planning and supervision.  Consideration of these areas allows for a 
specific risk estimate, ‘low’, ‘moderate’, or ‘high’ to be made for each 
area of risk (violence, self-harm, substance abuse, etc.).   
 
5.2.3.1. Outcome measures 
Motivation to change was measured using the University Rhode 
Island Change Assessment (URICA; McConnaughy, Prochaska, & Velicer, 
1983) scale.  The URICA consists of 32 questions which are answered on 
a five point Likert scale ranging from 1 (strong disagreement) to 5 
(strong agreement).  Responders are asked how closely they agree or 
disagree with each question.  Appendix 5.A shows the questionnaire.  
There are four subscales which measure the assumed stages of change; 
pre-contemplation, contemplation, action, and maintenance.  Its use is 
recommended in treatment and research to assess clinical progress and 
motivational readiness to change.  The URICA yields a readiness score 
which indicates the individual’s level of motivation to change in relation to 
the Stages of Change model.  The individual’s responses to each of the 
subscales are summed, and divided by the number of questions on the 
subscale.  These mean scores are then totalled, and the pre-
contemplation mean is subtracted from the total to obtain the readiness 
to change score.   
The URICA was designed to assess attitudes toward changing 
problem behaviours (McConnaughy et al., 1983).  It has good internal 
consistency, with coefficient alphas ranging between .79 and .89 
(McConnaughy, DiClemente, Prochaska, & Velicer, 1989).  It has also 
been shown to have good concurrent and predictive validity (DiClemente 
& Hughes, 1990).  Although most commonly used to measure change in 
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terms of substance abuse, it has been found effective in measuring 
change of attitudes towards treatment.  Dozois, Westra, Collins, Fung, 
and Garry (2004) administered the URICA to a sample of individuals with 
panic disorder at initial assessment, and following cognitive behavioural 
therapy.  They found that higher scores on the action stage scale 
predicted engagement in treatment.  However, as case study data can be 
difficult to generalise to wider populations, it can also be difficult to apply 
group research to individuals.  As such this should be noted when 
utilising instruments to assess individuals. 
 
5.2.4. Procedure 
5.2.4.1. Referral details 
Mr O was referred to the Risk and Protection Awareness training by 
his multidisciplinary team (MDT).  The aim was to improve his insight in 
relation to his risk factors and protective factors to enable him to 
progress further in his care pathway, and to allow him to develop a 
collaborative risk assessment and risk management plan with his MDT.  
To establish the suitability of Mr O’s referral his risks and needs were 
explored following the RNR model.   
 
5.2.4.2. Treatment needs analysis 
The assessment of risk allows the needs of the individual to be 
identified.  All admissions are treated the same: during a patient’s 
admission the HCR-20V3, SAPROF, and START are used to assess risk of 
future violence and other related risks.  The HCR-20V3 and the SAPROF 
are completed on a six monthly basis, and the START is updated every 
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three months.  The SAPROF and HCR-20V3 assessment were completed 
by a qualified psychologist, who conducted an exhaustive review of 
background documents, discussion with individuals who knew Mr O, and 
a clinical interview with Mr O.  The START was completed following the 
consensus model, where members of the MDT (nursing staff, medical 
professionals, psychologists, occupational therapists, and social workers) 
discuss and agree the ratings for each factor.   
The most recent assessments completed at the time of attendance 
at the training programme were used for evaluation of suitability for 
attendance, and also during the course of the intervention.  They were 
reviewed, and if Mr O was found to have difficulties in relation to insight 
into his offending behaviour and mental illness, as identified by factor 
‘C1: Problems with insight’ on the HCR-20V3, it was deemed an 
intervention aimed to improve this area, such as the Risk and Protection 
Awareness training, was needed.   
 
5.2.4.3. General treatment considerations 
To ensure the intervention was responsive to Mr O’s abilities, his 
engagement in previous psychological interventions was explored, and 
any difficulties he experienced were highlighted.  His level of cognitive 
functioning was reviewed to see if he might need any additional support 
during the intervention, and he was asked if he could foresee any 
difficulties or problems engaging.  His mental health was assessed to 
ensure this would not limit his engagement, and this included 
consideration of his ability to cope with the possible difficult emotions 
associated with viewing his risk assessment, for example, shame in terms 
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of previous violence, distress in terms of past traumatic experiences, or 
anger in terms of reaction to the MDT’s opinion. 
 
5.2.4.4. Assessment 
Mr O’s suitability to participate in the intervention was further 
assessed with the use of a qualitative questionnaire which aimed to 
gather information about his current knowledge and understanding of the 
risk assessment and risk management process.  This was completed by 
one of the training facilitators two weeks before the training was due to 
commence.  Mr O was considered suitable to attend the training as there 
were deficits in his knowledge and understanding in this regard.  Only 
patients who had a comprehensive awareness of risk assessment and risk 
management were excluded.  A copy of the pre-training questionnaire 
can be seen in appendix 5.B.  He was asked to complete the URICA 
questionnaire during the same session to provide a baseline measure of 
readiness to change.  
 
5.2.4.5. Intervention 
The ‘Risk and Protection Awareness Training’ was a group psycho-
education programme which aimed to improve patients’ understanding of 
the risk assessment and risk management process, and how it relates to 
their treatment plan.  It was predicted that following completion 
participants would be in a position to work collaboratively with their MDT 
to develop their risk assessment and risk management plans.   
There were ten one-hour training sessions in total, and a summary 
of the content can be seen in table 5.1.  Mr O was one of eight patients 
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who attended the training programme.  During the first session the 
participants were given an overview of what would be involved.  The 
remainder of the session described the risk assessment and risk 
management process at the MSU.  This included information about what 
risk assessment and risk management is, the differences between risk 
and protective factors, and the differences between static and dynamic 
factors.  An overview of the risk assessment tools used was given, 
including the steps involved in completing the assessments: information 
gathering, rating the presence and relevance of factors, risk formulation, 
and the development of management strategies.  During sessions two to 
seven patients were given further information about the core risk 
assessments used at the MSU (HCR-20V3, SAPROF, and START), and 
details about how they are used to guide treatment during their 
admission.  They were given the opportunity to rate the presence of risk 
and protective factors for themselves, and they were able to compare 
these to the ratings given by the MDT.  During session eight participants 
were given information about the process of risk formulation, how it is 
developed, and how it is used.  In sessions nine and ten participants were 
encouraged to think about management plans, how they link to 
treatment strategies, and what they would personally put in place to 
manage their risk factors and maintain and build on their protective 
factors. 
Throughout the training skills required for effective risk 
management were utilised to assist, build, and refine such abilities, for 
example brainstorming, problem solving, planning, and goal setting.  The 
information was presented in verbal and visual formats, with the use of 
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charts to help patients rate the presence of risk and protective factors, 
and handouts which they could take away with them, to help aid learning 
and retention.  At the end of the training each participant received a 
‘summary collaborative risk assessment and risk management plan’ 
which they could use to help them work with their MDT to update future 
risk assessments and risk management plans. 
 
 
Table 5.1 
 
Risk and Protection Awareness training session outline 
Number Content 
1 What is risk assessment and management? 
2 HCR-20 overview and rating own HCR-20 
3 Continue HCR-20 overview and rating own HCR-20  
Comparing own HCR-20 to MDT HCR-20 
4 SAPROF overview and rating own SAPROF 
5 Continue SAPROF overview and rating own SAPROF  
Comparing own SAPROF to MDT SAPROF 
6 START overview and rating own START 
7 Continue START overview and rating own START  
Comparing own START to MDT START 
8 What is formulation? 
9 What are management plans? 
10 Completing own summary risk assessment and management plan 
 
5.2.5. Evaluation 
5.2.5.1. Treatment outcome 
Following attendance at the training it was anticipated that 
patients would be able to work more collaboratively with the MDT to 
develop their risk assessment, risk management plan, and treatment 
goals.  The patient administration system was reviewed in the month 
after completion of the training to establish whether this had occurred.   
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5.2.5.2. Motivation 
It was also envisaged that training would increase patients’ 
motivation to engage in their treatment plan and give them more 
autonomy in relation to their care.  In addition to the URICA being 
completed during pre-training assessment, it was used at different time 
points during the training.  These were after viewing each of the risk 
assessments completed by their psychologist and MDT (end of sessions 
three, five, and seven). 
 
5.2.5.3. Ethical considerations 
 Informed consent was obtained from Mr O for this information to 
be used for the case study.  His capacity to consent was agreed by the 
MDT prior to approaching him.  See appendix 5.C for a copy of the 
information sheet and consent form.   
 
5.3. Results 
5.3.1. Treatment needs analysis 
Mr O was one of three group participants to receive a conclusively 
present rating on C1 of the HCR-20V3, suggesting he had a risk factor in 
the area of insight in terms of his offending behaviour and mental illness.  
Mr O’s level of insight was not significantly different from the group 
participants (z = 1), but his lack of insight was considered a perpetuating 
factor for future offending.  As such, improving his insight was 
determined to be a need to reduce the risk of Mr O reoffending in the 
future.  Improving insight may enhance his motivation to engage in any 
further treatment recommended during his admission (Bordin, 1979).  Mr 
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O was considered an appropriate referral to the Risk and Protection 
Awareness training. 
 
5.3.2. General treatment considerations 
Since his admission to the ward Mr O had engaged in individual 
psychological therapy and group treatment.  He had not had any 
difficulties in these processes, and it could therefore be assumed that a 
group training programme was suitable.  Mr O had average cognitive 
functioning abilities, according to the Wechsler Adult Intelligence Scale 
(WAIS-IV, Wechsler, 2008), with no obvious deterioration relative to his 
pre-morbid state, and there were no concerns regarding his reading and 
writing skills.  He did not think he required any additional support, and 
did not think he would have any particular difficulties engaging.  Mr O 
also reported there was nothing he would feel uncomfortable discussing 
in a group training setting.  He said if he did experience any difficulties he 
would feel confident in asking staff for extra support, as he has done in 
the past.  There were no concerns about Mr O attending the training. 
 
5.3.3. Assessment 
In the qualitative questionnaire Mr O reported that he would like to 
attend the training to gain more of an understanding of why ‘I did what I 
did’ (in reference to his index offence).  He said he felt enthusiastic about 
attending, and felt it would be a good opportunity to ‘learn about risks’.  
Mr O appeared to have a basic understanding of risk assessment and risk 
management, but was not aware of the specific risk assessment tools 
used during his admission.  He reported, and it was corroborated through 
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review of his notes, that his risk assessment had not been discussed with 
him, and he had not seen a copy of the report.  When asked what he felt 
might be a risk or protective factor, he gave examples in reference to his 
own experiences.  For example, he reported that his sense of humour 
and use of language was a risk factor because it led others to 
misinterpret what he meant.  On the other hand, he also thought his 
communication skills were a protective factor, along with an ability to 
empathise with others.  He was able to identify that feeling agitated (but 
not being sure of what was causing his agitation) was an example of a 
relapse indicator, and that when feeling this way he could let his support 
system know so they could monitor his behaviour.   
The qualitative questionnaire indicated that Mr O did not have a 
comprehensive understanding of risk assessment and the risk 
management process, and therefore was a suitable candidate for 
attendance at the Risk and Protection Awareness training. 
 
5.3.3.1. URICA 
Mr O achieved a readiness to change score of 9.86 (maximum 
achievable 15) prior to attending the training.  This placed him in the 
contemplation stage of change.  This suggests Mr O recognised that he 
had a mental illness and had engaged in offending behaviour in the past, 
and was considering what he needed to be doing to manage this.  All 
results can be seen in figure 5.7. 
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5.3.4. Intervention 
 Mr O was one of eight patients who attended the ‘Risk and 
Protection Awareness Training’.  He attended all 10 of the training 
sessions and he engaged well throughout.  Mr O completed his own 
ratings of the presence of risk and protective factors on the HCR-20V3, 
SAPROF, and START, and compared his own opinions to that of his MDT.  
Figures 5.2, 5.3, and 5.4 show his ratings in comparison to the MDT 
ratings.   
Mr O’s ratings on the HCR-20V3 differed considerably from that of 
the MDT; specifically he appeared to under-estimate his risk factors in 
comparison to the opinion of the MDT.  For example, on the HCR-20V3 he 
did not think he had definite or possible risk factors in 11 out of 20 areas, 
where as the MDT felt he had definite or possible risk factors in all areas 
except ‘other anti-social behaviour’.  Interestingly, Mr O felt he had risk 
factors in the areas of ‘personality disorder’ (H7) and ‘traumatic 
experiences’ (H8), which were not reflected in the MDT ratings.  He said 
he had only recently been diagnosed with a personality disorder which 
may explain the discrepancy between his rating and the MDT rating.  In 
terms of ‘traumatic experiences’ the MDT felt this was a possible risk 
factor, whereas Mr O felt it was a definite risk factor.   
In contrast, Mr O’s ratings on the SAPROF were very similar to the 
MDT ratings.  They only differed in five out of 17 areas, and both Mr O 
and the MDT felt the protective factor was present, but the degree to 
which it was present varied.  Mr O felt he had definite protective factors 
whereas the MDT felt they were possible protective factors. 
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Similarly, on the START Mr O’s opinions on his strengths 
(protective factors) were comparable to the MDT ratings, while his 
opinions in regard to his vulnerabilities (risk factors) were at odds to their 
ratings.  Mr O  felt he had maximum or moderate vulnerabilities in just 
three areas, where as the MDT felt he had maximum or moderate 
vulnerabilities in all areas except ‘substance use’ (8).  As with the 
SAPROF, Mr O and the MDT felt strengths were present in all areas, but 
the degree to which they were present varied.   
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Presence: 
2 = (Yes) Information indicates the factor is present 
1 = (Possible) Information indicates the factor is possibly or partially present 
0 = (No) Information indicates the factor is not present or does not apply 
 
Figure 5.2.  HCR-20 assessment 
 
 
 
Presence: 
2 = (Yes) The protective factor is clearly present 
1 = (Perhaps) The protective factor may be present or is present to some extent 
0 = (No) The protective factor is clearly absent, or there is no evidence that the protective factor is 
present 
 
Figure 5.3.  SAPROF assessment 
 
 
 
Presence: 
2 = Maximally present 
1 = Moderately present 
0 = Minimally present 
 
Figure 5.4.  START assessment 
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Due to the complex nature of risk formulation, participants of the 
training were given information about how a formulation is developed, 
and how it may relate to their treatment plans.  However, they did not 
develop their own risk formulations.  Mr O was able to use his 
identification of risk and protective factors to reflect on what a risk 
formulation related to his offending behaviour may look like.  Figure 5.5 
outlines the risk formulation using the MDT risk assessments as a basis 
for development. 
There appeared to be no early life experiences such as removal 
from the family home or childhood abuse which could be considered 
predisposing factors.  Mr O has a diagnosis of bipolar affective disorder, 
which may have predisposed him to be more likely to engage in risk 
behaviour.  He also experienced a series of bereavements within his 
family (father, brother, mother, grandson) and his wife’s family which 
may have contributed to this predisposition.  Factors which appeared to 
be catalysts for Mr O’s difficulties (precipitating factors) may have 
included being made redundant from his job as a nurse, a motorcycle 
accident, and difficulty managing the symptoms of his bipolar affective 
disorder.  A more immediate precipitating factor appeared to be the 
experience of auditory hallucinations which commanded him to hurt 
others.  Factors which maintained the possibility of risk behaviour 
(perpetuating factors) may have included post-traumatic stress disorder 
resulting from his motorcycle accident, which increased his symptoms of 
anxiety and depression, his diagnosis of bipolar affective disorder, and 
resultant difficulties coping with stress.   
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 Mr O also had a number of protective factors which may have 
reduced the likelihood of engaging in risk behaviour.  These included an 
average level of intelligence which would have allowed him to think 
rationally and act purposefully, a secure attachment in childhood, the 
ability to empathise with others, abstinence from drugs and alcohol, and 
the support of his wife. 
 
 
Figure 5.5.  Mr O’s risk formulation 
 
 In line with the risk assessment and risk management procedure 
Mr O was encouraged to identify which risk factors were relevant to the 
development of future risk management strategies, and which protective 
factors were essential for the prevention of future violent behaviour.  He 
was also asked to identify what his relapse indicators were, and what 
strategies could be put into place to help manage his risk factors, and 
maintain and build on his protective factors.  Finally, he was asked to set 
Predisposing factors 
Bipolar affective disorder, autistic 
personality traits, family 
bereavements 
Precipitating factors 
Redundancy, motorcycle accident, 
symptoms of bipolar affective disorder 
(low/elated mood), command 
auditory hallucinations  
Perpetuating factors 
PTSD, anxiety, depression, difficulty 
managing bipolar affective disorder, 
difficulty coping with stress 
Protective factors 
Intellect, secure childhood 
attachment, empathy, abstinence 
from drugs and alcohol, support from 
wife 
Index Offence  
GBH with intent 
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some goals to aid the management of his risk factors and development of 
protective factors.  Figure 5.6 outlines the plan he developed. 
 
 
Figure 5.6.  Mr O’s summary collaborative risk assessment and risk management 
plan 
 
 
•My family 
•Support from my partner 
•I take my medication 
•I have positive goals for the future 
•I’m looked after by mental health professionals 
My Strengths (protective factors) 
•I may have problems coping with stress 
•I find it difficult sometimes to understand my strengths and 
vulnerabilities 
•Personality disorder may have caused difficulties 
My Vulnerabilities (risk factors) and things 
that increase my risk 
•Not as smart in appearance (i.e. beard gets longer) 
•Not able to concentrate, especially with reading 
•Watching more TV than usual 
Signs things aren’t going right for me (relapse 
indicators) 
•Self monitor 
•Work with staff 
•Keep taking regular medication 
Things I need to do to keep myself safe 
•Listen to me and take step back before assessment 
Things other people need to do to help keep 
me safe 
•I would like to be better at managing my feelings in stressful 
situations 
•I would like to continue the support I get from my wife and family 
•To continue taking my medication 
My goals to help build my strengths and 
manage my vulnerabilities 
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5.3.5. Evaluation 
5.3.5.1. Treatment outcome 
Mr O appeared keen to collaborate with his MDT in the 
development of his risk assessment and risk management plans, 
evidenced by him approaching his psychologist and requesting to speak 
to her about his assessment.  Review of the patient administration 
system revealed that following attendance at the Risk and Protection 
Awareness training Mr O met with his psychologist to collaboratively 
develop his risk assessment and risk management plans.  Attendance at 
the training programme and subsequent collaborative discussion with his 
psychologist may have increased Mr O’s insight into his risks in terms of 
his mental illness and offending behaviour, enabling progression through 
his care pathway, and it may have increased his ability to address his risk 
of reoffending by developing shared goals for treatment.   
 
5.3.5.2. Motivation     
Mr O’s motivation to change was measured using the URICA after 
he viewed the team’s ratings on the HCR-20V3, SAPROF, and START.  
The results are shown in figure 5.7.  McConnaughy et al. (1983) state 
that scores less than 8 suggest the individual is in the pre-contemplation 
stage, scores between 8 and 11 suggest the contemplation stage, scores 
between 11 and 14 suggest the individual is in the action stage, and 
scores greater than 14 suggest the action stage of change.  Prior to 
attending the training Mr O’s readiness to change score was 9.86 (z = 
1.26), which fell in the contemplation stage.  After viewing the MDT’s 
ratings of his risk factors on the HCR-20V3, Mr O’s readiness to change 
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score was 10.00 (z = 1.26), which remained in the contemplation stage.  
The readiness to change score rose further to 10.86 (z = 1.47) after he 
viewed the MDT’s rating of his protective factors on the SAPROF.  This is 
approaching the action stage.  After viewing the MDT’s ratings of his 
strengths and vulnerabilities on the START, Mr O’s readiness to change 
score reduced to 9.29 (z = 1.33).  This was his lowest score, although it 
was higher than the baseline measure, and remained in the 
contemplation stage.  Although higher at all stages, none of Mr O’s 
readiness to change scores were significantly different from the group 
mean.  Investigation of clinically significant change and reliable change 
(Jacobson & Truax, 1991) found no reliable (RC = 1.78) or clinically 
significant (criterion A = >11.75) improvement.   
 
Figure 5.7. Mr O’s readiness to change in comparison to the group mean 
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185 
 
 
 
5.3.6. Further interventions identified in relation to reducing 
risk of future violence 
 Taking into account the risk factors and protective factors 
identified in the risk assessments completed, Mr O may benefit from 
interventions to help manage his risks and maintain and build on his 
protective factors.  In line with the strengths-based approach, these 
should focus on developing his strengths, using positive treatment and 
interventions to further enhance his motivation. 
Mr O may benefit from further offence focused work.  This may 
involve attendance at the Offending Behaviour Group which follows a 
cognitive behavioural therapy (CBT; Beck, 1967) framework which has 
been found effective in offender treatment (Craig, Dixon, & Gannon, 
2013).  The GLM is incorporated in the programme which would allow for 
a strengths focused approach (Ward and Stewart, 2003).  
Mr O may benefit from engaging in bereavement counselling to 
allow him to come to terms with the loss of family members, including his 
parents and brother.  He may also benefit from attaining more coping 
skills to allow him to cope with the symptoms of his bipolar disorder, 
anxiety, and depression.  This could be completed on an individual or 
group basis, perhaps following a CBT framework.   
Mr O’s relationship with his wife was a primary protective factor.  
To maintain this they may benefit from some family focused psycho-
education to enable her to help support him in coping with his mental 
illness, management of risk factors, and maintaining and building 
protective factors.  As Mr O approaches discharge he may wish to think 
about what leisure activities he would like to pursue to help him to 
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structure his time in a positive manner, and how he will maintain a 
positive relationship with mental health professionals to reduce the 
likelihood of deterioration in his mental state. 
 
5.4. Discussion 
The aim of this case study was to explore the impact of 
collaborative risk assessment and risk management training on a 
patient’s motivation to engage in treatment and interventions to manage 
risk.  The main objective was to establish whether risk assessment tools 
which follow a strengths-based approach and focus on protective factors, 
in comparison to those which focus on risk factors, have a positive impact 
on motivation to change in terms of the Stages to Change model 
(Prochaska & DiClemente, 1986), when used in the collaborative risk 
assessment and risk management process.  It was hypothesed that 
strengths-based collaborative risk assessment would have a positive 
impact on motivation to change. 
Mr O’s motivation increased after reviewing the HCR-20V3 and 
SAPROF assessments.   A possible explanation may be that viewing his 
risk and protective factors increased Mr O’s motivation to take action and 
manage them to enable his progression through the care pathway (Ryan 
& Deci, 2000).  Prior to attending the training, as identified in the 
assessment interview, he had limited understanding about what his risk 
and protective factors were.  Increasing his awareness may have helped 
encourage him to think about what he could do to change (Bordin, 1979). 
After viewing the SAPROF, Mr O’s readiness to change score rose 
to 10.86.  This was the peak level over the course of the training.  This 
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provides some support for a strengths-based approach towards risk 
assessment and risk management.  It suggests that understanding his 
risk factors may have increased his motivation to change, but 
understanding his protective factors might have increased his motivation 
to change further.  However, Mr O’s motivation decreased to its lowest 
point after viewing the START assessment.  This is surprising because the 
START contains risk factors (vulnerabilities) which are balanced by 
protective factors (strengths).  
Despite strengths-based collaborative risk assessment having 
some positive impact on motivation to change, the hypothesis was not 
supported as the change was not a reliable or clinicially significant.  There 
was no significant difference between strengths-based assessments and 
those which focused on risk factors.   
This case study demonstrated that a strengths-based shared 
understanding of risk and protection did not have a signiciant impact on 
motivation to change.  This has a number of clinical implications.  
Research suggests inclusion of the assessment of protective factors, such 
as use of the SAPROF, and not just using tools which assess purely risk 
factors, such as the HCR-20V3, balances the risk assessment for 
professionals (Laub & Lauritsen, 1994), but this case study does not 
support increased motivation for change in patients.  This suggests 
inclusion of protective factors may not be useful for patients. 
The importance of the collaborative process was highlighted (DoH, 
2007a).  When rating the presence of risk factors on the HCR-20V3, Mr O 
identified two which the MDT did not consider important.  One of these 
was explained by a recent diagnosis, which had been made following 
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completion of the risk assessment.  The other was in the area of 
‘traumatic experiences’, suggesting that Mr O felt this was more of a risk 
area than the MDT perceived.  The MDT may have acknowledged the 
issue, but due to clinical judgement may have felt the evidence did not 
justify a ‘yes’ rating.  A possible implication is that a treatment area was 
not identified, and as such the risk factor goes un-managed, which could 
result in an impact on future risk behaviours.  Alternatively, the 
differences may have arisen because Mr O and the MDT have a different 
level of experience in this sort of rating.  The MDT have received 
professional training, and are proficient in completing risk assessments.  
On the other hand Mr O’s experience is limited, and he has no 
professional training in the area of risk assessment.  During the 
collaborative process patients and the MDT may continue to disagree in 
their ratings, but it might also allow them to discuss their opinions to 
ensure nothing is overlooked, and to develop a shared understanding 
which they can use to jointly develop the management plan. 
Another element which supports the collaborative process, and 
which is demonstrated by the differences in Mr O’s and the MDT ratings, 
is the impact of a shared understanding on insight (Birchwood et al., 
2000).  Although insight was not measured or assessed in this case study 
it could be inferred that sharing the MDT views may have increased Mr 
O’s understanding of his mental illness and offending behaviour.  His 
ratings, compared to those of the MDT’s, demonstrated he tended to 
over-estimate his protective factors and under-estimate his risk factors.  
This may result in him finding it difficult to understand why he has been 
referred to attend treatment in those areas.  The collaborative process 
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may increase insight into the reasons for completing recommended 
interventions.  This in turn may increase motivation to engage. 
 If a patient’s motivation increases following collaborative risk 
assessment using a collaborative approach (albeit not significantly) it 
could be argued that a strengths-based risk management plan may also 
increase motivation.  Future interventions may benefit from following this 
approach, for example those which employ the GLM framework.  In 
addition, risk management plans that have been developed 
collaboratively between the individual and the MDT are more likely to be 
positively engaged with than those imposed on the individual.  At the end 
of the training Mr O had developed his own risk management plan which 
reflected a number of needs, including the requirement to improve his 
skills to be able to manage stressful situations.  Since he has recognised 
this need, he is more likely to be motivated to engage in an intervention 
to address it. 
 
5.4.1. Limitations 
 One of the main limitations of this case study is the process of the 
Risk and Protection Awareness training itself.  During the course the 
participants are given an outline of what the risk or protective factor 
means, and asked to rate how much they think that factor relates to 
them.  They are then given a copy of the MDT’s rating which they can 
compare to their own.  However, the MDT risk assessment shared does 
not include natural language explanations as to why that classification 
has been given.  This could lead to confusion about why they have been 
given the rating, and actually decrease motivation rather than increase it.  
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In an attempt to counter-act this, participants were encouraged to speak 
to their psychologists between training sessions to receive any 
clarification they felt they needed, but this would have occurred after 
their motivation was measured, so although clinically the impact was 
minimised, on a research level this was not addressed. 
 In addition, the order in which the risk assessments were 
introduced in the training programme may have impacted the results, 
and as such should be considered a confounding factor. 
 Use of the URICA to measure motivation to change has its 
limitations because there are mixed results in terms of its usefulness.  
For example, McMurran, Theodosi, and Sellen (2006) found the URICA 
did not consistently provide evidence of motivation for therapy and 
motivation to change.  They recommended that better measures of 
motivation need to be developed.  In addition, Blanchard, Morgenstern, 
Morgan, Labouvie, and Bux, (2003) found that readiness to change did 
not predict end of treatment outcomes, and they concluded the URICA 
showed limited clinical utility.  Despite the limitations of the URICA there 
are few other tools available for use or validated for use in this setting 
(McMurran et al., 2006).  In this case study motivation was also 
evaluated by investigating whether Mr O met with his MDT to collaborate 
on his risk assessment and risk management plan.  However this only 
occurred after completion of the training, and did not contribute to the 
measure of motivation following sharing of each assessment within the 
training.  Future explorations of motivation to change in this area may 
consider using alternative or multiple measures of motivation. 
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 This case study did not measure insight directly, but instead 
inferred insight of risk areas, protection, and need for treatment 
increased following sharing of risk assessment information.  However, 
giving information does not necessarily mean the individual will take on 
board that information and use it.  An interview following completion of 
training may have established whether insight into risk and protective 
factors was present, and longer term follow-up may have been of benefit 
to investigate whether engagement in treatment increased following 
attendance at the training. 
 The nature of a case study means the results cannot be 
generalised to the wider population.  To achieve this it may be useful to 
complete a similar investigation but with the use of a larger cohort study.  
However, this would lose the detail which this case study has provided, 
for example the details of Mr O’s formulation and the development of his 
individualised risk management plan. 
 
5.4.2. Future directions 
 Professionals seek to determine if the risk assessments they are 
using are effective in evaluating the risk of future violence.  It would be 
interesting to investigate whether the contribution of patient’s opinions to 
the risk assessment process increases or decreases the predictive validity 
of the risk assessment tool used. 
  
5.4.3. Conclusions 
 To enable risk management to be positive, collaborative, and 
strengths-based in forensic mental health settings, patients (and their 
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carers) need to be involved in the process, and assessments and plans 
need to focus on their strengths and protective factors (DoH, 2007a).  
This helps to improve insight into mental illness and offending behaviour, 
along with insight into the need to change, which enables individuals to 
effectively engage in interventions to help manage risk (Birchwood et al., 
2000 and Bordin, 1979).  Psycho-education is a useful tool to implement 
this (Baumi et al., 2006).  It should be commenced as early as possible, 
and continued throughout contact with services to enable the 
collaborative process to be fully integrated (DoH, 2007a).  This 
encourages individuals to become proficient at assessing and managing 
their own risk, reducing the likelihood of future offending or relapse of 
mental illness (Horstead & Cree, 2013).  However, this was not 
supported in this case study where no reliable or clinically significant 
change was found.  A larger cohort study should be considered for future 
research to allow further exploration of this area.   
193 
 
 
 
 
 
 
 
Chapter Six 
 
 
 
Discussion 
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The aim of this thesis was to explore and enhance the research 
evidence for the inclusion of protective factors in the violence risk 
assessment and management process in forensic mental health services, 
in the National Health Service (NHS).  More specifically it investigated 
whether assessment of protective factors improves predictive accuracy of 
violence risk assessment, and discusses the implications for clinical 
practice.  The impact on patient motivation to change is also considered. 
Chapter two critically evaluated the most widely used violence risk 
assessment tool, the recently updated Historical Clinical Risk-20 Version 
3 (HCR-20V3; Douglas, Hart, Webster, & Belfrage, 2013).  The HCR-20V3 
assists professionals to estimate a person’s likelihood of future violence, 
and determine the most appropriate treatment and management 
strategies.  An overview of the instrument was provided, and its 
measurable properties explored, considering its clinical and research 
applications, whilst also taking into account its use in forensic mental 
health settings.    The HCR-20 is considered the most researched and 
best empirically guided risk assessment of violence, and it has been 
widely adopted (Douglas, Shaffer, Blanchard, Guy, Reeves, & Weir 2014).  
Version 3 of the instrument was introduced in 2013, and as such the 
evidence base for its reliability, validity and clinical utility is still in its 
infancy.  Despite limited research, the evidence available suggested high 
levels of internal and inter-rater reliability, and good levels of concurrent 
and predictive validity.  Its clinical utility was also supported.   
One of the criticisms of the HCR-20V3 was the omission of 
assessment of protective factors in addition to risk factors.  The manual 
suggests protective factors should be considered when developing the 
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formulation and management plan; however there is no guidance in 
terms of what constitutes a protective factor.  Development of the HCR-
20V3 was guided by empirical literature relating to factors consistent with 
violence, of which there is a plethora (Douglas et al., 2014).  It is 
possible that assessment of protective factors alongside risk factors was 
not included because the empirical basis of what protects an individual 
from future violence remains in its infancy.  As such there is no 
consensus as to how to define a protective factor, or how they work to 
reduce risk.  As the popularity of including protective factors in the 
violence risk assessment process increases this is something which will 
no doubt improve.  Chapter one concluded that the neglect of 
assessment of protective factors alongside risk factors in the HCR-20V3 
supported the need of an additional tool such as the Structured 
Assessment of Protective Factors (SAPROF; de Vogel, de Ruiter, Bouman, 
& de Vries Robbé, 2012).   
Chapter three systematically reviewed the research literature on 
the predictive accuracy of the violence risk assessment tools 
recommended for use in forensic mental health services, in the NHS: 
HCR-20, SAPROF, and Short Term Assessment of Risk and Treatability 
(START; Webster, Martin, Brink, Nicolls, and Desmarais, 2004).  It aimed 
to establish whether the instruments including assessment of protective 
factors (the SAPROF and START) had enhanced predictive abilities (for 
absence of violence).  Following PRISMA guidelines, research 
investigating the predictive validity of the HCR-20, SAPROF, and START 
in a population of adult male offenders, with a primary diagnosis of 
mental illness or personality disorder, and an outcome measure of future 
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violent behaviour or re-offending was included.  The results suggested 
that the assessment tools have useful predictive validity.  The SAPROF 
was found to have the highest level of predictive validity (for absence of 
violence), followed by the HCR-20 (for presence of violence), and the 
START had the lowest level of predictive validity (for absence and 
presence of violence).  It was difficult to establish with any certainty 
whether the inclusion of protective factors improved the risk assessment 
process, but the combined use of the HCR-20 with the SAPROF, creating 
a new measure of risk balanced by protection, improved predictive 
accuracy for presence of violence, promoting the inclusion of protective 
factors.   
Despite the identified research supporting the use of the SAPROF, 
the systematic review identified only eight empirical studies investigating 
the tools use, and only one of those was completed in England.  In 
addition, the research conducted using an English population was 
completed using a community sample.  This highlighted the need for 
further research regarding the use of the SAPROF in forensic mental 
health services in the NHS. 
Chapter four investigated the reliability and validity of the SAPROF 
when implemented in a NHS forensic mental health service, to allow for a 
greater understanding of the effectiveness of its application in forensic 
inpatient settings.  The SAPROF was found to have good internal 
reliability, concurrent, construct, and discriminative validity.  The SAPROF 
demonstrated good predictive accuracy for absence of violence, and the 
results suggested the tool’s predictive abilities were superior to the HCR-
20V3, and the START, although not significantly.  Combining the use of 
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the SAPROF with the HCR-20V3 significantly increased the predictive 
accuracy for presence of violence.  The results heightened the argument 
for assessment of protective factors in the risk assessment process, and 
supported the use of the SAPROF alongside the HCR-20V3.   
Chapter five evaluated the impact of protective factors in 
assessment of violence risk on a patient’s motivation to change.  The 
clinical implications of the findings and recommendations for future 
research were also discussed.  The main objective was to establish 
whether risk assessment tools, which follow a strengths-based approach 
and focus on protective factors, had a positive impact on motivation to 
change when used in the collaborative risk assessment and management 
process.  The results showed that readiness to change was at its highest 
after the patient viewed his SAPROF assessment, although there was no 
reliable or significant change in motivation levels.  This suggested a focus 
on protective factors did not have a positive impact on motivation to 
change superior to that of a focus on risk factors.  
 
6.1. Limitations 
This thesis has some important limitations which should be noted.  
Chapter two provided a critical evaluation of the HCR-20V3 (Douglas et 
al., 2013), however because the tool is relatively new, research 
investigating its reliability and validity remains in its infancy.  In addition, 
much of the research was conducted by the tools authors or researchers 
associated with the authors.  Only two studies included in the critique 
had sample sizes of over 100 (Doyle et al., 2014, and Strub et al., 2014), 
and the majority of studies were conducted outside the United Kingdom 
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(Canada, Norway, Germany, Netherlands, and Sweden), making the 
results of the remaining studies hard to generalise.  It should also be 
noted that a number of the studies described in the critique were based 
on draft versions of the HCR-20V3, which will have differed from the 
published assessment.  Therefore the research described may not be 
applicable to the final published HCR-20V3. 
Some selection bias may have been present in chapter three which 
systematically reviewed the research literature on the predictive accuracy 
of the HCR-20, SAPROF, and START risk assessments.  Language bias 
may have been present with 17% of studies excluded on the basis of 
language or due to the full text being unavailable.  Additionally, due to 
time constraints it was not possible to contact the authors of relevant 
resources if there were missing data, which may have had implications in 
terms of the studies included, particularly in relation to the defined 
population.  Author bias was also an important factor in the review.  Half 
of the research investigating the predictive accuracy of the SAPROF and 
42% of research investigating the predictive validity of the START was 
completed by the authors (or those affliated with) of the tool. 
A meta-analysis was not conducted after completion of the 
systematic review.  The main reason for this was differing 
operationalisations of the outcome of ‘violent behaviour’.  For example, 
the outcome of ‘violence’ is different from ‘any aggressive behaviour’ 
which may include acts such as verbal aggression.  In addition, the 
outcomes differed for studies investigating the SAPROF (and some 
examining the START) as they assessed absence rather than presence of 
violence.   
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The comparison of absence of violence to presence of violence has 
a noteworthy impact on base rate levels, which should be acknowledged 
as limitation for both the systematic review and the research outlined in 
chapter four which investigated the reliability and validity of the SAPROF 
as an assessment tool.  The base rate was much higher for absence of 
violence, and investigation of high base rates is likely to produce higher 
incidences of the investigated construct (i.e. absence of violence) being 
identified independent of the usefulness of the tool (Conroy & Murrie, 
2007). 
In terms of other limitations for the empirical research, although 
low and medium secure settings were included, the results found may not 
generalise to other settings.  The outcomes may not be applicable to 
community settings and the sample was relatively homogenous.  As with 
the systematic review, the outcome measure of the empirical research 
may have been problematic as although it was local policy for all violent 
incidents to be reported, it was a subjective decision made by 
professionals as to whether an incident made the threshold for reporting, 
and only those observed would have been reported. 
Self-harm was included in the outcome as a form of violence in 
both the systematic review and the empirical project because research 
conducted by Abidin et al. (2013) had found the HCR-20, SAPROF, and 
START to be predictive of self-harm (to varying degrees).  However, it is 
not generally considered violent behaviour and is not included in the 
definition of violence in the HCR-20V3 (Douglas et al., 2013).  The 
inclusion of self-harm will have inflated the number of reported violent 
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incidents, and as such impacted on the base rates of absence and 
presence of violence. 
Overall, it should be remembered that in practice risk assessments 
are not used to predict whether or not a patient will be violent in the 
future.  The outcome of the risk assessment is recommendations for 
management plans and treatment during the patient’s admission.  
Whereas in research, risk assessments are reduced to numerical 
outcomes, and the qualitative information (which is the main benefit of 
SPJ tools) is lost.  The use of total scores on each of the assessment tools 
and calculated optimal cut-off scores is a noteworthy limitation of the 
empirical project (and the systematic review), as predictive validity based 
purely on the total scores (and generated cut-offs) may not be reflective 
of the level of risk identified by the clinician. 
This brings into question the relevance of investigating the 
predictive accuracy of violence risk assessment tools, and its application 
to clinical practice.  It could be argued it may be more effective to 
evaluate future violence dependent on the management and treatment 
plans implemented in response to the risk assessment, rather than the 
outcome of the risk assessment itself.   
Finally, in terms of limitations for the case study outlined in chaper 
five, which investigated the impact of collaborative risk assessment and 
management psycho-education training on a patient’s motivation to 
engage in treatment, and interventions to manage risk, the study design 
itself was limiting.  The nature of a case study means the results cannot 
be generalised to the wider population, insight was not directly measured 
in relation to collaborative risk assessment and management, and the 
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order in which the risk assessments were introduced in the training 
programme may have impacted the results.   In addition, the use of the 
URICA to measure motivation to change has its limitations because there 
are mixed results in terms of its usefulness (McMurran, Theodosi, & 
Sellen, 2006).    
 
6.2. Implications for practice 
Despite the limitations discussed there are a number of 
implications for practice.  This thesis provides research evidence for the 
inclusion of protective factors in the violence risk assessment and 
management process in forensic mental health services in the NHS.  The 
HCR-20, SAPROF, and START were found to hold good predictive validity 
for absence and presence of violence (dependent on the tool used), and 
the inclusion of protective factors improved predictive validity of the risk 
assessment tools, supporting the continued use of these instruments.   
The SAPROF’s Overall Risk Protection (ORP) index also achieved 
good concurrent, construct, predictive, and discriminative validity, and it 
was significantly more accurate than the HCR-20V3 in predicting 
presence of violence, advocating a measure where violence risk is 
balanced by protective factors.  However, the ORP index is purely a 
research concept, and is a result of substracting the SAPROF total score 
from the HCR-20 total score.  As already discussed, in practice ‘scores’ 
are not used, and as such it is difficult to comprehend how this can be 
applied in practice.  Perhaps though it further supports the proposal of 
considering protective factors in addition to risk factors when using 
clinical judgement to evaluate risk of future violence. 
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It should also be remembered that even the best evaluations of 
violence risk can only explain a moderate amount of variance (Lösel, 
2001).   Although all the evaluated risk assessment tools held good 
predictive validity, the thesis also showed the propensity for the 
assessments to identify non-violent individuals as violent, and vice versa.  
This highlights the instruction that risk assessment tools should be used 
to help guide clinical decision-making, but should not be used to replace 
this process.  
Despite the limitations of applying such research to practice, the 
findings remain important as they add to empirical evidence and 
recommendations for best clinical practice (Cooke & Michie, 2013).  This 
thesis found value in the inclusion of protective factors in violence risk 
assessment, and adds to the empirical basis of what constitutes a 
protective factor.   
With the popularity of strength-based approaches to treatment 
increasing, such as the Good Lives Model (GLM, Ward & Stewart, 2003), 
it could be reasoned strength-based risk assessment will become 
similarly prevalent, and further support the additional use of protection 
focused assessments.  However, criticisms of the GLM approach state 
that it adds nothing to the overarching theory of offender rehabilitation, 
the risk, need, and responsivity model (RNR; Andrews, Bonta, and 
Wormith, 2011), and the same might be said for strength-based risk 
assessment.  Perhaps what is more important though is the perception of 
staff and patients.  If staff who complete risk factor focused assessments 
see their patients as inherently ‘risky’ (Rogers, 2000), and patients who 
view risk factor focused assessments become demotivated (Miller, 2006), 
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surely it would be better for services (in terms of financial cost and 
resources), and patients (in terms of wellbeing) to focus on the 
assessment of positive protective factors. 
The importance of collaborative development of risk assessments 
and management plans is well documented (DoH, 2007a), and the case 
study goes some way to show how emphasis on protective factors can 
assist this process.  However, the case study did not show that a focus on 
protective factors was superior to a focus on risk factors.  Despite this, if 
collaborative risk assessment and management improves patient 
involvement, it could be argued this may enhance patient insight into 
their offending behaviour, and in turn reduce the likelihood of future 
offending.  With the increased involvement of patients in the 
development of their risk assessments and management plans, it may be 
worth considering the accuracy of these collaborative assessments, in 
comparison to those completed without the input of the patient. It could 
be predicted that due to the enhanced knowledge of their personal 
circumstances, the patient’s involvement would improve the assessments 
accuracy, and due to invested interest engagement in management and 
treatment plans would improve (DoH, 2007a).   
The need for an assessment of protective factors in addition to risk 
factors is highlighted, and in practice it is recommended the most 
appropriate tool for the identified need should be used (DoH, 2007a).  
This research would suggest that as the most accurate assessment, the 
SAPROF should be this instrument.  However, the SAPROF was not 
developed to be an assessment used independently of another valid SPJ 
tool, and it could be argued the balance would be tipped in the opposite 
204 
 
 
 
direction if risk factors were discounted.  This is not reflected in the 
results, which support assessment of specifically protective factors to 
evaluate violence risk. 
 
6.3. Suggestions for future research 
Future research should take into account the limitations discussed.  
The systematic review identified a number of confounding factors which 
would be areas of improvement for the quality of future research studies.  
These included study design, follow-up periods, sample size, implication 
of lost participants, selection bias, and measurement bias.  Systematic 
reviews investigating similar constructs should consider the possibility of 
a meta-analysis, and ensure the outcomes selected allow for this to 
occur. 
Research into the reliability and validity of the SAPROF remains in 
its infancy, and as such the empirical research should be replicated in 
other settings and populations with a larger sample size, and a variety of 
follow-up periods.  Due to the study design, the analysis of inter-rater 
reliability was not possible, and the researcher was not blind to the 
assessment information when collecting the follow-up data.  Both these 
factors may have impacted on the results of the research, and future 
investigations may wish to conduct such work blind to clinical 
information.  Research may also wish to consider using a standardised 
tool to explore the outcome measure, to reduce subjective report of 
violent behaviour.  Removal of self-harm as the outcome should be also 
be considered. 
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In practice the final judgement ratings of low, medium, and high 
are utilised by professionals to guide their assessment of level of 
protection (and risk; Douglas et al., 2013).  However, it was not possible 
to investigate this construct as the setting used for research did not 
consistently utilise the final judgement ratings.  Future research may 
wish to consider using the final judgement ratings in addition to the total 
scores. 
Finally, as suggested in the case study in chapter five, it would be 
interesting to investigate whether the contribution of patient’s opinions to 
the risk assessment and management process increases or decreases the 
predictive validity of the risk assessment tool used. 
 
6.4. Conclusions and recommendations 
This thesis aimed to explore and enhance the research evidence 
for the inclusion of protective factors in the violence risk assessment and 
management process in forensic mental health services, in the NHS.  
Value was found in the inclusion of protective factors which improved the 
predictive accuracy of violence risk assessment.  However, strengths-
based collaborative risk assessment did not improve patient motivation to 
a greater extent than traditional risk based methods.  It is recommended 
assessment of protective factors should continue to be considered in the 
risk assessment process in NHS forensic mental health services. 
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Appendix 3.A: Search syntax 
 
EBSCOhost: Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), completed 09th March 2015 
S1. "short term assessment of risk and treatability" Boolean/Phrase  (3) 
S2. "START" Boolean/Phrase (13,440) 
S3. "structured assessment of protective factors" Boolean/Phrase (0) 
S4. "SAPROF" Boolean/Phrase (0) 
S5. (MH "Predictive Validity") OR "predictive validity" OR (MH "Reliability and 
Validity") OR (MH "Instrument Validation") Boolean/Phrase (33,940) 
S6. (MH "Data Analysis, Statistical") OR "statistical validity" Boolean/Phrase 
(39,319) 
S7. "measurement" Boolean/Phrase (86,822) 
S8. (MH "Data Analysis, Statistical") OR "statistical analysis" Boolean/Phrase 
(46,187) 
S9. "statistical measurement" Boolean/Phrase (5) 
S10. (MH "Validity") OR "test validity" Boolean/Phrase (8.292) 
S11. "test reliability" OR (MH "Test-Retest Reliability") Boolean/Phrase (13,098) 
S12. "specificity" OR (MH "Sensitivity and Specificity") Boolean/Phrase (58,914) 
S13. "sensitivity" Boolean/Phrase (93,914) 
S14. "accuracy" Boolean/Phrase (24,892) 
S15. (MH "ROC Curve") OR "area under the curve" Boolean/Phrase (15,533) 
S16. "area under curve" Boolean/Phrase (265) 
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S17. "receiver operating characteristic" Boolean/Phrase (3,497) 
S18. "AUC" Boolean/Phrase (3,950) 
S19. "ROC" Boolean/Phrase (14,452) 
S20. "mentally ill offender*" OR (MH "Mentally Ill Offenders") Boolean/Phrase 
(1,535) 
S21. "mentally disordered offender*" Boolean/Phrase (126) 
S22. "MDO" Boolean/Phrase (10) 
S23. "offender*" Boolean/Phrase (8,491) 
S24. "violent offender*" Boolean/Phrase (93) 
S25. "patient*" Boolean/Phrase (1,007,666) 
S26. "violent patient*" Boolean/Phrase (204) 
S27. (MH "Inpatients") OR "inpatient*" Boolean/Phrase (75,115) 
S28. "violent inpatient*" Boolean/Phrase (3) 
S29. "service user*" Boolean/Phrase (3,599) 
S30. "violent service user*" Boolean/Phrase (1) 
S31. "client*" Boolean/Phrase (32,688) 
S32. "violent client*" Boolean/Phrase (14) 
S33. "forensic psychiatric patient*" Boolean/Phrase (43) 
S34. (MH "Psychiatric Patients") OR "psychiatric patient*" Boolean/Phrase 
(9,498) 
S35. "violent psychiatric patient*" Boolean/Phrase (3) 
S36. (MH "Public Offenders") Boolean/Phrase (2,724) 
S37. "criminal*" Boolean/Phrase (4,455) 
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S38. "prisoner*" OR (MH "Prisoners") Boolean/Phrase (6,403) 
S39. S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR 
S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR 
S38 Boolean/Phrase (1,066,788) 
S40. S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR 
S15 OR S16 OR S17 OR S18 OR S19 Boolean/Phrase (279,362) 
S41. "hcr-20" Boolean/Phrase (30) 
S42. "HCR-20V3" Boolean/Phrase (1) 
S43. "hcr-20 version 3" Boolean/Phrase (0)  
S44. "historical clinical risk management" Boolean/Phrase (3)  
S45. S1 OR S2 OR S3 OR S4 OR S41 OR S42 OR S43 OR S44 Boolean/Phrase 
(13,470) 
S46. S39 AND S40 AND S45 Boolean/Phrase (790) 
S47. S39 AND S40 AND S45 Published Date: 20000101-20151231 (720) 
 
 
OVID: PsycINFO (1806 to March Week 1 2015), completed 09th March 
2015 
1. (short term assessment of risk and treatability).mp. [mp=title, abstract, 
heading word, table of contents, key concepts, original title, tests & measures] 
(56) 
2. START.mp. (23.351) 
3. structured assessment of protective factors.mp. (18) 
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4. SAPROF.mp. (10) 
5. HCR-20.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] (255) 
6. HCR-20V3.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] (4) 
7. HCR-20 version 3.mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures] (6) 
8. historical clinical risk management.mp. [mp=title, abstract, heading word, 
table of contents, key concepts, original title, tests & measures] (159) 
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 (23,693) 
10. predictive validity.mp. or exp Statistical Validity/ (19,638) 
11. statistical validity.mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures] (14,933) 
12. exp Measurement/ or exp "Predictability (Measurement)"/ or exp Statistical 
Measurement/ or measurement.mp. (329,071) 
13. Statistical analysis.mp. or exp Statistical Analysis/ (82,305) 
14. statistical measurement.mp. (1,339) 
15. test validity.mp. or exp Test Validity/ (57,888) 
16. test reliability.mp. or exp Test Reliability/ (40,923) 
17. specificity.mp. (26,964) 
18. sensitivity.mp. (76,935) 
19. accuracy.mp. (53,432) 
20. area under curve.mp. (146) 
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21. area under the curve.mp. (1,609) 
22. AUC.mp. (1,457) 
23. receiver operating characteristic*.mp. (2,971) 
24. ROC.mp. (2,410) 
25. 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 
23 or 24 (492,047) 
26. exp Mentally Ill Offenders/ or mentally ill offender*.mp. (3,350) 
27. mentally disordered offender*.mp. (626) 
28. MDO.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] (40) 
29. offender*.mp. (28,024) 
30. violent offender*.mp. (1,041) 
31. patient*.mp. (568,894) 
32. exp Patient Violence/ or violent patient*.mp. (1,343) 
33. service user*.mp. (38,688) 
34. violent service user*.mp. (2) 
35. client*.mp. (120,404) 
36. exp Clients/ or violent client*.mp. (7,815) 
37. exp Psychiatric Patients/ or forensic psychiatric patient*.mp. (27,461) 
38. psychiatric patient*.mp. (35,473) 
39. violent psychiatric patient*.mp. (35) 
40. exp Criminals/ (16,647) 
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41. criminal*.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures] (45,280) 
42. exp Prisoners/ or prisoner*.mp. (13,853) 
43. exp Hospitalized Patients/ or inpatient*.mp. (46,459) 
44. violent inpatient*.mp.(19) 
45. 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 
39 or 40 or 41 or 42 or 43 or 44 (723,441) 
46. 9 and 25 and 45 (661) 
47. limit 46 to yr="2000 -Current" (582) 
 
 
OVID: Embase (1980 to 2015 Week 10), completed 09th March 2015 
1. (short term assessment of risk and treatability).mp. [mp=title, abstract, 
subject headings, heading word, drug trade name, original title, device 
manufacturer, drug manufacturer, device trade name, keyword] 17 
2. START.mp. (135,588) 
3. structured assessment of protective factors.mp. (3) 
4. SAPROF.mp. (5) 
5. predictive validity.mp. or exp predictive validity/ (9,061) 
6. statistical validity.mp. (303) 
7. statistical analysis.mp. or exp statistical analysis/ (1,407,563) 
8. statistical measurement.mp. (53) 
9. test validity.mp. (450) 
270 
 
 
 
10. exp reliability/ or test reliability.mp. (113,431) 
11. Specificity.mp. or exp "sensitivity and specificity"/ (615,539) 
12. sensitivity.mp. (939,078) 
13. exp accuracy/ or accuracy.mp. (517,009) 
14. area under curve.mp. or exp area under the curve/ (82,519) 
15. area under the curve.mp. (95,994) 
16. AUC.mp. (54,625) 
17. exp receiver operating characteristic/ or exp roc curve/ or receiver operating 
characteristic*.mp. (62,995) 
18. ROC.mp. (43,880) 
19. measurement.mp. or exp measurement/ (1,926,025) 
20. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 
19 (4,478,432) 
21. exp offender/ or mentally ill offender*.mp. or exp mental patient/ (27,307) 
22. mentally disordered offender*.mp. (478) 
23. MDO.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] (196) 
24. offender*.mp. (15,352) 
25. violent offender*.mp. (542) 
26. patient*.mp. or exp patient/ or exp hospital patient/ (6,685,862) 
27. violent patient*.mp. (453) 
28. inpatient*.mp. (98,492) 
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29. violent inpatient*.mp. (10) 
30. service user*.mp. (3,708) 
31. violent service user*.mp. (0) 
32. client*.mp. (50,345) 
33. violent client*.mp. (20) 
34. exp prisoner/ or forensic psychiatric patient*.mp. (11,733) 
35. psychiatric patient*.mp. (13,347) 
36. violent psychiatric patient*.mp. (24) 
37. criminal*.mp. (27,103) 
38. prisoner*.mp. (13,922) 
39. 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 
34 or 35 or 36 or 37 or 38 (6,767,656) 
40. HCR-20.mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword] (160) 
41. HCR-20V3.mp. [mp=title, abstract, subject headings, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword] (0) 
42. HCR-20 version 3.mp. [mp=title, abstract, subject headings, heading word, 
drug trade name, original title, device manufacturer, drug manufacturer, device 
trade name, keyword] (0) 
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43. historical clinical risk management.mp. [mp=title, abstract, subject headings, 
heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] (35) 
44. 1 or 3 or 4 or 40 or 41 or 42 or 43 (178) 
45. 20 and 39 and 44 (106) 
46. limit 45 to yr="2000 -Current" (103) 
 
 
OVID: MEDLINE (R) (1946 to March Week 1 2015), completed 09th March 
2015 
1. (short term assessment of risk and treatability).mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword heading 
word, protocol supplementary concept word, rare disease supplementary concept 
word, unique identifier] (8) 
2. START.mp. (94,375) 
3. structured assessment of protective factors.mp. (1) 
4. SAPROF.mp. (3) 
5. HCR-20.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier] (83) 
6. HCR-20V3.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier] (0) 
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7. HCR-20 version 3.mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary 
concept word, rare disease supplementary concept word, unique identifier] (0) 
8. historical clinical risk management.mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier] (17) 
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 (94,457) 
10. exp "Reproducibility of Results"/ or predictive validity.mp. (286,392) 
11. exp Data Interpretation, Statistical/ or statistical validity.mp. (49,457) 
12. measurement.mp. (417,739) 
13. statistical analysis.mp. (59,164) 
14. statistical measurement.mp. (34) 
15. test reliability.mp. (624) 
16. area under curve.mp. or exp Area Under Curve/ (28,980) 
17. receiver operating characteristic*.mp. (27,780) 
18. ROC.mp. (42,273) 
19. test validity.mp. (279) 
20. exp "Sensitivity and Specificity"/ (431,374) 
21. area under the curve.mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier] (45,260) 
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22. Specificity.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier] (821,105) 
23. sensitivity.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique identifier] (780,218) 
24. accuracy.mp. (209,310) 
25. AUC.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier] (33,177) 
26. 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 
23 or 24 or 25 (2,100,766) 
27. exp Prisoners/ or exp Mentally Ill Persons/ or mentally ill offender*.mp. 
(16,851) 
28. mentally disordered offender*.mp. or exp Criminals/ (1,453) 
29. MDO.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier] (142) 
30. offender*.mp. (7,378) 
31. violent offender*.mp. (352) 
32. patient*.mp. (4,717,092) 
33. violent patient*.mp. (364) 
34. inpatient*.mp. or exp Inpatients/ (6,664) 
275 
 
 
 
35. violent inpatient*.mp. (9) 
36. service user*.mp. (2,307) 
37. violent service user*.mp. (0) 
38. client*.mp. (37,852) 
39. violent client*.mp. (16) 
40. forensic psychiatric patient*.mp. (120) 
41. psychiatric patient*.mp. (10,839) 
42. violent psychiatric patient*.mp. (17) 
43. criminal*.mp. (21,174) 
44. prisoner*.mp. (14,587) 
45. 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 
40 or 41 or 42 or 43 or 44 (4,787,657) 
46. 9 and 26 and 45 (4,560) 
47. limit 46 to yr="2000 -Current" (3,322) 
 
 
ProQuest: Applied Social Sciences Index and Abstracts (ASSIA), 
completed 09th March 2015 
(short term assessment of risk treatability OR START OR structured assessment 
of protective factors OR SAPROF OR HCR-20 OR HCR-20V3 OR HCR-20 version 3 
OR historical clinical risk management)  AND (predictive validity OR statistical 
validity OR measurement OR statistical analysis OR statistical measurement OR 
test validity OR test reliability OR specificity OR sensitivity OR accuracy OR area 
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under curve OR area under the curve OR AUC OR receiver operating 
characteristic* OR ROC)  AND (mentally ill offender* OR mentally disordered 
offender* OR MDO OR offender* OR violent offender* OR patient* OR violent 
patient* OR inpatient* OR violent inpatient* OR service user* OR violent service 
user* OR client* OR violent client* OR forensic psychiatric patient* OR 
psychiatric patient* OR violent psychiatric patient* OR criminal* OR prisoner*) 
(114) 
 
 
Web of Science (Science Citation Index Expanded (SCI-EXPANDED), 
Social Sciences Citation Index (SSCI), Arts and Humanities Citation 
Index (A&HCI), Conference Proceedings Citation Index – Science (CPCI-
S), Conference Proceedings Citation Index – Social Science and 
Humanities (CPCI-SSH)) (Timespan = 2000-2015), completed 11th March 
2015 
1. TS = ("short term assessment of risk and treatability" OR "structured 
assessment of protective factors" OR SAPROF OR "historical clinical risk 
management" OR HCR-20 version 3 OR HCR-20 20 V3 OR HCR-20) 
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2000-
2015 (229) 
2. TI=(START) Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH 
Timespan=2000-2015 (18,809) 
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3. #2 OR #1 Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH 
Timespan=2000-2015 (19,028) 
4. TS = (predictive validity OR statistical validity OR measurement OR statistical 
analysis OR statistical measurement OR test validity OR test reliability OR 
specificity OR sensitivity OR accuracy OR "area under curve" OR "area under the 
curve" OR AUC OR "receiver operating characteristic*" OR ROC) Indexes=SCI-
EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2000-2015 (2,860,663) 
5. TS = ("mentally ill offender*" OR "mentally disordered offender*" OR MDO OR 
offender* OR "violent offender*" OR patient* OR "violent patient*" OR inpatient* 
OR "violent inpatient*" OR "service user*" OR "violent service user*" OR client* 
OR "violent client*" OR "forensic psychiatric patient*" OR "psychiatric patient*" 
OR "violent psychiatric patient*" OR criminal* OR prisoner*) Indexes=SCI-
EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2000-2015 (3,003,071) 
6. #5 AND #4 AND #3 Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-
SSH Timespan=2000-2015 (321) 
 
 
Cochrane Library, completed on 09th March 2015 
1. short term assessment of risk and treatability (3) 
2. START (38,231) 
3. structured assessment of protective factors (279) 
4. SAPROF (0) 
5. HCR-20 (3) 
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6. HCR-20V3 (0) 
7. HCR-20 version 3 (1) 
8. historical clinical risk management (793) 
9. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 (38,898) 
10. predictive validity (1,783) 
11. statistical validity (16,565) 
12. measurement (39,998) 
13. statistical analysis (39,370) 
14. statistical measurement (7,825) 
15. test validity (12,660) 
16. test validity (12,660) 
17. specificity (18,236) 
18. sensitivity (51,166) 
19. accuracy (14,630) 
20. area under curve (15,996) 
21. area under the curve (15,942) 
22. AUC (10,057) 
23. receiver operating characteristic (2,184) 
24. ROC (2,911) 
25. #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or 
#20 or #21 or #22 or #23 or #24 (131,892) 
26. mentally ill offender (8) 
27. mentally disordered offender (9) 
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28. MDO (38) 
29. offender (216) 
30. violent offender (34) 
31. patient (163,520) 
32. violent patient (202) 
33. service user (982) 
34. violent service user (34) 
35. client (1,639) 
36. violent client (42) 
37. forensic psychiatric patient (56) 
38. psychiatric patient (6,118) 
39. violent psychiatric patient (134) 
40. criminal (714) 
41. prisoner (82) 
42. inpatient (6,565) 
43. violent inpatient (86) 
44. #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or 
#36 or #37 or #38 or #39 or #40 or #41 or #42 or #42 (167,531) 
45. #9 and #25 and #44 (6,670) 
46. #1 or #3 or #4 or #5 or #6 or #7 or #8 (1056) 
47. #46 and #25 and #44 (678) 
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Appendix 3.B: Inclusion and exclusion criteria 
 
 INCLUDE CRITERIA EXCLUDE CRITERIA 
P
o
p
u
la
ti
o
n
  Males  
 Adults aged 18 years and 
over  
 Primary diagnosis of mental 
illness or personality 
disorder  
 History of violent behaviour 
(convicted or not) 
 Females only 
 Children and adolescents 
aged 17 years and under 
only 
 Other primary diagnosis, 
e.g. learning disability, or 
no diagnosis only 
 History of sexually violent 
behaviour only 
 No history of violent 
behaviour  
E
x
p
o
s
u
r
e
  Full HCR-20V2 and/or V3 
and/or 
 Full START and/or 
 Full SAPROF  
 No violence risk assessment 
tool 
 Risk assessment tool not 
listed in inclusion criteria 
 Select scales of HCR-
20V2/V3/START/ SAPROF 
only 
O
u
tc
o
m
e
  HCR-20/START and/or 
START 
vulnerabilities/SAPROF: 
 Actual, attempted, 
threatened harm to 
others/self 
 Self-reported/observed 
aggression to others/self 
 Self-reported/observed 
violence to others/self 
 Violent reoffending 
 Violent reconviction 
 Violent recidivism 
 Readmission 
 
 SAPROF/START strengths: 
 Absence of actual, 
attempted, threatened harm 
to others/self 
 Absence of self-
reported/observed 
aggression to others/self 
 Absence of self-
reported/observed violence 
to others/self 
 Absence of violent 
reoffending 
 Absence of violent 
reconviction 
 Absence of violent 
recidivism 
 Absence of readmission 
 HCR-20/START and/or 
START 
vulnerabilities/SAPROF: 
 Self-reported/observed 
sexual aggression only 
 Self-reported/observed 
sexual violence only 
 Sexual reoffending only 
 Sexual reconviction only 
 Sexual recidivism only 
 
 SAPROF/START strengths: 
 Absence of self-
reported/observed sexual 
aggression only 
 Absence of self-
reported/observed sexual 
violence only 
 Absence of sexual 
reoffending only 
 Absence of sexual 
reconviction only 
 Absence of sexual 
recidivism only 
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S
e
tt
in
g
  Any setting  Setting is not considered 
grounds for exclusion 
S
tu
d
y
 
d
e
s
ig
n
  All quantitative study 
designs 
 Quantitative and qualitative 
study designs combined 
 No statistical analysis of 
predictive validity (AUC) 
 Literature review or 
systematic review 
 Meta-analysis 
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Appendix 3.C: Quality Assessment Form: Cohort 
 
A group of participants is identified and followed over time to assess 
specific outcomes.  There may or may not be a concurrent control group. 
 
Reference:  
 
Question Score Comments 
Are the results of the study valid? 
Were the study objectives clear? 
1. Will a cohort design address the objectives? 
- Prospective (Y) 
- Retrospective (P) 
 
 
Selection bias (Was the cohort recruited in an acceptable way?) 
2. Was the cohort clearly defined?   
3. Was the cohort representative of a defined population? 
- multi-site (Y) 
- range of age, ethnicity, diagnosis, violent offence, 
length of stay (P) 
 
 
4. Was everybody included who should have been 
included? 
- all inpatients of a ward/unit (Y) 
- all discharged of a ward/unit (Y) 
- nothing special about the cohort (Y) 
- Subjects excluded, but valid reason reported (P) 
 
 
Measurement bias (exposure, i.e. risk assessment tool) 
5. Was the risk assessment tool clearly stated?   
6. Was the same risk assessment tool used across the 
cohort?  If not, were the subjects allocated using the 
same procedure? 
 
 
7. Were the assessors trained/experienced enough to be 
competent in applying the risk assessment tool (as 
defined in the manual)? 
 
 
8. Was the assessor blind to the outcome?   
9. Was the risk assessment tool completed using 
information gathered from more than one source (as 
directed in the manual)? 
- more than 2 sources (Y) 
- 2 sources (P) 
 
 
10. Was consensus rating used?   
11. Was inter-rater reliability assessed?   
12. Was inter-rater reliability for total risk assessment 
tool: 
- r = 0.80 or above (Y) 
- ICC = .75 or above (Y) 
 
 
13. Was missing information discussed and dealt with 
appropriately (pro-rated as directed in the manual)? 
 
 
Measurement bias (outcome, i.e. actual, attempted, threatened harm to 
others/self) 
14. Was the outcome clearly defined?    
15. Was the outcome data source clearly stated?   
16. Was the outcome measure clearly stated, and did 
it truly reflect the defined outcome? Or, if an objective 
tool was used to measure the outcome, and was it 
reliable and valid?   
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17. Was the same measure of outcome used across the 
sample?  If not, were the subjects allocated using the 
same procedure? 
 
 
18. Was the assessor blind to the exposure?   
19. Was missing information discussed and dealt with 
appropriately? 
 
 
Follow up period 
20. Was the follow up period long enough? 
HCR-20/SAPROF: 
- 12 months or longer (Y) 
- 6 - 12 months (P) 
START: 
- 3 months or longer (Y) 
- 1-2 months (P) 
 
 
21. Were subjects lost during the follow up period 
discussed, and the reasons why recorded? 
 
 
22. Were the implications of lost subjects discussed?   
What are the results? 
23. Were the results clearly reported (AUC values)?   
24. Was predictive validity clearly stated?   
25. Was the base rate of the outcome reported?   
26. If two risk assessment tools are used (e.g. HCR-20 
and SAPROF) is incremental validity discussed (effect of 
combined tools on predictive validity)? 
 
 
27. Was construct validity discussed (correlation between 
risk assessment tool and outcome)? 
 
 
28. Was concurrent validity discussed (correlation 
between risk assessment tool and previously validated 
risk assessment tools)? 
 
 
29. Were confounding factors identified and/or 
discussed? 
 
 
30. Taking into account any bias identified, are the 
results reliable? 
 
 
Will the results help locally? 
31. Can the results be applied to the local population 
(generalizable to all adult male offenders with a diagnosis 
of mental illness or personality disorder, and a history of 
violent behaviour)? 
 
 
32. Do the results of this study fit with other available 
evidence? 
 
 
33. Are the implications of this study for practice 
discussed? 
 
 
Quality score (66) Y = 2, P = 
1, N = 0, U 
= unclear 
No. Unclear 
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Appendix 3.D: Quality Assessment Form:  Case Control 
 
A group of participants with a particular condition are matched for age 
and other characteristics with a control group of participants who do not 
have the condition. 
 
Reference:  
 
Question Score Comments 
Are the results of the study valid? 
Were the study objectives clear? 
1. Will a case control study  address the objectives?   
Selection bias (Were the cases and controls recruited in an acceptable way?) 
2. Were cases clearly defined?   
3. Were controls clearly defined?   
4. Were cases and controls randomly selected from the 
population? 
 
 
5. Were cases reliably assessed as such?   
6. Were controls reliably assessed as such?   
7. Were demographics of cases and controls clear?   
8. Were demographics of cases and controls comparable?   
Measurement bias (exposure, i.e. risk assessment tool) 
9. Was the risk assessment tool clearly stated?   
10. Was the same risk assessment tool used across the 
cases and controls?  If not, were the subjects allocated 
using the same procedure? 
 
 
11. Were the assessors trained/experienced enough to be 
competent in applying the risk assessment tool (as defined 
in the manual)? 
 
 
12. Was the assessor blind to the outcome?   
13. Was the risk assessment tool completed using 
information gathered from more than one source (as 
directed in the manual)? 
- more than 2 sources (Y) 
- 2 sources (P) 
 
 
14. Was consensus rating used?   
15. Was inter-rater reliability assessed?   
16. Was inter-rater reliability for total risk assessment 
tool: 
- r = 0.8 or above (Y) 
- ICC = .75 or above (Y) 
 
 
17. Was missing information discussed and dealt with 
appropriately (pro-rated as directed in the manual)? 
 
 
Measurement bias (outcome, i.e. actual, attempted, threatened harm to 
others/self) 
18. Was the outcome clearly defined?    
19. Was the outcome data source clearly stated?   
20. Was the outcome measure clearly stated, and did 
it truly reflect the defined outcome? Or, if an objective tool 
was used to measure the outcome, and was it reliable and 
valid?   
 
 
21. Was the same measure of outcome used across the 
sample?  If not, were the subjects allocated using the 
same procedure? 
 
 
22. Was the assessor blind to the exposure?   
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23. Was missing information discussed and dealt with 
appropriately? 
 
 
Follow up period 
24. Was the follow up period long enough? 
HCR-20/SAPROF: 
- 12 months or longer (Y) 
- 6 - 12 months (P) 
START: 
- 3 months or longer (Y) 
- 1-2 months (P) 
 
 
25. Were subjects lost during the follow up period 
discussed, and the reasons why recorded? 
 
 
26. Were the implications of lost subjects discussed?   
What are the results? 
27. Were the results clearly reported (AUC values)?   
28. Was predictive validity clearly stated?   
29. Was the base rate of the outcome reported?   
30. If two risk assessment tools are used (e.g. HCR-20 
and SAPROF) is incremental validity discussed (effect of 
combined tools on predictive validity)? 
 
 
31. Was construct validity discussed (correlation between 
risk assessment tool and outcome)? 
 
 
32. Was concurrent validity discussed (correlation between 
risk assessment tool and previously validated risk 
assessment tools)? 
 
 
33. Were confounding factors identified and/or discussed?   
34. Taking into account any bias identified, are the results 
reliable? 
 
 
Will the results help locally? 
35. Can the results be applied to the local population 
(generalizable to all adult male offenders with a diagnosis 
of mental illness or personality disorder, and a history of 
violent behaviour)? 
 
 
36. Do the results of this study fit with other available 
evidence? 
 
 
37. Are the implications of this study for practice 
discussed? 
 
 
Quality score (74) Y = 2, P = 
1, N = 0, U 
= unclear 
No. Unclear 
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Appendix 3.E: Data extraction form 
 
Reference: 
Risk tool 
Additional assessment 
Country 
Setting 
Study design 
Follow-up 
Sample size 
% male 
M age 
% history of violence 
% diagnosis of mental illness 
% diagnosis of personality disorder 
Outcome 
Average base rate 
Inter-rater reliability 
AUC 
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Appendix 3.F: References excluded - stage 1 (137) 
 
Reference Reason for exclusion 
Abou-Sinna and Luebbers (2012) Study design  
Babalola, Gormez, Alwan, Johnstone, and Sampson 
(2014) 
Exposure and study 
design  
Bjorkly, Hartvig, Roaldset, and Singh (2014) Exposure and study 
design 
Buchanan (2014) Study design  
Campbell, French, and Gendreau (2009) Study design  
Castellettic, Rivellini, and Stratico (2014) Study design  
Chakhssi, de Ruiter, and Bernstein (2010) Exposure 
Cote, Crocker, Nicholls, and Seto (2012) Study design 
Crocker, Braithwaite, Laferriere, Gagnon, Venegas, 
and Jenkins (2011) 
Study design 
Davoren, Abidin, Naughton, Gibbons, Nulty, Wright, 
and Kennedy (2013) 
Study design 
Daffern and Howels (2007) Exposure 
Davoren, Abidin, Naughton, Gibbons, Nulty, Wright, 
and Kennedy (2013) 
Study design 
De Ruiter and Nicholls (2011) Study design 
De Vogel and de Ruiter (2004) Study design 
De Vogel, de Ruiter, Bouman, and de Vries Robbé 
(2009a) 
Study design 
De Vogel, de Ruiter, Bouman, and de Vries Robbé 
(2009b) 
Study design 
De Vogel, de Vries Robbé, van Kalmthout, and Place 
(2014) 
Population and exposure 
De Vries Robbé (2014) Population and outcome 
De Vries Robbé and de Vogel (2013) Study design 
De Vries Robbé, de Vogel, and Stam (2012) Study design 
De Vries Robbé, Mann, Maruna, and Thornton (2014) Exposure and study 
design 
Desmarais, Collins, Nicholls, and Brink (2011) Study design 
Desmarais, Sellers, Viljoen, Cruise, Nicholls, and 
Dvoskin (2012) 
Population 
Dietiker, Dittmann, and Graf (2007) Study design 
Dolan and Fullam (2007) Exposure and study 
design 
Douglas (2004) Outcome 
Douglas (2014) Study design 
Douglas (2014) Study design 
Douglas and Belfrage (2014) Study design 
Douglas, Hart, Webster, Belfrage, Guy, and Wilson 
(2014) 
Study design 
Douglas and Kropp (2002) Study design 
Douglas and Ogloff (2003) Study design 
Doyle, Coid, Archer-Power, Dewa, Hunter-
Didrichsen, Stevenson, Wainwright, Kallis, Ullrich, 
and Shaw (2014) 
Exposure and study 
design 
Doyle and Dolan (2002) Exposure and study 
design 
Doyle, Lewis, and Brisbane Study design 
Dunbar, Quinones, and Crevecoeur (2005) Study design 
Edworthy and Khalifa (2014) Exposure and study 
design 
Eidhammer, Selmer, and Bjorkly (2013) Study design 
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Reference Reason for exclusion 
Fazel, Singh, Doll, and Grann (2012) Study design 
Fluttert, Van Meijel, Webster, Nijman, Bartels, and 
Grypdonck (2008) 
Exposure and study 
design 
Gairing, de Tribolet-Hardy, Vohs, and Habermeyer 
(2013) 
Study design 
Gravier and Lustenberger (2005) Exposure and study 
design 
Guy (2010) Study design 
Guy, Douglas, and Hendry (2010) Study design 
Guy, Packer, and Warnken (2012) Study design 
Habermeyer, Gairing, and Lau (2010) Study design 
Hartvig, Alfarnes, Ostberg, Skjonberg, and Moger 
(2006) 
Exposure 
Hartvig, Roaldset, Moger, Ostberg, and Bjorkly 
(2011) 
Exposure 
Heibrun, Holliday, and Brooks (2013) Exposure and study 
design 
Hilterman, Philipse, and de Graaf (2011) Exposure 
Hodgins, Tengstrom, Eriksson, Osterman, 
Kronstrand, Eaves, Hart, Webster, Ross, Levin, 
Levander, Tuninger, Muller-Isberner, Freese, 
Tiiihonen, Kotilainen, Repo-Tiihonen, Vaananen, 
Eronen, Vokkolainen, and Vartiainen (2007) 
Exposure and study 
design 
Horstead (2013) Study design 
Hurducas, Singh, de Ruiter, Petrila (2014) Study design 
Inett, Wright, Roberts, and Sheeran (2014) Population 
Izycky, Braham, Williams, and Hogue (2010) Exposure 
Jung, Ledi, and Daniels (2013) Study design 
Khiroya, Weaver, Maden (2009) Study design 
Kӧtter, von Franqué, Bolzmacher, Eucker, Holsinger, 
and Müller-Isberner (2014) 
Study design 
Kroppan, Nesset, Nonstad, Pederson, Almvik, and 
Palmstierna (2011) 
Study design 
Langton (2007) Exposure and study 
design 
Lewis and Webster (2004) Study design 
Lindsay, Hastings, and Beail (2013) Population, exposure, 
and study design 
Litwack (2001) Study design 
Liu, Yang, Ramsey, Li, and Coid (2011) Study design 
Logan (2014) Study design 
Long and Dolley (2012) Population and exposure 
Lussier, Verdun-Jones, Deslauriers-Varin, Nicholls, 
and Brink (2010) 
Study design 
Lv, Han, and Wang (2013) Study design 
Mann, Matias, and Allen (2014) Exposure and study 
design 
McDermott, Dualan, and Scott (2011) Exposure 
McDougall, Pearson, Willoughby, and Bowles (2013) Exposure and study 
design 
McKeown (2010) Population 
Megargee (2013) Study design 
Mills, Kroner, and Hemmati (2007) Exposure 
Mills, Kroner, and Morgan (2011) Study design 
Mills and Gray (2013) Exposure 
Moons, Boriau, and Ferdinande (2008) Exposure 
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Reference Reason for exclusion 
Muller-Isberner, Webster, and Gretenkord (2007) Study design 
Murphy (2007) Study design 
Nanayakkara, O’Driscoll, and Allnutt (2012) Study design 
Nicholls (2004) Population 
Nieberding, Moore, and Dematatis (2002) Study design 
O’Shea and Dickens (2014) Study design 
O’Shea, Mitchell, Picchioni, and Dickens (2013) Study design 
O’Shea, Picchioni, Mason, Sugarman, and Dickens 
(2014) 
Outcome 
Ogloff and Daffern (2006) Exposure 
Olsson, Strand, Kristiansen, Sjoling, and Asplund 
(2013) 
Study design 
Penney, McMaster, and Wilkie (2014) Study design 
Philipse, Koeter, Van Der Staak, and Van Den Brink 
(2005) 
Exposure and study 
design 
Pillay, Oliver, Butler, and Kennedy (2008) Study design 
Pyott (2005) Study design 
Reimann and Nussbaum (2011) Outcome 
Reynolds, Jones, Davies, Freeth, and Heyman (2014) Study design 
Rice and Harris (2013) Exposure and study 
design 
Rizzo and Smith (2012) Study design 
Roaldset, Olav, Hartvig, Linaker, and Bjorkly (2012) Exposure 
Roberts and Coid (2007) Exposure 
Rogers and Jackson (2005) Population, exposure, 
and study design 
Rossegger, Frank, Elbert, Fries, and Endrass (2010) Population 
Rufino, Boccaccini, and Guy (2011) Study design 
Schaap, Lammers, and de Vogel (2009) Population 
Selenius, Hellstrom, and Belfrage (2011) Study design 
Sevilla-Sanchez, Espaulella, de Andres-Lazaro, 
Torres-Allezpuz, Soldevila-Llagostera, and Codina-
Jane (2012) 
Exposure 
Singh, Desmarais, Hurducas, Arbach-Lucioni, 
Condemarin, Dean, Doyle, Folino, Godoy-Cervera, 
Grann, Ho, Large, Nielsen, Pham, Rebocho, Reeves, 
Rettenberger, de Ruiter, Seewald, and Otto (2014) 
Study design 
Singh, Fazel, Gueorguieva, and Buchanan (2014) Study design 
Singh, Grann, and Fazel (2011) Study design 
Singh, Serper, Reinharth, and Fazel (2011) Study design 
Skipworth (2005) Exposure and study 
design 
Smith, Kelley, Rulseh, Sӧrman, and Edens (2014) Study design 
Smith and White (2007) Study design 
Snowden, Gray, Taylor, and MacCulloch (2007) Exposure 
Stadtland, Hollweg, Kleindienst, Dietl, Reich, and 
Nedopil (2005) 
Population 
Stadtland and Nedopil (2005) Exposure and study 
design 
Stalans, Yarnold, Seng, Olson, and Repp (2004) Exposure 
Stanfill, O’Brien, and Viglione (2014) Study design 
Strand and Belfrage (2001) Population and study 
design 
Stübner, Groβ, and Nedopil (2006) Exposure and study 
design 
Sturup, Monahan, and Kristiansson (2013) Exposure 
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Reference Reason for exclusion 
Tardiff and Hughes (2011) Study design 
Telles, Day, Folino, and Taborda (2009) Study design 
Tengstrom (2001) Exposure 
Tiegreen (2010) Exposure 
Tozdan (2014) Population 
Ullrich and Coid (2011) Exposure and study 
design 
Van Den Berg and de Vogel (2011) Population and study 
design 
Van Den Brink, Hooijschuur, van Os, Savenije, and 
Wiersma (2010) 
Exposure 
Van den Broek and de Vries Robbé (2008) Study design 
Viljoen, Nicholls, Greaves, Ruiter, and Brink (2011) Population 
Vitacco, Erickson, Kurus, and Apple (2012) Study design 
Vladejic, Vladejic, and Popovic (2011) Study design 
Vogel, Ruiter, Bouman, and Robbé (2010) Study design 
Walters, Kroner, DeMatteo, and Locklair (2014) Study design 
Warren, south, Burnette, Rogersm Friend, Bale, and 
Van Patten (2005) 
Population 
Watt, Topping-Morris, Rogersm Doyle, and Mason 
(2003) 
Study design 
Webster, Muller-Isberner, and Fransson (2002) Study design 
Webster, Nicholls, Martin, Desmarais, and Brink Study design 
Yao, Li, Hu, and Cheng (2012) Exposure 
 
 
  
291 
 
 
 
Appendix 3.G: References excluded - stage 2 (34) 
 
Reference Reason for exclusion 
Belfrage, Fransson, and Strand (2000)  Study design 
Blum (2004) Exposure 
Cesniene (2010) Exposure 
Chu, Daffern, and Ogloff (2013) Exposure 
Daffern (2007) Study design 
Dahle (2006) Population 
De Vogel, de Vries Robbé, de Ruiter, and Bouman 
(2011) 
Study design 
De Vries Robbé (2014) Dissertation – studies 
within already included 
De Vries Robbé, de Vogel, Douglas, and Nijman 
(2015) 
Population and outcome 
De Vries Robbée, de Vogel, Koster, and Bogaerts 
(2015) 
Population and outcome 
Desmarais, van Dorn, Telford, Petrila, and Coffey 
(2012) 
Study design 
Douglas, Yeomans, and Boer (2005) Population 
Doyle, Dolan, and McGovern (2002) Exposure 
Garcia-Mansilla, Rosenfeld, and Cruise (2011) Exposure 
Gray, Hill, McGleish, Timmons, MacCulloch, and 
Snowden (2003) 
Exposure 
Green, Griswold, Schreiber, Prentky, and Kunz 
(2014) 
Exposure 
Grevatt, Thomas-Peter, and Hughes (2004) Exposure 
Hill, Rettenberger, Habermann, Berner, Eher, and 
Briken (2012) 
Population 
Ho, Thomson, and Darjee (2009) Exposure 
Jovanovic, Tosevski, Ivkovic, Damjanovic, and Gasic 
(2009) 
Population 
Kroner and Mills (2001) Population 
Lindsay, Hogue, Taylor, Steptoe, Mooney, O’Brien, 
Johnston, and Smith (2008) 
Population 
Mokros, Stadtland, Osterheider, and Nedopil (2010) Exposure 
Morrissey, Beeley, and Milton (2014) Study design 
Nicholls, Ogloff, and Douglas (2004) Exposure 
Nicholls, Petersen, Brink, and Webster (2011) Study design 
Nilsson, Wallinius, Gustavson, Anckarsater, and 
Kerekes (2011) 
Exposure 
O’Shea, Picchioni, McCarthy, Mason, and Dickens 
(2015) 
Population 
Polvi (2001) Exposure 
Stadtland, Hollweg, Kleindienst, Dietl, Reich, and 
Nedopil (2006) 
Population 
Sturup, Karlberg, Fredriksson, Lihoff, and 
Kristiansson (2015) 
Population 
Teo, Holley, Leary, and McNiel (2012) Exposure 
Thomson, Davidson, Brett, Steele, and Darjee 
(2008) 
Exposure 
Yoon, Spehr, and Briken (2011) Population 
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Appendix 3.H: References excluded – not available in timeframe 
(9) 
 
Reference Reason for exclusion 
Claix and Pham (2004) Non English language 
(Dutch) 
Martinaki, Tsopelas, Ploupidis, Douzenis, Tzavara, 
Skapinakis, and Mavreas (2013) 
Non English language 
(Greek) 
Matiasko (2010) Non English Language 
(Czech) 
McNiel, Gregory, Lam, Binder, and Sullivan (2003) Unobtainable despite author 
contact 
Mudde, Nijman, van der Hulst, and van den Bout 
(2011) 
Non English language 
(Dutch) 
Nedopil (2009) Unobtainable despite author 
contact 
Pham, Chevrier, Nioche, Ducro, and Reveillere 
(2005) 
Non English language 
(French) 
Pham, Ducros, Marghem, and Reveillee (2005) Non English language 
(French) 
Sinani, Kola, Cenko, Elezi, Balaj, Saraci, Dervishi, 
and Gjolena (2013) 
Unobtainable and unable to 
contact authors 
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Appendix 3.I: References excluded – in previously completed 
systematic review 
 
De Vogel, de Ruiter, Hildebrand, Bos, and van de Ven (2004) 
De Vogel and de Ruiter (2005) 
De Vogel and de Ruiter (2006) 
Dolan and Khawaja (2004) 
Douglas, Ogloff, and Hart (2003) 
Douglas and Ogloff (2003) 
Dowsett (2005) 
Doyle and Dolan (2006) 
Fujii, Tokioka, Lichton, and Hishinuma (2005) 
Gray, Snowden, MacCulloch, Phillips, Taylor, and MacCulloch (2004) 
Gray, Fitzgerald, Taylor, MacCulloch, and Snowden (2007) 
Gray, Taylor, and Snowden (2008) 
Macpherson and Kevan (2004) 
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Appendix 3.J: Quality assessment (part 1) 
 
 Are the results of the study valid? 
  Selection bias 
Measurement bias 
(exposure) 
Measurement bias 
(outcome) 
Follow-up 
period 
Cohort 1 2 3 4 5 6 7 8 9 
1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
1
7 
1
8 
1
9 
2
0 
2
1 
2
2 
Abidin, et al. (2013)   ?    U     ?      ?  ?   
Arbach-Lucioni, et al. (2011)   ?     U ?       ?       
Barber-Rioja, et al. (2012) ?  ?     U  ?      ?       
Barnard-Croft (2014)       U U ?       ?  U     
Braithwaite et al. (2010)   ? ?    U        ?    ?   
Chu, et al. (2011) ?  ? ?     ? ?    ?  ?  U  ?   
Chu, et al. (2011) ?  ? ?      ?      ?  U  ?   
Coid, et al. (2009)   ? ?    U ?     ?  ?  U  ? ? ? 
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Appendix 3.K: Quality assessment (part 2) 
 
 What are the results? 
Will the results help 
locally? Total unclear 
Quality 
score (66) 
Cohort 23 24 25 26 27 28 29 30 31 32 33 
Abidin, et al. (2013)       ? ? ?   1 45 
Arbach-Lucioni, et al. (2011)       ? ? ?  ? 1 39 
Barber-Rioja, et al. (2012)    ?    ? ?  ? 1 38 
Barnard-Croft (2014)       ? ?  ? ? 3 42 
Braithwaite et al. (2010)       ? ? ?   1 35 
Chu, et al. (2011a)        ? ? ?  1 31 
Chu, et al. (2011b)  ?      ? ?   1 35 
Coid, et al.  (2009)        ?    2 39 
Coid, et al. (2011)       ? ?   ? 3 37 
Coid, et al. (2013)        ?    2 39 
Coupland (2015)        ? ?   0 46 
De Borba Telles, et al. (2012)       ? ? ?   5 35 
De Vogel, et al. (2014)        ? ?  ? 4 29 
de Vries Robbé and de Vogel 
(2011)  
     
 
 ? ?  ? 
6 28 
De Vries Robbé, et al. (2011)         ? ?   1 47 
De Vries Robbé, et al. (2013)    ?    ? ? ?   1 47 
De Vries Robbe, et al. (2014)        ? ?   2 38 
Dernevik, et al. (2002)        ?   ? 3 38 
Desmarais, et al. (2010)       ? ? ?   1 44 
Desmarais, et al. (2012)     ?    ?   0 43 
Dolan and Blattner (2010)       ? ? ?   2 34 
Doyle, et al. (2012)       ? ?    2 44 
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Doyle, et al. (2014)        ?    2 46 
Gray, et al. (2011a)        ?   ? 2 37 
Gray, et al. (2011b)        ? ?  ? 2 37 
Ho, et al. (2013)       ? ? ?   1 42 
Langton, et al. (2009)        ?  ?  2 40 
McDermott, et al. (2008)       ? ? ? U  5 33 
Michel, et al. (2013)       ? ?    2 43 
Neves, et al. (2011)        ? ?   2 44 
Nicholls, et al. (2006)        ? ?   0 41 
Nonstad, et al. (2010)     ?    ?   3 34 
O’Shea, et al. (2014)        ? ?   1 34 
Pedersen, et al. (2010)       ? ? ?   2 35 
Pedersen, et al. (2012)       ? ? ? ?  3 34 
Quinn, et al. (2013)        ? ?   1 38 
Snowden, et al. (2010)        ? ?   1 39 
Strub, et al. (2014)        ?  ?  2 43 
Troquete, et al. (2014)       ? ? ? ?  2 38 
Viljoen (2014)       ? ? ? ?  2 41 
Vojt, et al. (2013)        ? ?   4 33 
Whittington, et al. (2014)        ? ?  ? 3 32 
              
Case Control 27 28 29 30 31 32 33 34 35 36 37 Total unclear 
Quality 
score (74) 
Wilson, et al. (2010)       ? ? ?   1 50 
Wilson, et al. (2013)        ? ?   2 47 
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Appendix 3.L: Data from studies evaluating the predictive validity of specified violence risk assessment tools in 
adults, with a diagnosis of mental illness and/or personality disorder, with a history of violence 
 
Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
HCR-20V2 
 
Abidin, et al. (2013)  6 months .87 harm to others 
.88 harm to self 
.78 
.79 
.96 
.97 
 Arbach-Lucioni, et al. (2011)  1-4 months .75    
   5-8 months .69   
   9-12 months .77   
 Barber-Rioja, et al. (2012) ICC = .90 12 months .71 re-incarceration 
.79 non-compliance 
.61 
.71 
.79 
.86 
 Chu, et al. (2011a)  1 month .78 interpersonal violence 
.68 verbal threat 
.72 any inpatient aggression 
.66 
.45 
.58 
.91 
.91 
.87 
   3 months .75 interpersonal violence 
.69 verbal threat 
.78 any inpatient aggression 
.60 
.46 
.64 
.90 
.92 
.93 
   6 months .62 interpersonal violence 
.62 verbal threat 
.59 any inpatient aggression 
.40 
.35 
.38 
.84 
.88 
.81 
 Coid, et al. (2009) ICC = .98 M 1.97 years .67 violence 
.69 acquisitive 
.67 any 
.63 
.66 
.64 
.71 
.72 
.70 
 Coid, et al. (2011)  ICC = .98 M 1.97 years .67 violence .63 .71 
 Coid, et al. (2013) ICC = .98 M 1.97 years .68 no DSM-IV Axis I disorder 
.64 DSM-IV Axis I disorder 
.62 schizophrenia 
.63 lifetime depression 
.62 
.60 
.52 
.56 
.75 
.69 
.72 
.70 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
.63 drug dependence 
.60 alcohol disorder 
.70 no Axis II disorder 
.58 Axis II disorder (not ASPD) 
.60 ASPD 
.67 low PCL-R score 
.61 medium PCL-R score 
.44 high PCL-R score 
.57 
.53 
.60 
.45 
.56 
.62 
.56 
.30 
.68 
.68 
.79 
.71 
.64 
.72 
.67 
.58 
 Coupland (2015) Pre-
treatment: 
ICC = .93 
 
Post 
treatment: 
ICC = .94 
 
M 9.7 years Community recidivism (convictions): 
Pre-treatment: 
.64 all violent 
.65 nonsexual violent 
.75 any recidivism 
 
Post treatment: 
.72 all violent 
.72 nonsexual violent 
.81 any recidivism 
 
Community recidivism (all charges): 
Pre-treatment: 
.70 all violent 
.70 nonsexual violent 
.75 any recidivism 
 
Post treatment: 
.77 all violent 
.78 nonsexual violent 
 
 
.55 
.55 
.64 
 
 
.63 
.64 
.73 
 
 
 
.59 
.59 
.64 
 
 
.69 
.69 
 
 
.74 
.75 
.86 
 
 
.80 
.81 
.90 
 
 
 
.80 
.81 
.87 
 
 
.86 
.86 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
.83 any recidivism 
 
Institutional recidivism: 
 pre-treatment: 
.55 major 
.49 minor 
.50 violent 
.50 any 
 
Institutional recidivism: 
HCR-20 post treatment: 
.60 major 
.48 minor 
.54 violent 
.51 any 
.75 
 
 
 
.46 
.40 
.39 
.41 
 
 
 
.51 
.39 
.41 
.42 
.91 
 
 
 
.64 
.57 
.61 
.59 
 
 
 
.69 
.56 
.67 
.59 
 De Borba Telles, et al. (2012)  12 months .82 general offending 
.73 violent offending 
  
 de Vries Robbé & de Vogel (2011)   12 months .74 violent 
.85 sexual 
.79 total 
  
 De Vries Robbé, et al. (2011)   12 months .81   
   24 months .77   
   36 months .68   
 De Vries Robbé, et al. (2013)  ICC = .74 12 months .84 .73 .95 
   36 months .73 .62 .84 
   Long term .64 .56 .73 
 De Vries Robbe, et al. (2014)  12 months .79 total 
.80 total male 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
.75 total female 
.68 intramural/supervised 
.85 unsupervised/transmural 
.73 violent 
.89 sexual 
.81 major mental illness 
.77 personality disorder 
.76 high psychopathy 
 Dernevik, et al. (2002)  12 months .68 total incidents 
.68 total incidents excluding self-harm 
.64 weeks in high risk management 
.64 high risk management excluding self-harm 
.78 medium risk management 
.82 medium risk management excluding self-harm 
.71 low risk management 
.52 
.54 
.46 
.46 
.62 
.67 
.51 
.83 
.83 
.82 
.82 
.95 
.98 
.91 
 Desmarais, et al. (2012)  12 months .80 any aggression 
.80 verbal aggression 
.79 physical aggression – objects 
.75 physical aggression – others 
.72 
.72 
.69 
.65 
.88 
.88 
.89 
.86 
 Dolan and Blattner (2010)  12 months .86 .78 .94 
 Doyle, et al. (2012) Historical: 
ICC = .97 
 
Clinical: 
ICC = .85 
 
Risk:  
ICC = .83 
5 months .68 .56 .80 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
 Gray, et al. (2011a) r = .80  Reconviction: 
.69 all mental disorders 
.72 schizophrenia 
.62 personality disorder 
.63 substance use 
.80 mental retardation 
.63 mood disorder 
 
Violent reconviction: 
.73 all mental disorders 
.74 schizophrenia 
.62 personality disorder 
.65 substance use 
.80 mental retardation 
.67 mood disorder 
 
 
 
 Ho, et al. (2013) ICC = .37 6 months .67 verbal violence 
.71 violence against others 
.79 violent conviction 
.70 any violence 
  
   12 months .62 verbal violence 
.68 violence against others 
.79 violent conviction 
.68 any violence 
  
 Langton, et al. (2009)  12 months .58 physical aggression 
.60 damage to property 
.39 
.38 
.78 
.82 
   Full period .68 physical aggression 
.70 damage to property 
.52 
.53 
.84 
.87 
 McDermott, et al. (2008) Risk: 6 months .69 impulsive aggression   
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
ICC = .97  .89 predatory aggression 
.73 psychotic aggression 
   Full period .67 impulsive aggression 
.68 predatory aggression 
.57 psychotic aggression 
  
 Michel, et al. (2013) Historical: 
ICC =.90 
 
Clinical: 
ICC = .78 
 
Risk: 
ICC = .52  
6 months .74 forensic 
.60 general psychiatric 
  
  
   12 months .67 forensic 
.74 general psychiatric 
  
   18 months .70 forensic 
.72 general psychiatric 
  
   24 months .72 forensic 
.72 general psychiatric 
  
 Neves, et al. (2011)  M 12.82 
months 
.84 general recidivism 
.81 violent behaviour 
.82 non-violent recidivism 
.78 
.72 
.74 
.90 
.89 
.90 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
 O’Shea, et al. (2014)  3 months Any aggression: 
.72 full sample 
.70 male 
.78 female 
.74 schizophrenia 
.71 personality disorder 
.69 schizophrenia and personality disorder 
.67 developmental 
.64 organic 
.64 Caucasian 
.66 non-Caucasian 
 
Physical aggression: 
.66 full sample 
.62 male 
.70 female 
.70 schizophrenia 
.66 personality disorder 
.62 schizophrenia and personality disorder 
.56 developmental 
.52 organic 
.55 Caucasian 
.64 non-Caucasian 
 
.66 
.62 
.68 
.66 
.64 
.61 
.57 
.52 
.55 
.52 
 
 
.59 
.54 
.58 
.61 
.58 
.54 
.47 
.39 
.44 
.48 
 
.78 
.77 
.86 
.81 
.79 
.77 
.76 
.76 
.72 
.78 
 
 
.72 
.70 
.81 
.79 
.74 
.69 
.67 
.65 
.66 
.79 
 Pedersen, et al. (2010) ICC = .90 M 6 years .73 any crime 
.74 violent crime 
.63 
.64 
.83 
.83 
 Pedersen, et al. (2012)  M 21 years .70 inpatient aggression 
.66 violent recidivism 
.57 
.52 
.83 
.80 
 Snowden, et al. (2010) ICC = .80 24 months .71 all offenders   
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
.72 white offenders 
.66 black offenders 
 Troquete, et al. (2014)  3 months .59 violent and criminal behaviour 
.58 as defined by START  
.48 
.47 
.69 
.69 
   6 months .61 violent and criminal behaviour 
.58 as defined by START 
.52 
.48 
.70 
.69 
 Viljoen (2014) ICC = .80 
 
6 months .55 violence 
.51 physical aggression 
.61 verbal aggression 
.57 sexual aggression 
.42 serious physical aggression 
.51 serious verbal aggression 
.48 serious sexual aggression 
.56 most serious incident 
.55 most serious violent incident 
.56 most serious sexual incident 
  
   12 months .60 violence 
.56 physical aggression 
.62 verbal aggression 
.59 sexual aggression 
.52 serious physical aggression 
.61 serious verbal aggression 
.47 serious sexual aggression 
.58 most serious incident 
.57 most serious violent incident 
.63 most serious sexual incident 
  
 Vojt, et al. (2013)  M 31 months .50 all incidents 
.54 minor incidents 
.39 
.43 
.61 
.65 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
.86 serious incidents 
.60 any convictions 
.76 
.33 
.96 
.87 
 Wilson, et al. (2013)  ICC = .88 3 months .86 physical aggression or sexually inappropriate 
behaviour 
.73 1.00 
   6 months .81 physical aggression or sexually inappropriate 
behaviour 
.65 .97 
   9 months .74 physical aggression or sexually inappropriate 
behaviour 
.51 .98 
   12 months .81 physical aggression or sexually inappropriate 
behaviour 
.88 any aggression 
.57 
 
.76 
1.00 
 
1.00 
HCR-20V3 De Vogel, et al. (2014) ICC = .83 12 months .77 total score 
.82 summary risk ratings 
  
   24 months .75 total score 
.74 summary risk ratings 
  
   36 months .67 total score 
.71 summary risk ratings 
  
 Doyle, et al. (2014) ICC = .92 6 months .73   
   12 months .70   
 Strub, et al. (2014)  4-6 weeks Presence: 
.78 combined 
.88 patient 
.70 offender 
 
Relevance: 
.71 combined 
.82 patient 
.63 offender 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
   6-8 months Presence: 
.46 combined 
.70 patient 
.79 offender 
 
Relevance: 
.68 combined 
.72 patient 
.64 offender 
  
SAPROF Abidin, et al. (2013) r = .83 
 
6 months .85 harm to others 
.77 harm to self 
.72 
.60 
.97 
.93 
 Barnard-Croft (2014) ICC > .90 6 months .78 MI 
.70 PD 
.71 co-morbid 
.72 
.47 
.57 
.84 
.95 
.84 
   12 months .69 MI 
.76 PD 
.71 co-morbid 
.62 
.55 
.56 
.76 
.96 
.81 
 Coupland (2015) Pre-
treatment: 
ICC = .73 
 
Post 
treatment: 
ICC = .79 
 
At release: 
ICC = .80 
M 9.7 years Community recidivism (convictions): 
Pre-treatment: 
.64 all violent 
.65 nonsexual violent 
.73 any recidivism 
 
Post treatment: 
.65 all violent 
.66 nonsexual violent 
.72 any recidivism 
 
 
 
.55 
.56 
.64 
 
 
.57 
.58 
.63 
 
 
 
.73 
.74 
.83 
 
 
.74 
.75 
.81 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
Pre-release: 
.71 all violent 
.72 nonsexual violent 
.76 any recidivism 
 
Community recidivism (all charges): 
Pre-treatment: 
.70 all violent 
.71 nonsexual violent 
.72 any recidivism 
 
Post treatment: 
.71 all violent 
.72 nonsexual violent 
.72 any recidivism 
 
Pre-release: 
.75 all violent 
.76 nonsexual violent 
.75 any recidivism 
 
Institutional recidivism: 
Pre-treatment: 
.55 major 
.50 minor 
.50 violent 
.52 any 
 
 
.63 
.64 
.67 
 
 
 
.61 
.62 
.62 
 
 
.62 
.64 
.62 
 
 
.67 
.68 
.66 
 
 
 
.46 
.41 
.38 
.43 
 
 
.80 
.80 
.85 
 
 
 
.79 
.80 
.83 
 
 
.80 
.81 
.82 
 
 
.84 
.85 
.85 
 
 
 
.64 
.59 
.62 
.60 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
Institutional recidivism: 
Post treatment: 
.57 major 
.51 minor 
.49 violent 
.53 any 
 
 
.47 
.42 
.37 
.44 
 
 
.66 
.59 
.61 
.61 
 de Vries Robbé & de Vogel (2011)   12 months .77 violent 
.81 sexual 
.78 total 
  
 De Vries Robbé, et al. (2011)  ICC = .88 12 months .85   
   24 months .80   
   36 months .74   
 De Vries Robbé, et al. (2013)  ICC = .79 12 months .85 .74 .96 
   36 months .75 .65 .85 
   Long term .73 .66 .81 
 De Vries Robbe, et al. (2014)  12 months .75 total 
.76 total male 
.71 total female 
.66 intramural/supervised 
.78 unsupervised/transmural 
.72 violent 
.84 sexual 
.79 major mental illness 
.68 personality disorder 
.76 high psychopathy 
  
 Viljoen (2014) ICC = .75 6 months .59 violence 
.52 physical aggression 
.60 verbal aggression 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
.61 sexual aggression 
.50 serious physical aggression 
.62 serious verbal aggression 
.68 serious sexual aggression 
.58 most serious incident 
.52 most serious violent incident 
.70 most serious sexual incident 
   12 months .59 violence 
.54 physical aggression 
.63 verbal aggression 
.60 sexual aggression 
.55 serious physical aggression 
.67 serious verbal aggression 
.58 serious sexual aggression 
.60 most serious incident 
.58 most serious violent incident 
.71 most serious sexual incident 
  
START Abidin, et al. (2013) START/S:  
r = .69 
 
START/V:  
r = .85 
6 months START/S: 
.78 harm to others 
.64 harm to self 
 
START/V: 
.82 harm to others 
.54 harm to self 
 
.65 
.45 
 
 
.71 
.46 
 
.90 
.83 
 
 
.94 
.85 
 Braithwaite et al. (2010)  30 days START/S: 
.65 aggression toward others 
.57 self-harm 
 
 
.56 
.38 
 
 
.74 
.76 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
START/V: 
.66 aggression toward others 
.58 self-harm 
 
.56 
.20 
 
.75 
.75 
 Chu, et al. (2011a)  1 month .75 interpersonal violence 
.79 verbal threat 
.74 any inpatient aggression 
.60 
.59 
.59 
.91 
.99 
.90 
   3 months .79 interpersonal violence 
.82 verbal threat 
.83 any inpatient aggression 
.63 
.51 
.68 
.95 
1.00 
.98 
   6 months .74 interpersonal violence 
.79 verbal threat 
.74 any inpatient aggression 
.54 
.55 
.55 
.95 
1.00 
.93 
 Chu, et al. (2011b)  1 month START/S: 
.71 any inpatient aggression 
.75 interpersonal violence 
.64 verbal threat 
 
START/R: 
.76 any inpatient aggression 
.78 interpersonal violence 
.77 verbal threat 
 
.56 
.59 
.44 
 
 
.59 
.61 
.53 
 
.86 
.91 
.84 
 
 
.93 
.94 
1.00 
 Desmarais, et al. (2010) ICC = .87 12 months Full sample: 
Low/moderate confidence: 
.83 any aggression 
.85 verbal aggression 
.80 physical aggression - objects 
.77 physical aggression – others 
.88 self-harm 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
 
High confidence: 
.70 any aggression 
.68 verbal aggression 
.70 physical aggression – objects 
.65 physical aggression – others 
.57 self-harm 
 
Inpatient subsample: 
Low/moderate confidence: 
.88 any aggression 
.94 verbal aggression 
.90 physical aggression – objects 
.83 physical aggression – others 
.76 self-harm 
 
High confidence: 
.60 any aggression 
.61 verbal aggression 
.56 physical aggression – objects 
.60 physical aggression – others 
.63 self-harm 
 Desmarais, et al. (2012) START/S: 
ICC = .93 
 
START/V: 
ICC = .95 
 
12 months START/S: 
.76 any aggression 
.75 verbal aggression 
.77 physical aggression – objects 
.80 physical aggression – others 
 
 
.68 
.66 
.65 
.70 
 
 
.85 
.84 
.89 
.89 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
START/R: 
ICC = .85 
START/V: 
.79 any aggression 
.79 verbal aggression 
.80 physical aggression – objects 
.77 physical aggression – others 
 
START/R: 
.80 any aggression 
.78 verbal aggression 
.84 physical aggression – objects 
.85 physical aggression – others 
 
.71 
.70 
.71 
.66 
 
 
.72 
.69 
.76 
.77 
 
.87 
.87 
.89 
.88 
 
 
.88 
.86 
.92 
.93 
 Gray, et al. (2011b)  M 114 days START/S: 
.21 violence to others 
.28 verbal aggression 
.61 self-harm 
 
START/V: 
.68 violence to others 
.74 verbal aggression 
.48 self-harm 
 
START/R: 
.65 violence to others 
.70 verbal aggression 
.86 self-harm 
  
 Nicholls, et al. (2006)  12 months Full sample: 
.67 verbal aggression 
.69 physical aggression – objects 
 
.61 
.62 
 
.73 
.76 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
.65 physical aggression – others 
.65 sexually inappropriate 
.66 self-harm 
 
Inpatient sample: 
.72 verbal aggression 
.67 physical aggression – objects 
.70 physical aggression – others 
.92 sexually inappropriate 
.67 self-harm 
.57 
.43 
.54 
 
 
.58 
.52 
.55 
.79 
.50 
.72 
.86 
.77 
 
 
.86 
.83 
.85 
1.05 
.84 
 Nonstad, et al. (2010)  3 months .77 START/S 
.77 START/V 
.64 
.64 
.91 
.91 
 Quinn, et al. (2013)  1 month .14 START/S 
.85 START/V 
.91 START/R 
  
   3 months .32 START/S 
.74 START/V 
.68 START/R 
  
   6 months .43 START/S 
.67 START/V 
.58 START/R 
  
 Troquete, et al. (2014) START/S: 
ICC = .49 
 
START/V: 
ICC = .64 
 
START/R: 
3 months HCR-20-START/V: 
.59 violent and criminal behaviour 
.58 as defined by START 
 
HCR-20-START/V-START/S: 
.59 violent and criminal behaviour 
.58 as defined by START 
 
.49 
.47 
 
 
.49 
.47 
 
.70 
.69 
 
 
.70 
.69 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
ICC = .58  
HCR-20-START/V-START/S-START/R: 
.62 violent and criminal behaviour 
.58 as defined by START 
 
 
.52 
.47 
 
 
.72 
.69 
   6 months HCR-20-START/V: 
.62 violent and criminal behaviour 
.59 as defined by START 
 
HCR-20-START/V-START/S: 
.62 violent and criminal behaviour 
.59 as defined by START 
 
HCR-20-START/V-START/S-START/R: 
.65 violent and criminal behaviour 
.62 as defined by START 
 
.52 
.48 
 
 
.52 
.48 
 
 
.56 
.52 
 
.71 
.69 
 
 
.72 
.69 
 
 
.74 
.72 
 Viljoen (2014) START/S: 
ICC = .44 
 
START/V: 
ICC = .56 
 
START/R: 
ICC = .24 
6 months START/S: 
.63 violence 
.65 physical aggression 
.61 verbal aggression 
.60 sexual aggression 
.62 serious physical aggression 
.62 serious verbal aggression 
.61 serious sexual aggression 
.66 most serious incident 
.66 most serious violent incident 
.57 most serious sexual incident 
 
START/V: 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
.54 violence 
.50 physical aggression 
.59 verbal aggression 
.60 sexual aggression 
.51 serious physical aggression 
.64 serious verbal aggression 
.53 serious sexual aggression 
.55 most serious incident 
.52 most serious violent incident 
.61 most serious sexual incident 
 
START/R: 
.68 violence 
.69 physical aggression 
.68 verbal aggression 
.64 sexual aggression 
.61 serious physical aggression 
.62 serious verbal aggression 
.72 serious sexual aggression 
.67 most serious incident 
.69 most serious violent incident 
.54 most serious sexual incident 
   12 months START/S: 
.60 violence 
.60 physical aggression 
.64 verbal aggression 
.55 sexual aggression 
.64 serious physical aggression 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
.56 serious verbal aggression 
.51 serious sexual aggression 
.62 most serious incident 
.64 most serious violent incident 
.59 most serious sexual incident 
 
START/V: 
.54 violence 
.52 physical aggression 
.61 verbal aggression 
.59 sexual aggression 
.54 serious physical aggression 
.62 serious verbal aggression 
.48 serious sexual aggression 
.56 most serious incident 
.54 most serious violent incident 
.69 most serious sexual incident 
 
START/R: 
.67 violence 
.67 physical aggression 
.63 verbal aggression 
.66 sexual aggression 
.72 serious physical aggression 
.66 serious verbal aggression 
.71 serious sexual aggression 
.69 most serious incident 
.68 most serious violent incident 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
.62 most serious sexual incident 
 Whittington, et al. (2014)  30 days .55 START/S 
.74 START/V 
.47 
.64 
.64 
.84 
   M 231 days .75 START/S 
.69 START/V 
.59 
.52 
.89 
.85 
 Wilson, et al. (2010) START/S: 
ICC = .85 
 
START/V: 
ICC = .90 
3 months .74 START/S 
.70 START/V 
  
   6 months .81 START/S 
.81 START/V 
  
   9 months .71 START/S 
.70 START/V 
  
   12 months .80 START/S 
.73 START/V 
  
 Wilson, et al. (2013)  START/S: 
ICC = .85 
 
START/V: 
ICC = .90 
3 months START/S: 
.74 physical aggression or sexually inappropriate 
behaviour 
 
START/V: 
.73 physical aggression or sexually inappropriate 
behaviour 
 
.52 
 
 
 
.48 
 
.97 
 
 
 
.98 
   6 months START/S: 
.81 physical aggression or sexually inappropriate 
behaviour 
 
START/V: 
 
.64 
 
 
 
 
.99 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
.81 physical aggression or sexually inappropriate 
behaviour 
.65 .98 
   9 months START/S: 
.71 physical aggression or sexually inappropriate 
behaviour 
 
START/V: 
.70 physical aggression or sexually inappropriate 
behaviour 
 
.49 
 
 
 
.44 
 
.93 
 
 
 
.96 
   12 months START/S: 
.80 physical aggression or sexually inappropriate 
behaviour 
.84 any aggression 
 
START/V: 
.73 physical aggression or sexually inappropriate 
behaviour 
.82 any aggression 
 
.54 
 
.70 
 
 
.41 
 
.67 
 
1.00 
 
.98 
 
 
1.00 
 
.98 
HCR-20/ 
SAPROF 
Coupland (2015)  M 9.7 years Community recidivism (convictions): 
Pre-treatment: 
.66 all violent 
.66 nonsexual violent 
.71 any recidivism 
 
Post treatment: 
.65 all violent 
.66 nonsexual violent 
.70 any recidivism 
 
 
.56 
.57 
.59 
 
 
.56 
.57 
.60 
 
 
.75 
.76 
.82 
 
 
.74 
.75 
.81 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
 
Pre-release: 
.65 all violent 
.66 nonsexual violent 
.71 any recidivism 
 
Community recidivism (all charges): 
Pre-treatment: 
.70 all violent 
.71 nonsexual violent 
.70 any recidivism 
 
Post treatment: 
.69 all violent 
.70 nonsexual violent 
.70 any recidivism 
 
Pre-release: 
.72 all violent 
.73 nonsexual violent 
.72 any recidivism 
 
Institutional recidivism: 
Pre-treatment: 
.54 major 
.51 minor 
.54 violent 
.51 any 
 
 
.56 
.57 
.61 
 
 
 
.60 
.61 
.59 
 
 
.60 
.61 
.61 
 
 
.63 
.64 
.61 
 
 
 
.45 
.43 
.42 
.42 
 
 
.74 
.75 
.82 
 
 
 
.80 
.81 
.82 
 
 
.79 
.79 
.81 
 
 
.82 
.82 
.82 
 
 
 
.63 
.60 
.66 
.60 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
 
Institutional recidivism: 
Post treatment: 
.61 major 
.52 minor 
.64 violent 
.54 any 
 
 
 
.52 
.44 
.53 
.45 
 
 
 
.71 
.61 
.76 
.62 
 de Vries Robbé & de Vogel (2011)  ICC = .80 12 months .81 violent 
.84 sexual 
.82 total 
  
 De Vries Robbé, et al. (2011)  12 months .85   
   24 months .81   
   36 months .72   
 De Vries Robbé, et al. (2013)  12 months .87 .76 .97 
   36 months .76 .65 .86 
   Long term .70 .62 .78 
 De Vries Robbe, et al. (2014)  12 months .80 total 
.82 total male 
.74 total female 
.70 intramural/supervised 
.85 unsupervised/transmural 
.76 violent 
.88 sexual 
.82 major mental illness 
.75 personality disorder 
.79 high psychopathy 
  
 Viljoen (2014)  6 months .58 violence 
.53 physical aggression 
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Risk tool Research Inter-rater 
reliability 
Follow-up Predictive validity (AUC)c Lower 
95% CI 
Upper 
95% CI 
.64 verbal aggression 
.62 sexual aggression 
.46 serious physical aggression 
.58 serious verbal aggression 
.56 serious sexual aggression 
.58 most serious incident 
.55 most serious violent incident 
.64 most serious sexual incident 
   12 months .61 violence 
.58 physical aggression 
.67 verbal aggression 
.63 sexual aggression 
.54 serious physical aggression 
.66 serious verbal aggression 
.51 serious sexual aggression 
.61 most serious incident 
.60 most serious violent incident 
.68 most serious sexual incident 
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Appendix 5.A.  URICA 
 
Name:        Date: 
 
Each statement below describes how a person might feel when starting therapy 
or approaching problems in his/her life.  Please indicate the extent to which you 
tend to agree or disagree with each statement.   
 
In each case, make your choice in terms of how you feel right now, not what you 
have felt in the past or would like to feel.   
 
For all the statements that refer to your ‘problem’, answer in terms of problems 
related to mental health or offending behaviour.  The words ‘here’ and ‘this 
place’ refer to the MSU. 
 
Circle the response that best describes how much you agree or disagree with 
each statement. 
 
 
 
 1 2 3 4 5 
1 As far as I am 
concerned, I don’t 
have any 
problems that 
need changing. 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
2 I think I might be 
ready for some 
self-improvement 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
3 I am doing 
something about 
the problems that 
had been 
bothering me 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
4 It might be 
worthwhile to 
work on my 
problem 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
5 It worries me that 
I might slip back 
on a problem I 
have already 
changed, so I am 
here to seek help 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
6 I am not the 
problem one.  It 
doesn’t make 
much sense for 
me to consider 
changing 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
7 I am finally doing 
some work on my 
problem 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
8 I have been 
thinking that I 
might want to 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
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change something 
about myself 
9 I have been 
successful in 
working on my 
problem, but I’m 
not sure I can 
keep up the effort 
on my own 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
10 At times my 
problem is 
difficult, but I am 
working on it 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
11 Trying to change 
is pretty much a 
waste of time for 
me because the 
problem doesn’t 
have anything to 
do with me 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
12 I’m hoping that I 
will be able to 
understand myself 
better 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
13 I guess I have 
faults, but there’s 
nothing that I 
really need to 
change 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
14 I am really 
working hard to 
change 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
15 I have a problem 
and I really think I 
should work on it 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
16 I’m not following 
through with what 
I had already 
changed as well as 
I had hoped, and I 
want to prevent a 
relapse of the 
problem 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
17 Even though I’m 
not always 
successful in 
changing, I am at 
least working on 
my problem 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
18 I thought once I 
had resolved the 
problem I would 
be free of it, but 
sometimes I still 
find myself 
struggling with it 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
19 I wish I had more Strongly Disagree Undecided Agree Strongly 
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ideas on how to 
solve my problems 
disagree Agree 
20 I have started 
working on my 
problem, but I 
would like help 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
21 Maybe someone or 
something will be 
able to help me 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
22 I may need a 
boost right now to 
help me maintain 
the changes I’ve 
already made 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
23 I may be part of 
the problem, but I 
don’t  really think 
I am 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
24 I hope that 
someone will have 
some good advice 
for me 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
25 Anyone can talk 
about changing, 
I’m actually doing 
something about it 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
26 All this talk about 
psychology is 
boring.  Why can’t 
people just forget 
about their 
problems 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
27 I’m struggling to 
prevent myself 
from having a 
relapse of my 
problem 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
28 It is frustrating, 
but I feel I might 
have recurrence of 
a problem I 
thought I had 
resolved 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
29 I have worries, 
but so does the 
next guy 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
30 I am actively 
working on my 
problem 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
31 I would rather 
cope with my 
faults than try to 
change them 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
32 After all I had 
done to try and 
change my 
Strongly 
disagree 
Disagree Undecided Agree 
Strongly 
Agree 
326 
 
 
 
problem every 
now and again it 
comes back to 
haunt me 
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Appendix 5.B.  Pre-training questionnaire 
 
 
 
Risk and Protection Awareness Training 
 
You have been put forward by your multidisciplinary team as someone who may 
be interested in attending this training.  This is an opportunity for you to learn 
more about your risk assessment and risk management plans, and it will help 
you to work collaboratively with your multidisciplinary team in the development 
of these.   
 
The aims of this group are to: 
 Improve your understanding of the risk assessment and risk 
management process. 
 Improve your understanding of how your risk assessment and risk 
management plan relates to your treatment plan. 
 Help you to work collaboratively with the team in developing your risk 
assessment, risk management plan, and treatment plan. 
 Help you to feel more in control of your treatment. 
 Increase your motivation to engage in your treatment plan. 
 
At the end of the group you will have learnt what each of the core risk 
assessments used are, and how they are used to guide your treatment during 
your stay.  You will have been able to see an overview of your own risk 
assessments and you will be in a position to have a discussion with your team 
psychologist about the content of your risk assessment.  You will also be able 
raise discussions with your team if your views differ from theirs. 
 
 10 x 1 hour sessions, with no break. 
 It is important to attend all sessions. 
 If you miss a session due to circumstances beyond your control the 
material you have missed will be covered with you individually. 
 There are no individual sessions in this group but if you feel you need 
extra support please ask. 
 
 
 
Pre Group Interview 
 
Do you think you have completed this group, or a group like it before? 
 
 
 
 
 
Information gathered from this assessment will be used to create a care plan for 
your attendance at the training.  Attendance at this group can help you to 
achieve goals within all sections of the My Shared Pathway.  Do you have any 
personal goals which you think this training could help you with? 
 
 
 
 
 
How do you feel about being asked to take part in this training? 
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Is there anything you think may prevent you from taking part or anything you 
find particularly difficult? 
 
 
 
 
 
Is there anything you would not feel comfortable discussing within a group 
setting? 
 
 
 
 
 
Do you have any worries about the training? 
 
 
 
 
 
Can name any of the risk assessments used here?  
 
 
 
 
 
Has anyone ever discussed with you what is in your risk assessment and risk 
management report? 
 
 
 
 
 
Have you seen copies of your risk assessment and risk management reports? 
 
 
 
 
Can you tell me what a risk factor (or vulnerability) is? 
 
 
 
 
 
Can you tell me what your risk factors are? 
 
 
 
 
 
Can you tell what a protective factor (or strength) is? 
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Can you tell me what your protective factors are? 
 
 
 
 
 
Do you know what the signs are if things aren’t going right for you (your relapse 
indicators)? 
 
 
 
 
 
Can you tell me what you need to do to keep yourself safe or to reduce your risk 
of reoffending in the future? 
 
 
 
 
 
Can you tell me what others need to do to keep you safe or to reduce your risk 
of reoffending in the future? 
 
 
 
 
 
It is hoped that by the end of the group you will have an increased 
understanding about all of these things, and you will also be aware of what your 
team’s views are. 
 
Do you have any questions? 
 
Additional comments…  
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Appendix 5.C. Information sheet and consent form 
 
 
 
 
 
 
 
CASE STUDY INFORMATION SHEET 
 
The value of protective factors 
 
During your admission risk assessments of future violence are completed.  Until 
recently these risk assessments focused purely on risk factors.  In 2014, the 
SAPROF was introduced to assess the presence of protective factors and it is 
incorporated into your risk assessment with the aim of providing a more 
‘balanced’ assessment.   
 
We would like to explore the impact of the introduction of the SAPROF, focusing 
on the following questions: 
 
1) Does the presence of protective factors result in an absence of violence? 
2) Does a risk assessment based on risk and protective factors increase the 
motivation of an individual to change their behaviour more than an 
assessment based purely on risk factors? 
 
We hope that the results of this evaluation will help to further improve the 
process of risk assessment and risk management. 
 
Who is organising this case study? 
Rachel Whitehead (Forensic Psychologist in Training) 
Professor Vincent Egan (University of Nottingham) 
Dr Grant Broad (Clinical and Forensic Psychologist).  
 
The outcomes of the evaluation will form part of Doctoral project for Rachel 
Whitehead who is a postgraduate student at the University of Nottingham. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take 
part you will get this information sheet to keep and you will be asked to sign a 
consent form. If you decide to take part you can still withdraw at any time 
without giving a reason. If you decide to not take part or to withdraw at any 
stage it will not affect your leave, your rights and privileges, or your access to 
medical care. You should also know that taking part in this research will not 
increase your rights or privileges in any way. 
 
What will happen to me if I take part?  
You will firstly be asked to sign a consent form to show you have agreed to take 
part.   A report will be written which describes your past experiences, focusing 
particularly on the presence or absence of risk and protective factors at the time 
of your index offence and how these have changed during your admission.  In 
addition, your engagement in the Risk and Protection Awareness Training will be 
explored, focusing on whether your motivation to change was affected by the 
risk assessments that were shared with you. 
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Basic demographic information about you, such as your age, ethnicity, diagnosis, 
and how long you have been in hospital for will also be collected from your 
hospital records. No information collected about you will have your name on it. 
 
What are the possible benefits from taking part?  
You will receive no direct benefit from taking part in the case study but your 
participation may mean that we can improve services for residents in units like 
this one. Taking part will help us gain a further understanding about the 
importance of considering protective factors in our risk assessments. 
 
Will my taking part in the case study be kept confidential?  
We will make a record in your notes that we have seen you for the purpose of 
this case study. However, any information collected will not be communicated to 
your clinical team or anyone else outside of the research team.  
 
Should you disclose either the intention to harm yourself, harm another 
individual, attempt to escape, disclose a previously unknown offence, or act in 
any way that may result in a breach of security, it would be the duty of the 
researcher to inform your clinical team of such information so that they may 
take appropriate action.   
 
 Any information removed from the hospital will have your name removed and 
will be stored in a secure location at the University. 
 Your consent form (which you signed) will be kept in a locked cabinet 
separate to any other information you have provided. 
 Your identity will not be recorded as part of your data, and will not be 
revealed in any publication that may result from this case study. Data will be 
collected with only a participation number to identify it.  
 The data collected in this study will be used only for the purpose described in 
this form, and will be available only to the research team. 
 Data gathered from this study will be maintained as long as required by 
regulations, which is up to 5 years following the publication of empirical 
articles or communications describing the results of the study. 
 
What if I have a concern about the case study? 
If you wish to complain, or have any concerns about any aspect of the way you 
have been approached or treated in the course of this case study, please contact 
Dr. Lona Lockerbie (Lead for Psychological Practice and Quality) in writing, 
providing a detailed description of your concern.  
 
What will happen to the results of the case study? 
Rachel Whitehead will write up the results of the case study for a Doctorate 
degree research project in Forensic Psychology.  You will get the opportunity to 
read this if you wish.  The results will also be used to make revisions and 
improvements to the risk assessment process. It will not be possible for anyone 
to tell that you took part in the case study. However, we will keep the data, 
without identifying information for up to 5 years after publication.  
 
Thank you for taking the time to hear about this case study. It has important 
implications and so I hope that you will consider taking part in it. 
 
 
Rachel Whitehead 
Forensic Psychologist in Training 
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CONSENT FORM 
(Final version 1.0: 20.05.15) 
 
 
Title of Case Study: The value of protective factors 
 
Name of Researcher: Rachel Whitehead      
   
Name of Participant: Mr O 
 
1. I confirm that I have read and understand the information sheet 
version number 1 dated 20.05.2015 for the above case study and 
have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason, and without 
my care, treatment, and legal rights being affected.  
 
3. I understand that relevant sections of my treatment and 
psychiatric notes, and the data collected in the case study, may be 
looked at by authorised individuals from the University of 
Nottingham, the researcher’s supervisors, and regulatory 
authorities where it is relevant to my taking part in the study. I 
give permission for these individuals to have access to these 
records and to collect, store, analyse, and publish anonymous 
information obtained from my participation in this case study. I 
understand that my personal details will be kept confidential. 
 
4. I understand and agree that data from my engagement with the 
Risk and Protection Awareness Training will be used to write this 
case study, along with information about the presence or absence 
of risk and protective factors at the time of my index offence and 
how these have changed during admission.   
 
5. I am aware my responsible clinician knows that I am taking part in 
this case study; however they will not be informed of the results 
without my consent (unless you disclose anything as described in 
the information sheet). 
 
6. I agree to take part in the above study. 
 
 
 
 
 
 
___________________________________________________ 
Name of Participant   Date          Signature 
 
 
 
 
___________________________________________________   
Name of Researcher   Date          Signature 
 
3 copies: 1 for participant, 1 for the project notes and 1 for the care and treatment notes 
of participant  
